















The biological role and mechanism of 
action of rbpA and carD in Streptomyces 







Thesis submitted for the degree of Doctor of Philosophy 
 
Heena Jagatia  
 
Biochemistry and Biomedicine 
School of Life Sciences 











I hereby declare that this thesis has not been and will not be submitted in whole or in part to another 

























RbpA is unique to and conserved across the Actinobacteria and binds to the group I sigma 
factors to form an RNA polymerase holoenzyme complex resulting in stabilisation of the 
transcription initiation bubble. RbpA is composed of an unstructured N-terminus, RbpA core 
domain (RCD), Basic linker (BL) and Sigma Interaction Domain (SID). The function of the RbpA-
SID is the only well characterised domain. Therefore, this study focuses on elucidating the 
function of the RbpA BL. A recently published full length RbpA crystal structure has shown that 
the RbpA BL is positioned to interact with the extended -10 promoter DNA. Alanine 
substitutions of the RbpA BL did show a small colony phenotype with actinorhodin production 
in S. coelicolor. The equivalent RbpA BL residue substitutions with alanine in M. tuberculosis 
were constructed and tested in vivo. The RbpA BL mutant (3KRA) failed to culture on solid 
media, but no growth inhibitory phenotype was present in liquid media. Additionally, RNA-seq 
of the BL mutant in both organisms revealed major transcriptional changes. Together these 
studies, suggest that the RbpA BL does not contribute to the essential function of RbpA and 
therefore RbpA may fulfil other functions. To explore these alternative functions, we 
constructed mutations in HrdB, a principle sigma factor in S. coelicolor, which prevented RbpA 
binding to RNAP/σHrdB holoenzyme. Chromatin immunoprecipitation techniques followed by 
high-throughput ChIP sequencing of the HrdB mutant revealed that HrdB was capable of co-
localising at all RbpA dependant promoters in the absence of RbpA binding.  
CarD is another essential transcription factor in Mycobacterium spp which binds to RNAP/σA 
holoenzyme. Several structural models have suggested that RbpA and CarD bind to the 
extended -10 promoter DNA from opposite sides of the double helix DNA. Therefore, to 
explore a potential relationship between RbpA and CarD, we constructed a degradation tag 
system to enable co-depletion of RbpA and CarD. This provides a genetic tool for studying 
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Transcription initation is catalysed by RNA polymerase (RNAP) which consists of a core enzyme 
composed of five subunits (αββ’ω) and a dissociable σ-factor which provides promoter 
specificity for transcription of a gene. Much of our understanding of transcription initation 
originates from studies on Escherichia coli RNAP. However, studies have shown that 
Mycobacterium tuberculosis and other Actinobacteria such as Streptomyces coelicolor differ 
from this paradigm in requiring two additional essential transcription factors- RbpA and CarD.  
S. coelicolor, is a Gram-positive bacterium found in the soil environment and was the model 
organism for the Streptomyces spp due to the production of four pigmented antibiotics. M. 
tuberculosis shares the phylum Actinobacteria with S. coelicolor and is an acid-fast bacilli.  
This study focuses on the general transcription factors RbpA and CarD in both S. coelicolor and 
M. tuberculosis. It utilises the non-pathogenic S. coelicolor to investigate the transcriptional 
factors and the influence of these transcriptional factors on growth in M. tuberculosis.  
 
1.1.1 Phylum Actinobacteria 
Actinomycetes are the largest bacterial phylum and is comprised of Gram-positive bacteria 
with a high GC DNA content (Ludwig et al., 2005), ranging from 53.5% in Corynebacterium spp 
to 72% in Streptomyces spp and Frankia spp. Actinobacteria are found in diverse settings such 
as soil, air, human gastrointestinal tract and the marine environment (Barka et al., 2016). 
Morphologies vary widely across the class and strains are well known to produce extracellular 
enzymes and secondary metabolites (Barka et al., 2016; Schrempf, 2001).  
The class of Actinobacteria are the largest within the Actinomycete phylum and includes the 
industrially important Streptomyces genus which is responsible for producing two-thirds of all 
known  naturally derived antibiotics  (Bentley et al., 2002; Papagianni, 2012) and  M. 
tuberculosis that infects a third of the world’s population (Doroghazi & Metcalf, 2013). The 
Actinobacteria phylum also includes the Nocardia spp, Corynebacterium spp, Gordonia spp, 
Rhodococcus spp, Bifidobacterium spp, Leifsonia spp, Gardnerella spp, Frankia spp and 
Thermobifida spp genus’ (Barka et al., 2016). Norcardia spp are usually the causative agents of 
opportunistic infections in immunocompromised patients, usually acquired through inhalation 
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or percutaneous inoculation from the soil (Abreu et al., 2015) and is closely related to 
Rhodococcus which together belong to the family Nocardiaceae. The Corynebacterium genus 
includes the industrially important C. glutamicum, which produces valuable amino acids such 
as glutamate, lysine and tryptophan (Papagianni, 2012) whilst C. diphtheriae and C. ulcerans 
cause infections in humans (Barka et al., 2016). Frankia spp are involved in nitrogen-fixing 
(Ventura et al., 2007) and Gardnerella spp are the causative agent of bacterial vaginosis. Lastly, 
Bifidobacterium spp are non-spore forming, non-filamentous and have probiotic properties 
(Barka et al., 2016). 
 
1.1.2 Streptomyces genus 
The soil dwelling Streptomyces genus belongs to the Streptomycetaceae family and has over 
3,000 species within the genera (Ochi, 1995). Streptomycetaceae are thought to have 
originated around 382 million years ago when the first land plants began to emerge and were 
responsible for the solubilisation of cell walls and surface material of fungi, plants and insects 
and thus were involved in early composting (Chater & Chandra, 2006; McDonald & Curriea, 
2017). Unlike most bacteria, Streptomyces have a complex lifestyle and therefore it was 
difficult to classify in the early days, initially being classified as a fungus (Hopwood, 1999). The 
confusion remains with the name Streptomyces which means ‘twisted or chain-like fungus’. 
This genus is well known for its clinically relevant production of antibiotics and anti-tumour 
compounds (Chater, 2016). S. coelicolor has been the model organism for genetic analysis of 
differentiation and antibiotic production in the Streptomyces genus since the early 1960’s. The 
developmental differentiation of S. coelicolor is defined into two classes by mutants blocking 
distinct stages of the life cycle (Bush et al., 2013). The bld mutants are unable to form aerial 
hyphae and have a characteristic shiny “bald” phenotype, whilst the wild-type colony appears 
“fuzzy” in appearance (Flärdh & Buttner, 2009). The whi mutants can form aerial hyphae but 
unable to produce mature chains of spores, therefore the colonies appear white on solid media 
compared to a grey pigment in a wild-type colony (Flärdh & Buttner, 2009). However, S. 
coelicolor is unable to sporulate in liquid media and therefore Streptomyces venezualae has 




1.1.2.1 Streptomyces coelicolor A3 (2) 
Streptomyces coelicolor A3 (2) is a filamentous soil bacterium and the most well studied 
organism as it best represents the Streptomyces genus (Hopwood, 1999). S. coelicolor can 
produce a rich array of secondary metabolites as a result of the biosynthetic gene clusters 
(Thakur et al., 2013). S. coelicolor produces at least four antibiotics, actinorhodin (ACT) and 
undecylprodigiosins (RED), calcium-dependent antibiotic (CDA) and methylenomycin (MM) 
(Liu et al., 2013; Fig. 1.2).  
 
1.1.2.2 Genome of S. coelicolor 
S. coelicolor has a large linear genome spanning 8,667,507 bp with a 72.12 % GC content which 
is characteristic of the Actinobacteria phylum (Bentley et al., 2002). The coding density of the 
genome centralises genes involved in cell division, DNA replication, transcription, translation 
and amino acid biosynthesis into the core and are located close to the oriC which is also 
centralised in the chromosome (Bentley et al., 2002). The density is slightly decreased in the 
distal regions where accessory genes such as those coding for specialised metabolites and 
hydrolytic exoenzymes are located (Bentley et al., 2002). The S. coelicolor genome has a 
predicted 7,825 genes, giving it high coding potential. In addition to this large genome, are two 
plasmids: 350 kb linear, low copy number SCP1 and the 31.4 kb circular, low copy number SCP2 
(Kinashi & Shimaji-Murayama, 1991). An estimated 965 proteins are associated with 
regulation, including 65 sigma factors which bind to promoter sequences affecting promoter 
specific transcription initiation upon detection of specific stresses (Bentley et al., 2002). The 
genome sequence also revealed a large number of two-component systems, 85 sensor kinases, 
79 response regulators and approximately 53 sensor-regulator pairs.  Large numbers of 
transcriptional regulation proteins have also been identified and belong to some of the most 
widely known families such as TetR, GntR, IcIR and MerR. Aside from transcriptional regulators, 
614 proteins are involved in transport of substrates and metabolites, such as the ABC 
transporters, permeases and ATP binding proteins, and 819 secreted proteins which allow S. 




1.1.2.3 Life cycle of S. coelicolor 
The life cycle of S. coelicolor and other Streptomycetes is unlike most other bacteria, it 
resembles the life cycle of fungi. The dormant spores are activated upon detection of an 
appropriate nutrient source (Fig. 1.1A; Sigle et al., 2015), one or two extensions termed germ 
tubes extend from the spore during germination (Fig. 1.1B; Wolánski et al., 2011). Growth 
occurs at the hyphal tip ends (Flärdh, 2003a) and is unlike other rod-shaped bacteria such as 
E. coli, where cell elongation is orchestrated by the helical cytoskeleton formed by bacterial 
actin homologue MreB and new peptidoglycan material is added to the lateral wall and the cell 
poles remain inert after cell division (Flärdh & Buttner, 2009). Most Actinobacteria do not code 
for mreB genes and yet still grow by extension at the cell poles. However, S. coelicolor does 
contain a complete mre gene cluster, although tip extension in S. coelicolor does not depend 
on Mre proteins (Sigle et al., 2015; Flärdh & Buttner, 2009). Actinobacteria without mreB 
depend on a coiled coil protein called DivIVA. DivIVA is an essential protein in S. coelicolor and 
is implicated in tip extension, branching and cell shape (Fig. 1.1C). Partial depletion of DivIVA 
causes defective hyphal growth and without DivIVA spores are unable to produce germ tubes 
(Flärdh, 2003b; Flärdh & Buttner, 2009).  The hyphae develop into vegetative mycelium which 





Figure 1.1 The life cycle of Streptomyces coelicolor. (A) Dry spore detects nutrient source, (B) 
one or two germ tubes extend from the germinating spore, (C) Germ tube tip extension 
regulated by DivIVA, (D) Formation of vegetative hyphae anchoring the colony into the solid 
agar, (E) Nutrient limitation detected, (F) Aerial hyphae formation, (G) Multi-genomic 
sporogenic cell without septation, then septation by FtsZ, and single chromosomal copies 
packed into each cell by ParAB and Ftsk (H) Spore maturation and increased cell wall thickening 
(Newton & Fahey, 2008) and (I) individual dry spores.  
 
When the hyphae detect nutrient limitations (Fig. 1.1E), they begin to extend as aerial hyphae 
(Fig. 1.1F). The vegetative hyphae are coated in a hydrophobic sheath and a surfactant peptide 
SapB which reduces the surface tension allowing extension in the air and gives S. coelicolor its 
characteristic fuzzy appearance (Flärdh & Buttner, 2009). SapB is a Lantibiotic-like peptide with 
no antibiotic activity, derived from ramS encoded pre-peptide which undergoes extensive 
RamC-mediated post-translational modification (Kodani et al., 2004). SapB is not produced in 
minimal medium, which suggests that S. coelicolor may utilise a SapB-independent pathway. 
The SapB-independent pathway is mediated by the chaplin and rodlin proteins which 
constitute to the hydrophobic sheath (Flärdh & Buttner, 2009). Chaplin proteins are encoded 
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by the chpABCDEH operon and are an assortment of long and short chaplins which self-
assemble into amyloid-like filaments at the water/air interface. ChpA-C encode large chaplins, 
with an amino-terminal Sec signal peptide, two chaplin domains separated by a linker and a C-
terminal which targets the chaplins for covalent attachment to the cell wall of the aerial hyphae 
via a sortase enzyme (Claessen et al., 2003). ChpD-H encode short chaplins and consists of a 
chaplin domain followed by a Sec signal peptide (Claessen et al., 2003). The expression of chp 
genes is activated before aerial hyphae formation and strains that have defective SapB or 
chaplin proteins exhibit a bld phenotype (Capstick et al., 2007). bld mutants are unable to erect 
aerial hyphae and therefore appear ‘bald’ and lack the characteristic fuzzy phenotype (Flärdh 
& Buttner, 2009). Multiple bld genes are important for aerial hyphae production, for example, 
bldA encodes for the only tRNA that translates the rare codon TTA in Streptomyces spp. BldA 
produces mature tRNA during later stationary phase and the presence of the rare TTA codon 
in all four-antibiotic biosynthetic cluster, influences the production of antibiotics (McCormick 
& Flärdh, 2012). Another component of the hydrophobic sheath is the rodlin proteins, RdlA 
and RdlB. Strains lacking RdlA and RdlB still exhibit normal aerial hyphae, however the small 
basketwork filaments are disrupted (Claessen et al., 2003; Fig. 1.1F).  
Next the aerial hyphae undergo a developmental change from aerial hyphae extension to 
septation. During the early aerial hyphal growth, hyphae are long, non-septated and an apical 
compartment known as the sporogenic cell forms. The sporogenic cell synthesises more than 
50 copies of the chromosome, and arrests extension of the hyphae for cell division to take 
place (Claessen et al., 2003). The developmental stage of cell division is controlled by a 
bacterial tubulin homologue, FtsZ which initiates septation. FtsZ assembles into helical 
filaments which are modelled in Z-rings that direct septation and recruitment of other cell-
division associated proteins. S. coelicolor ftsZ null mutants can produce aerial hyphae but are 
unable to produce spores (McCormick et al., 1994). The sporogenic cell can contain more than 
50 copies initially which span the length of the cell, however the DNA then segregates into 
unigenomic spores followed complete partitioning into individual nucleoids (Fig. 1.1G), and this 
process is controlled by ParAB and FtsK.  ParAB encodes for a cytoskeletal ATPase ParA and the 
DNA-binding protein ParB, which binds to parS sites. Disrupted parAB does not display any 
growth phenotype but parB affects chromosomal partitioning in aerial hyphae (Jakimowicz et 
al., 2006). ParB binds to the numerous parS sites located around the oriC which enables ParB 
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to assemble into a large nucleoprotein complex present at foci which are regularly distributed 
in a sporogenic cell ready for the formation of prespore compartments (Jakimowicz et al., 
2006). Ftsk is localised at septa and is important for pumping DNA through the septa, ftsK 
mutants demonstrate irregular DNA content and is a result of chromosomal DNA trapping at 
the septa causing chromosomal rearrangements and deletions (Claessen et al., 2003).  
Lastly, the prespore matures by thickening of the wall and rounding into a spherical spore (Fig. 
1.1G, 1.1H). As S. coelicolor contains the complete mre cluster, MreB regulates the assembly 
of the mature spore wall. S. coelicolor spore mreB null mutants exhibit thin walls and irregular 
shaping (Sigle et al., 2015). The process of sporulation requires many proteins, S. coelicolor 
mutants that fail to produce a grey pigment have been defined as demonstrating a ‘whi’ 
phenotype (Flärdh & Buttner, 2009).   
 
1.1.2.4 Regulation of antibiotic production in S. coelicolor 
The genome sequence of S. coelicolor revealed more than 18 gene clusters associated with 
secondary metabolite production located on the distal arms of the chromosome (Bentley et 
al., 2002). The secondary metabolites include: antibiotics, siderophores, terpenoids, lipids and 
other molecules (Bentley et al., 2002; Čihák et al., 2017). The structures of as many as 30% of 
the secondary metabolites are known, but the remaining 70% are produced by ‘cryptic gene 
clusters’, which are not activated by using common culturing conditions in the laboratory thus 
far.  S. coelicolor has been known to produce four antibiotics which are discussed in further 
detail below. 
Methylenomycin (MM) was the first to be discovered in S. violaceoruber in 1974 (Haneishi et 
al., 1974) and the first known antibiotic identified in S. coelicolor. The mmy gene cluster is 
located on the linear plasmid SCP1 and is regulated by small autoregulatory molecules, 
methylenomycin furans (MMFs) (Liu et al., 2013). The gene cluster is composed of three furan 
biosynthesis genes (mmfL, mmfH and mmfP) and two regulatory genes (mmyR and mmfR) (Liu 
et al., 2013). A proposed theory is that an increase in the MM concentration causes repression 
of the mmyR and the mmfR bidirectional promoter, which causes increased biosynthesis of the 
MMFs relieving the MmyR/MmfR-mediated repression of mmyB which then activates the MM 
biosynthetic genes (Liu et al., 2013).   
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The second antibiotic discovered in S. coelicolor was Actinorhodin (ACT) identified in the late 
1960s and displayed inhibitory action against Gram-positive bacteria (Rudd and Hopwood, 
1979), the mass spectra similarities of the isolated actinorhodin preparation from Brockmann 
(1966), Wright and Hopwood (1976) identified the secondary metabolite in S. coelicolor. ACT 
is very soluble and blue-pigmented at a pH above 7, whilst it appears red and highly insoluble 
below pH 7 (Rudd & Hopwood, 1979). The act gene cluster is activated by the transcription 
factor ActII-ORF4, and its promoter is regulated through multiple pathways (van Wezel & 
McDowall, 2011). For example, AbsA2 is a repressor of ActII-ORF4 and the absA operon 
consists of the sensor kinase, absA1 which phosphorylates the response regulator, absA2 and 
mutants of either of these causes antibiotic production (Sheeler et al., 2005). DasR is another 
repressor of actII-ORF4 belonging to the GntR transcriptional regulatory family, which 
regulates the GlcNAc regulon and GlcNAc causes growth arrest of S. coelicolor in rich media 
(Rigali et al., 2008). Glucosamine-6-phosphate inhibits DasR binding to DNA, dasR mutants 
display increased production of ACT (Rigali et al., 2008; Wiatek-Połatyńska et al., 2015). The 
soil contains very poor concentrations of nitrogen and carbon for S. coelicolor to survive. 
Therefore, the nitrogen and carbon source N-acetylglucosamine (GlcNAc) which forms 
bacterial peptidoglycan and chitin monomers is an appropriate energy source. The 
actinorhodin-associated transcriptional regulator, AtrA is an activator of actII-ORF4 (Uguru et 
al., 2005), AtrA may adjust acetyl-CoA metabolism which provides the precursors for 
polyketides and thus antibiotic production (van Wezel & McDowall, 2011). Disruption of atrA 
causes a reduction in the production of actinorhodin and the levels of mRNA are also reduced, 
suggestive that AtrA is a transcriptional regulator of actII-ORF4 (Uguru et al., 2005).  
Red complex of undecylprodigiosin (RED), is a red pigmented antibiotic and was the third 
antibiotic to be identified in S. coelicolor (Rudd & Hopwood, 1980). Prodiginine production in 
S. coelicolor is controlled by the redA-E biosynthetic gene cluster. The red pathway is regulated 
by the response regulator, RedZ which activates expression of a direct activator of the red 
biosynthesis gene cluster ( Liu et al., 2013). 
Calcium-dependant antibiotic (CDA demonstrates antimicrobial action in the presence of 
calcium and was the fourth antibiotic identified in S. coelicolor (Lakey et al., 1983). The two-
component system, absA1/absA2 is proposed to regulate cdaR which activates the cda 
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biosynthesis gene cluster (Liu et al., 2013).The phosphorylation of absA2 causes repression of 
the cdaR promoter (Sheeler et al., 2005).  
bldA mutants are viable but morphological differentiation and the production of all four, ACT, 
MM, CDA and RED secondary metabolites is inhibited (Chater & Chandra, 2008). The bldA tRNA 
recognises the TTA codon present in actII-ORF4, mmyB, mmfL and redZ. Therefore, bldA 
mutants are unable to produce ACT, RED and MM, whilst substitution to an alternative leucine 
codon restores ACT production (Leskiw et al., 1991). 
Coelimycin P1 is a yellow-pigmented metabolic product of the ‘cryptic cpk gene cluster’ and 
was discovered in a S. coelicolor M1148 strain which lacks the act, red and cda antibiotic 
biosynthetic gene clusters. Mutations in the RNAP, rpoB gene prevents production of ACT, RED 
and CDA and thus reduces the competition for precursors, allowing expression of the cryptic 





Figure 1.2 The structure of the four main compounds and Coelimycin P1 produced by S. 
coelicolor. Actinorhodin (ACT), methylenomycin (MM), undecylprodigiosin (RED), calcium-
dependent antibiotic (CDA) are the four main compounds produced by S. coelicolor whilst 
coelimycin P1 is produced in the absence of the ACT, MM, RED and CDA gene clusters (Gomez-
Escribano et al., 2012; G. Liu et al., 2013). 
 
1.1.3 The Mycobacterium genus 
There are around 170 Mycobacterium spp belonging to the Mycobacterium genus of the 
Mycobacteriaceae family (Forbes, 2017). Most of the mycobacterial genus are found in the 
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environment and have been isolated from soil, water, domestic/wild animals (Falkinham, 
2009). The infectious M. tuberculosis complex includes Mycobacterium tuberculosis, 
Mycobacterium bovis, Mycobacterium africanum, Mycobacterium microti and Mycobacterium 
leprae, and the laboratory mutant strain of M. bovis known as M. bovis var BCG. BCG is also 
the vaccine strain that was first introduced in 1921 and has been used to vaccinate against 
childhood tuberculosis (Dye, 2013). M. canetti and M africanum and are closely related to M. 
tuberculosis and has been isolated from African patients. M. bovis affects humans and cattle, 
whilst M. caprae has been isolated from goats and M. microti has been isolated from rodents 
and immunocompromised patients (Brosch et al., 2002; Forrellad et al., 2013). Mycobacteria 
are classified as a Gram-positive bacterium as they lack an outer membrane, however 
Mycobacteria spp do share some resemblance to Gram-negative bacteria by the failure to 
retain the Gram stain, and contain porins in the outer membrane (Hett & Rubin, 2008). 
Mycobacteria spp are referred to as acid-fast because of the carbol fuchsin dye retention (Hett 
& Rubin, 2008). The presence of a lipid-rich outer membrane is the major determinant of 
Mycobacteria ecology and epidemiology as it contributes to the cells hydrophobicity, 
impermeability (Falkinham, 2009). The impermeability of the cell wall renders Mycobacteria 
spp naturally resistant to many antimicrobial drugs (Hett & Rubin, 2008). 
 
1.1.3.1 Mycobacterium tuberculosis 
M. tuberculosis was first identified by Robert Koch, a German physician and microbiologist in 
1882 and who was subsequently awarded the Physiology or Medicine Nobel prize in 1905 for 
his discovery (nobelprize.org). M. tuberculosis are curved non-motile, acid-fast rods and 
obligate aerobes that are naturally resistant to acid, alkalis and dehydration  with a doubling 
time of 22 h (McMurray, 1996). M. tuberculosis is the causative agent of tuberculosis infection 
that caused 9 million new cases and 1.7 million deaths in 2016 (WHO, 2017). M. tuberculosis 
was classified as one of the top ten causes of deaths worldwide in 2016 (WHO, 2017) and 
infects 1 in 3 people worldwide, of these people 3-5% develop symptomatic tuberculosis 
disease (Smith, 2003). Tuberculosis is not an eradicated disease in the UK despite public 
misconceptions, there are still ~6,000 new cases annually in the UK (Public Health England, 
2017). The complex bacterial cell wall composed of arabinogalactan and mycolic acids has 
proven to be difficult to penetrate therapeutically which goes in some way to explaining 
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continued difficulty in eradicating tuberculosis. Some of the risk factors for tuberculosis 
include, homelessness, HIV, immigration, drug use and close living arrangements (Narasimhan 
et al., 2013). M. tuberculosis is spread through air-borne droplets, usually coughed into the air 
and transmitted person-to-person. Symptoms of tuberculosis include: coughing blood, severe 
tiredness, night sweats and fever. The most common site of infection is the lungs (pulmonary 
disease), however infections may also be seen in the bones/brain/lymph nodes/intestines and 
other extra-pulmonary sites (Pollett et al., 2016).  
 
1.1.3.2 Genome of M. tuberculosis 
The reference M. tuberculosis H37Rv strain was originally isolated from a pulmonary 
tuberculosis patient in 1905. The M. tuberculosis genome was sequenced in 1998, and at the 
time was the largest genome sequenced after E. coli (Cole et al., 1998). The genome is 
4,411,529 bp with 65.6% GC content and 3,924 genes (Cole et al., 1998). The start codon of 
dnaA marks the numbering of genes (Cole et al., 1998). A single ribosomal RNA operon is 
located 1.5 kb from the oriC, which is unusual as most bacteria have more than one rRNA 
operon. The lack of multiple rrn operons may contribute to the slow growth rate of M. 
tuberculosis (Cole et al., 1998). The M. tuberculosis genome encodes more than 214 regulatory 
proteins (Minch et al., 2015; Rustad et al., 2014; Turkarslan et al., 2015), including 13 sigma 
factors, 11 two-component systems and a large family of eukaryotic-like serine/threonine 
protein kinases involved in signal transduction. The genome sequence includes 14 potential 
drug-efflux systems and ABC transporters that may enable the bacilli to be naturally resistant 
to many antibiotics (Cole et al., 1998). There are 250 distinct enzymes involved in fatty acid 
metabolism compared to 50 in E. coli. Lastly, 10% of the genome encodes members of the PE 
and PPE protein families. The names PE and PPE derive from Pro-Glu and Pro-Pro-Glu repeats, 
respectively. The M. tuberculosis H37Rv, reference strain codes for 99 PE genes that are 
scattered throughout the genome and that share a highly conserved N-terminal domain of 90-
100 amino acids in length (Brennan, 2017). PPE proteins also share highly conserved N-terminal 
domains of 180 amino acids in length and PE and PPE genes are often co-transcribed. The 
functions of PE and PPE families remain unclear; however, a large number of the PE/PPE 
proteins display immuno-modulatory properties (Brennan, 2017). 
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1.1.3.3 Pathogenesis of M. tuberculosis infection 
M. tuberculosis is aerosolised when coughed out of the lungs of an infected individual, 
inhalation of the infectious droplets allows entry of the bacilli into the alveolar of the new host. 
Alveolar macrophages phagocytose the bacilli, the host macrophages can  clear the infection. 
Alternatively, the bacilli can reside within the macrophage vacuoles, avoiding phago-lysosomal 
fusion, and begin to divide (Bermudez & Goodman, 1996).  Bacilli antigen detection by 
dendritic cells causes an immune response to be mounted.  There are many mechanisms by 
which M. tuberculosis evades clearance by the host which have not been discussed here. 
Infections result in the formation of an aggregate of immune cells known as a granuloma, the 
hallmark of mycobacterial infection. Bacilli are able to survive within these granulomas and 
persist for decades, the dysregulation of the immune system can then lead to the granuloma 
progression and disease (Guirado & Schlesinger, 2013). 
 
1.1.3.4 Therapeutics  
The standard tuberculosis treatment is a six-month long regimen consisting of four antibiotics 
(WHO, 2015): isoniazid, rifampicin, pyrazinamide and ethambutol for the first two months and 
then isoniazid and rifampicin for the last four months (Vilchèz et al., 2013). This is a long drug 
regimen, which can lead to poor patient compliance or incomplete treatment, all factors 
associated with the rise of antimicrobial resistance. The symptoms of tuberculosis are non-
specific and therefore it can take a long time for diagnosis. Isoniazid (INH) has been used 
clinically since 1952 for the treatment of tuberculosis. Isoniazid is a prodrug that enters by 
passive diffusion into M. tuberculosis (Bardou et al., 1998), this is activated by catalase 
peroxidase, katG in M. tuberculosis. The INH-NAD adduct produces radicals that can react with 
the mycobacterial cell and inhibit mycolic acid synthesis resulting in cell death of replicating M. 
tuberculosis (Winder & Collins, 1970). Pyrazinamide (PZA) was recognised as an anti-
tuberculosis drug in 1952. Pyrazinamide is converted to pyrazinoic acid by nicotinamidase 
encoded by pncA and is only active against bacilli in an acidic pH or within macrophages 
(Scorpio & Zhang, 1996).  Ethambutol was introduced in 1961, it inhibits the cell wall 
arabinogalactan biosynthesis (Deng et al., 1995).  Rifampicin is a potent anti-tuberculosis drug 
that was introduced into the anti-tuberculosis regimen in 1968. Rifampicin inhibits RNA 
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synthesis by binding to the β subunit of DNA-dependent RNA polymerase whilst resistance is 
associated with mutations in rpoB (Campbell et al., 2001; Hartmann et al., 1967). 
 
1.1.4 Overview of bacterial transcription 
Transcription is the process by which information from DNA is transferred to RNA. The first 
phase of transcription is initiation and begins with DNA-dependent RNA polymerase in bacteria 
binding to a promoter DNA sequence found upstream of a gene. Transcription initiation is 
tightly controlled by positive and negative regulators of RNAP (Murakami & Darst, 2003). The 
second phase is elongation which requires disassociation of the σ subunit, and the elongation 
complex progresses along the DNA template whilst producing nascent RNA as well as regular 
pausing to regulate the accuracy of DNA transcription. The final phase is termination, RNAP 
dissociates from the DNA template and releases the nascent RNA. 
 
1.1.4.1 Bacterial DNA-dependent RNA polymerase  
Core RNA polymerase consists of a catalytic core composed of five subunits, two alpha subunits 
(α), one beta subunit (β), one beta prime subunit (β’) and one omega subunit (ω; Fig. 1.3). The 
molecular mass of core RNA polymerase is 400 kDA and is conserved across all cellular 
organisms making it a well-studied structure (Archambault & Friesen, 1993). Electron 
microscopy was used to determine the first three-dimensional structure of RNA polymerase in 
E. coli (Darst et al., 1989). This was followed by the X-ray crystallography of the three-
dimensional Thermus aquaticus RNA polymerase structure, resolution of 3.3 Å (Zhang et al., 
1999). The RNA polymerase structure is 150 Å long, 115 Å tall, and 110 Å wide (Zhang et al., 
1999). The structure suggests a ‘crab claw’ like shape, one arm represents the β subunit, whilst 
the second arm is the β’subunit, with an internal channel running along the length of the ‘claw’ 
(Darst et al., 1989). The β and β’ subunits make extensive interactions with one another, the 
active site carries Mg2+ which exists between the two subunits (Zhang et al., 1999). The α 
subunit is composed of two domains; an amino terminal domain (αNTD) linked by a flexible 
linker to a carboxyl-terminal domain (αCTD). The αNTD is the domain which dimerises whilst 
the αCTD domain only dimerises weakly (Ebright, 1995). The αNTD dimer aids in the assembly 
of β and β’ and is not involved in catalysis (Zhang et al., 1999). The αCTD may contact the 
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upstream promoter DNA, and deletion of αCTD limits transcription at highly expressed 
ribosomal rrnB promoters (Ross et al., 1993). The flexible linker may allow the αCTD to contact 
the upstream promoter element of -35. The ω subunit encoded by rpoZ, interacts exclusively 
with the C-terminal tail of β’ subunit, and may play a chaperone like function in the assembly 
of the final RNA polymerase structure (Mukherjee & Chatterji, 1997). The RNA polymerase 
inhibitory site for rifampicin binding is roughly 20 Å from the Mg2+ chelating active site (Zhang 
et al., 1999), -2 to -3 initiating nucleotides of the template DNA covalently attach to rifampicin 
(Mustaev et al., 1994). The structure of RNA polymerase consists of a sixth dissociable, σ-factor. 
The RNAP/ σ-factor complex is referred to as holoenzyme (Fig. 1.3). The sigma factor provides 
promoter specific transcription initiation of specific genes. 
 
Figure 1.2 Crystal structure of Mycobacterium smegmatis transcription initiation complex. 
Structure of M. smegmatis RNA polymerase transcription initiation complex with σA. The β 
subunit in mint, β’ in orange, α1 in pink, α2 in cyan, ω in blue and σA in green. The structure 
was downloaded from RCSB PDB, accession number 5TW1 and visualised with PyMOL (version 




1.1.5 Structure and function of primary sigma factors 
Sigma factors were first discovered by Burgess and Dunn, who described that σ factors 
enhanced RNA synthesis dependant on the DNA template (Burgess et al., 1969). Most bacterial 
σ factors that fall into one of two main families exemplified by the model of σ factors in E. coli: 
σ70 and σ54. The σ54 family are phylogenetically distinct and respond to environmental stimuli 
(Paget & Helmann., 2003; Wigneshweraraj et al., 2008), and are not considered further here. 
The σ70 family of sigma factors can be divided into 4 distinct groups (Fig. 1.4). Domains σ2, σ3, 
and σ4 interact with the -10 (TATAAT), extended -10 and -35 (TTGACA) respectively, and RNAP 
(Paget, 2015). 
Group I are primary sigma factors which direct the transcription of essential genes associated 
with growth and have four domains, σ1.1, σ2, σ3, σ4 joined by flexible linkers. Most bacteria 
encode for at least one group I sigma factor (Murakami & Darst, 2003).  
 
Figure 1.3 The domain organisation for the four sigma factor groups. The four sigma sub-groups 
of σ70 family. The σ group I includes domain σ1.1 in fuchsia, σ2 in blue/purple and red, σ3 in 
grey and σ4 in green. The σ group II is structurally the same as group I. The σ group III does not 
include domain σ1.1. Group IV does not include domains σ3 and σ1.1. (This figure is modified 
from  Paget., 2015). 
 
Group II of the σ70 family are structurally similar to group I but lack domain σ1.1 (Fig. 1.4) and 
are not required for the transcription of essential growth-related genes (Paget, 2015). This 
group is known to be capable of recognising the same promoter -10 and -35 elements as the 
group I sigma factors (Lonetto et al., 1992). The well characterised σs, also known as KatF or 
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σ38 in E. coli is classified as a group II sigma factor. During the transition of E. coli from 
exponential to stationary phase, σs complexes with RNA polymerase and activates the 
transcription at the promoters of >500 genes or operons in response to a wide range of 
stresses, including nutrient limitation, pH alterations, osmotic changes and DNA damage 
(Lange & Hengge-Aronis, 1994). Almost 140 of the σs-dependant genes share the promoter 
sequence motif 5’-TCTATACTTAA-3’ (Weber et al., 2005) and holoenzyme composed of σs or 
σ70 can activate the same promoters in vitro (Kusano et al., 1996), subtle changes in the 
extended -10 regions can sway promoter preference to either holoenzyme with σs or σ70.  
Group III of the σ70 family are structurally and functionally diverse from group I and II sigma 
factors and usually contains sigma domain, σ2, σ3 and σ4 but lacks domain σ1.1 (Fig. 1.4). Group 
III sigma factors are implicated in a general stress response, sporulation, heat shock and 
flagellar biosynthesis (Paget & Helmann, 2003; Wösten, 1998).  
Group IV only consist of the structural sigma domains σ2 and σ4, and lack domains σ1.1, σ1.2, σ3 
(Fig. 1.4). This group is referred to as the Extra-Cytoplasmic Factors (ECF) and are involved in 
sensing and responding to signals generated outside of the cell or in the membrane. The lack 
of σ3 makes the ECFs more dependent on the σ4 to bind to the -35-promoter element 
(Campagne et al., 2014). In addition to this, the group I σ2 domain diverges from group IV σ2 in 
the σ2.3 domain which means that the recognition of the -10 element is slightly different in 
group IV (Campagne et al., 2014). An example of a group IV sigma factor in E. coli is σE, 
associated with responding to cell envelope stress. The σ2 domain of σE binds to the non-
template ssDNA (single stranded DNA) at the -10 promoter element and has specificity for the 
motif, 5’-G-12 TCNNN-7 -3’. Unlike group I sigma factors which require A-11 and T-7 at the -10 
promoter element to flip out of the dsDNA, the sigma factor, σE2.3 only requires C-10 to be 
flipped out (Campagne et al., 2014).   
 
1.1.5.1 The σ1.1 region 
The N-terminal domain of σ70 can be divided into sub-domains 1.1 and 1.2 (Wilson & 
Dombroski, 1997). The σ1.1 domain is made up of three-helix bundles, connected to σ1.2 domain 
by a flexible linker. The σ1.1 domain is highly conserved across only group I sigma factors and 
does not contact DNA but assists in the conversion of RNA polymerase closed complex (RPc) 
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to RNA polymerase open complex (RPo; Wilson & Dombroski, 1997). The σ1.1 and a spacer 
found immediately downstream of domain 1 play an autoinhibitory function, by preventing 
DNA binding to free σ (Dombroski et al., 1993). In an autoinhibited state, σ1.1 may crosslink to 
σ4, thus preventing binding of σ4 to the -35-promoter sequence (Schwartz et al., 2008).  The 
σ1.2 domain is conserved across primary and alternative sigma factors (Dombroski et al., 1993), 
and is important for the overall function of σ70. 
 
1.1.5.2 The σ2 domain 
The binding of the -10 promoter sequence to σ2, causes a 90° bend in the downstream DNA 
backbone, which makes contact with the active site cleft of RNA polymerase (Feklistov, 2013). 
The active site cleft can only accommodate ssDNA and therefore unwinds the dsDNA (Zhang 
et al., 2012). The σ2 domain binds to the single stranded -10 consensus (T-12 A-11T-10 A-9 A-8 T-7) 
promoter element and stabilises the separated DNA strands (Feklistov & Darst., 2011; Fig. 1.5), 
this domain is not essential during exponential growth. The σ2.3 domain recognises the bases 
of the ssDNA non-template DNA at the -10 element. The highly conserved DNA bases of the 
non-template ssDNA at A-11 and T-7 flip out of the double helix stack and buries itself in a 
hydrophobic pocket of σ2 (Fig. 1.5; Marr & Roberts, 1997). This event causes a process of 
isomerisation from the RPc to RPo, whereby ~13 bp upstream of the -10 promoter region is 
melted to expose the template DNA (Gries et al., 2010). The σ2.4 region recognises dsDNA 
upstream of the -10 element and contacts the base at position -12, which supports the flipping 
out of A-11. In E. coli, the W-433 residue which lies within σ2 is implicated in the stabilisation of 





Figure 1.4. Sliced view of the σ2 domain binding to promoter DNA in Thermus aquaticus. This is 
a magnified view of RNA polymerase holoenzyme in T. aquaticus. The σ2 domain is bound to 
the -10 promoter double helix in blue which represents RPc, whilst the yellow bases A-11 and T-
7 of the non-template strand in yellow represents RPo. This figure was modified with 
permission from Feklistov and Darst, 2011 (Elsevier).  
 
1.1.5.3 The σ3 domain 
The σ3 domain is composed of three α helices, sub-domain σ3.0 is responsible for binding to the 
major groove of the extended -10 promoter element and the stabilisation of the RPo allowing 
the DNA to bend towards the σ3 domain (Zuo & Steitz, 2015). The σ3.2 loop lies within the active 
site of RNA polymerase and it has been suggested that the clashing between the growing 
nascent RNA strand and σ3.2 loop, causes abortive initial RNA synthesis (Samanta & Martin, 
2013). The σ3.2 loop is not believed to make direct contact with the initiating nucleotides but 
rather stimulates the binding of the initiating nucleotides, σ3.2 mutants are still able to stabilise 
small RNAs but the production of long transcripts prevents promoter escape (Kulbachinskiy & 




1.1.5.4 The σ4 domain 
σ4.2 region is composed of a helix-turn-helix (HTH) which recognises the -35 promoter element, 
TTGACA, and inserts into the non-template strand and major groove of DNA, causing 30° DNA 
bending (Zuo & Steitz, 2015). Promoter escape involves the release of the σ4 domain from the 
β flap which destabilises interactions with -35 element (Murakami & Darst, 2003). 
 
1.1.5.5 Structure and function of anti-sigma factors 
The activity of some alternative sigma factors is partially controlled by anti-σ factors and 
adaptor proteins (Treviño-Quintanilla et al., 2013). Anti-sigma factors often consist of a σ-
binding domain and sensor domain that responds to signals received from inside or outside of 
the cell (Paget, 2015). In general, anti-σ factors prevent σ factors from associating with RNAP 
by inserting between the σ2 and σ4 domains and/or wrapping around the compact σ2 and σ4 
domains. The anti- σ factor is released from the σ factor by regulated proteolysis, partner-
switching or conformational change brought about by direct sensing (Paget, 2015). An example 
of regulated proteolysis is of σE/RseA in E. coli, which responds to outer membrane 
dysfunction. An accumulation of unfolded outer membrane proteins in the periplasm causes 
the C-terminus of RseA to undergo cleavage mediated by a periplasmic protease, DegS (Flynn 
et al., 2004).  This proteolysis activates another protease, RseP which cleaves the cytoplasmic 
RseA domain and generates a ClpXP recognition tag which is degraded and subsequently 
releases σE (Flynn et al., 2004).  
Some anti- σ factors can directly sense signals and respond by undergoing a conformational 
change to release the σ factor. An example of this is the σR /RsrA system in S. coelicolor. RsrA 
lacks membrane spanning or periplasmic domains but is cysteine-rich whilst σR is a global 
regulator of gene expression which provides protective mechanisms to cope with disulphide 
stress (Paget et al., 2001). Oxidative stress causes disulphide bridges to form in cytoplasmic 
proteins. σR mutants have an increased sensitivity to diamide and  the induction of diamide 
stress at the hyphal structures of S. coelicolor leads to activation of σR which initiates the 
transcription of the trxBA operon, this produces thioredoxin, thioredoxin reductase and more 
σR (Paget et al., 1998). It is the induction of diamide stress which causes the formation of 
intramolecular disulphide bonds in RsrA leading to conformational changes and the release of 
22 
 
σR, resulting in binding to the trxBA operon (Paget et al., 2001). This activates the thioredoxin 
pathway which reduces RsrA back to a state it can hold σR inactive (Paget et al., 2001).  
An example of partner switching can be found in B. subtilis with σB, anti- σ factor (RsbW), anti-
anti-σ factor (RsbV) and a phosphatase complex (RsbTU or RsbQP; Paget, 2015). RsbTU and 
RsbQP consist of a phosphatase component (RsbU/ RsbP) and cognate activator (RsbT/ RsbQ) 
which recognise the environmental stresses. σB is held in an inactive state by RsbW during 
unstressed conditions. During a general stress response, RsbTU or RsbQP dephosphorylates 
RsbV, RsbV is free to bind to RsbW, subsequently liberating σB (Paget, 2015). 
 
1.1.5.6 Streptomyces coelicolor sigma factors 
Before the S. coelicolor genome sequencing, RNA polymerase was found to exist in multiple 
forms in S. coelicolor, holoenzymes composed of σ35, σ28 and σ49 (Buttner et al., 1988; 
Westpheling et al., 1985). A probe designed with 10 amino acids from the σA, rpoD in Bacillus 
subtilis were used to identify four sigma factors, σHrdA, σHrdB, σHrdC and σHrdD in S. coelicolor 
(Buttner et al., 1990). The hrdA, hrdC and hrdD mutants do not display any phenotype whilst 
the failed attempts to disrupt hrdB indicated its essential function as a primary sigma factor in 
S. coelicolor  (Buttner et al., 1990). Later, the genome sequence of S. coelicolor revealed 65 σ 
factors, 45 of which belong to the ECF family (Bentley et al., 2002).  
 
1.1.5.7 Mycobacterium tuberculosis sigma factors 
The M. tuberculosis genome encodes 13 σ factors which all belong to the σ70 family (Cole et 
al., 1998; Manganelli et al., 2004). σA, σB and σF belong to groups I, II and III respectively whilst 
the remaining 10 σ factors belong to group IV (Cole et al., 1998). The M. tuberculosis group I 
sigma factor, σA is constitutively expressed and mRNA expression remains the same despite a 
multitude of stresses (Manganelli et al., 1999). The expression of sigA may increase upon 
phagocytosis by macrophages in clinical M. tuberculosis strains (Rodrigue et al., 2006; Wu et 
al., 2004).  σB belongs to the group II sigma factors, and shares homology with conserved 
regions 2, 3 and 4 of group I (Rodrigue et al., 2006). sigB is located 3 kb downstream of sigA  
and is involved in a stress response, ΔsigB is completely viable in human macrophages 
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(Doukhan et al., 1995). σF belongs to group III and is induced in response to many stresses 
including, antibiotics, cold shock, oxidative stress, nutrient limitation and during stationary 
phase.   
 
1.1.6 Transcription initiation 
The dissociable sigma subunit binds to RNA polymerase and forms a holoenzyme which 
dictates specific promoter recognition. The σ2.4 region binds to the dsDNA at position -12 of 
the DNA fork junction. The σ4.2 region recognises position -35 of the non-template DNA, causing 
the DNA to bend 30° (Zuo & Steitz, 2015; Fig. 1.6A).  The promoter DNA lies across one face of 
the holoenzyme and outside of the RNAP active-site channel (Murakami & Darst, 2003). The 
σ1.1 region may play an important role in the RPo complex formation by stabilising promoter-
complexes (Miropolskaya et al., 2012). The positioning of the σ3.2 region in the RNA exit channel 
suggests that it may be involved in promoter clearance by RNAP, mutations in σ3.2 are unable 
to perform abortive transcription or promoter escape (Pupov et al., 2014). During the 
intermediary step, the melted promoter DNA is temporarily stabilised whilst also introducing 
flexibility into the DNA (Murakami & Darst, 2003), ready for entry into the active site channel 
(Fig. 1.6B). The RNAP-promoter open complex, RPo, occurs when upstream DNA bends around 
RNAP at positions -35 (36°) and -25 (8°). At position -16, the DNA makes another sharp turn at 
37° towards RNAP (the DNA melting extends past the transcriptional start site) (Murakami et 
al., 2002). The non-template ssDNA at the -10 element interacts with the exposed aromatic 
residues of σ2.3 domain. Positions -2 to +4 are held in a groove between β1 and β2 and the 
ssDNA is directed into the positively charged active site of RNAP by bending 90°, where it pairs 
up with the initiating nucleotides (Murakami & Darst, 2003) The RNA synthesis result is an RNA 
molecule, 12 nucleotides long which fills the RNA-DNA hybrid and the upstream RNA exist 
channel, this displaces the σ3.2 loop and ends abortive initiation (Fig. 1.6D). The displacement 
of σ3.2 causes the destabilisation of interactions between the σ2 and σ4 at positions -10 and -35, 
respectively (Fig. 1.6E). RNAP can then escape transcription initiation into elongation (Fig. 1.6F; 






Figure 1.5 The steps of transcription initiation. (A)  Recognition of promoter -35 and -10 DNA 
elements and formation of the initial RPc. (B), (C) Intermediate and start of RPo and abortive 
initiation. (D) End of abortive initiation. (E) The σ dissociates and RNAP undergoes promoter 
clearance. (F) Transcription elongation complex. Figure received permission from Murakami 
and Darst, 2003 (Elsevier).σ (orange), non-template DNA (light green), template DNA (dark 
green), RNAP (subunits in grey and β flap in blue and Mg2+ in the active site is yellow) together 
form the transcription initiation complex. 
 
Transcription initiation is usually the target for many transcription factors that act as activators 
or repressors of transcription. Some examples of these include: CRP and bacteriophage λ 
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repressors (Lloyd et al., 2001). The cyclic AMP receptor protein, CRP binds to the C-terminal 
domain of the RNAP α subunit and modulates the expression of >100s of genes in response to 
changes in cAMP concentrations (Savery et al., 1998). The CRP binding sites are usually 
upstream of the -35 promoter element or overlapping the -35 sequence (Savery et al., 1998). 
Some activators interact with the RNAP σ subunit, others alter the promoter conformation 
(Lloyd et al., 2001). Repressors tend to bind to promoter DNA or close to the transcriptional 
start site to prevent RNAP binding. The lac operon includes interactions between RNAP, 
repressor and operator and is good example of repressor activity. In the absence of the 
inducer, the lac repressor binds to the operator and prevents transcription of the lac operon 
(Becker et al., 2013; Schmitz & Galas, 1979)   
 
1.1.6.1 Transcription elongation 
The elongation complex is formed directly after RNAP promoter escape, usually with a 
significant conformational change as a result of the loss of σ (Vassylyev et al., 2007). The largest 
conformational change occurs at the β and β’ RNAP domains (crab-claw-like structure) which 
bind to σ in the RNAP holoenzyme (Vassylyev et al., 2007). The downstream DNA enters RNAP 
and approximately 9 nt of RNA at the growing end are annealed to the template DNA strand, 
forming a RNA/DNA hybrid (Roberts et al., 2008).  
RNAP can move backwards along the DNA template, also referred to as ‘backtracking’, by 
reversing the steps of the nascent RNA assembly back towards the RNAP secondary channel 
(Borukhov et al., 2005). Backtracking is a response to errors that occur during transcription 
such as mis-incorporation or mispairing of the RNA/DNA hybrid (Roberts et al., 2008). The Gre 
proteins, GreA and GreB in E. coli stimulate hydrolysis of the backtracked elongation complex, 
by cleaving the extruding portion of 3’ RNA so that transcription elongation can resume 
(Borukhov et al., 2005). GreA prevents transcription arrest whilst GreB can reactivate pre-
arrested transcription complexes (Borukhov et al., 2005). 
The transcription repair coupling factor, Mfd reactivates or recycles stalled or arrested RNAPs, 
through reverse backtracking, allowing RNAP to re-engage with the 3’ RNA. A proposed model 
suggests, Mfd binds to the stalled RNAP and causes disassociation of RNAP and RNA from the 
template DNA. Mfd remains slightly attached to RNAP, and complexes with UvrA-UvrB, two 
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damage recognition proteins, which result in the complete release of Mfd/RNAP and delivery 
of UvrA-UvrB to the damage site (Selby, 2017). UvrA-UvrB excise the phosphodiester backbone 
of damaged DNA, five bases at 3’ end and eight bases 5’ end of the damaged site (Selby, 2017). 
Mfd increases DNA repair upon UV damage and mfd knockouts increase the frequency of 
mutations (Selby, 2017). 
 
1.1.6.2 Transcription termination 
The final stage of transcription is termination, RNAP dissociates from the DNA template and as 
a result the nascent RNA molecule is released. There are two types of termination in 
prokaryotes: intrinsic termination (Rho-independent) and Rho-dependent termination.  
Transcription factors can bind to elongation complexes and affect/modulate termination in a 
cell (Ray-Soni et al., 2016). For example, NusA and NusG binds to elongating RNAP and nascent 
RNA and influences transcriptional pausing for transcription termination and anti-termination. 
NusA competes with the RNA binding factor, Rho which terminates transcription of 
untranslated operons, for termination binding sites (Yakhnin et al., 2016; Qayyum et al., 2016). 
Intrinsic termination occurs at inverted repeats directly followed by multiple uridine residues, 
with the formation of a  stem-loop structure in the nascent RNA (Washburn & Gottesma., 
2015). Intrinsic termination is governed by specific timing of the stem loop formation, size, 
length and sequence before RNAP moves towards the hairpin structure. The transcriptional 
elongation complex pauses upon encountering the hairpin structure and dissociates from the 
weak RNA(U) (U-tract)/DNA(A) hybrid at the seventh or eighth uridine, releasing the DNA 
template (Czyz et al., 2014; Washburn & Gottesman, 2015). There are cases of intrinsic 
termination occurring without a U-tract in the RNA molecule, however this is not fully 
understood (Czyz et al., 2014). Unlike intrinsic termination, Rho-dependent termination occurs 
in the absence of RNA secondary structures. The homohexameric RecA-family helicase, Rho 
binds to the RNA as it exists through the RNAP exit channel. Rho favours binding to rut sites 
which are C-rich and G-poor, this also reduces the formation of secondary structures at the 
Rho binding sites. These rut sites are found upstream of the termination site, usually 80-90 nt 
long (Bear et al., 1988),  which is sufficient for the binding of the six monomeric Rho proteins, 
each monomer binds to 13 nt on the RNA molecule (Bear et al., 1988; Ray-Soni et al., 2016). 
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Upon Rho binding to rut RNA, ATP induces ring closure of Rho and activation of catalysis. Rho 
translocates the nascent RNA via ATP hydrolysis (Ray-Soni et al., 2016). 
 
1.1.7 RNAP binding regulatory factors  
Transcriptional activators of the RNAP-σ70 holoenzyme increase transcription from promoters 
by three different mechanisms: class I and class II activate and/or cause a conformational 
change of promoter DNA (Wu et al., 2018). Class I activation involves an activator binding 
upstream of the -35 DNA element and recruiting RNAP. Class II activators bind to the binding 
site overlapping the promoter -35 and recruits RNAP through interactions with the α subunit 
and σ4. Lastly, some proteins can bind to -35 and -10 promoter DNA and alter the DNA 
structure which promotes RNAP binding (Wu et al., 2018). Aside from sigma factors interacting 
with RNAP to regulate transcription, there are other proteins that also regulate the 
transcription cycle. For example, the Gre factors (1.2.1.11), GreA and GreB resolve backtracked 
complexes by interacting with the secondary channel of RNAP and repositions the 3’ nascent 




The response to starvation is referred to as the stringent response and causes extensive 
transcriptional reprogramming (Ross et al., 2013). The stringent factor, ppGpp is responsible 
for the detection and response to nutrient starvation (Hesketh et al., 2007). ppGpp regulates 
transcription in E. coli by binding to two allosteric sites of RNAP at ppGpp-specific promoters 
(Ross et al., 2013). Additionally, ppGpp inhibits DNA replication by binding to the active site of 
RNAP primase DnaG (Maciag et al., 2010). The level of (p)ppGpp is balanced by 
pyrophosphokinase and pyrophosphohydrolase activities of, two homologous enzymes in E. 
coli, SpoT and RelA. Under amino acid limitation, the E. coli, RelA is associated with ribosomes 
and is responsible for ribosome-dependent synthesis of ppGpp as it binds to the uncharged 
tRNA (Potrykus et al., 2011). The stringent response also occurs in Streptomyces spp and is 
thought to be important in the triggering of antibiotic production in certain strains. The S. 
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coelicolor homologue ΔrelA strain demonstrates a deficiency in ACT and RED (Chakraburtty & 
Bibb, 1997; Sun et al., 2001). SpoT-dependent ppGpp synthesis is activated by carbon and 
phosphate limitation in a ribosome-independent manner (Sun et al., 2001). In S. coelicolor, 
transcription of rshA is activated upon ppGpp synthesis and over-expression of rshA can 
restore antibiotic production and sporulation (Sun et al., 2001). Both relA and rshA are similar 
to E. coli SpoT as they display hydrolase and synthetase activity (Sun et al., 2001). Yet the 
mechanism of ppGpp action remains unclear in Streptomyces but is unlikely similar to the 
ppGpp function in E. coli as the binding sites for RNAP are absent.  
 
1.1.7.2 Crl  
Crl was originally found in the cytoplasm of E. coli and was thought to activate the cryptic curlin 
subunit gene which results in curli formation and fibronectin binding (Arnqvist et al., 1992). 
However, more recent work shows Crl binds to the master regulator of general stress, σS and 
positively regulates σS- dependant genes (Monteil et al., 2010). Crl can bind to free σS and the 
RNAP/σS complex (Gaal et al., 2006). Crl has the ability to also bind to σ70 at lower binding 
affinities, but more likely increases holoenzyme formation with σS (Gaal et al., 2006). Most 





DksA (DnaK suppressor A) is a 17.5 kDa protein conserved in proteobacteria and is composed 
of five α helices organised into three domains (Perederina et al., 2004). DksA modulates RNAP 
activity in a similar way to GreA through insertion of a coiled coil into the secondary channel 
of RNAP (Wilma Ross et al., 2016). Both DksA and ppGpp act as important regulators in the 
stringent response and together can negatively and positively regulate the expression of many 
genes (Perederina et al., 2015). DksA and ppGpp together activate amino acid biosynthetic 
promoters and stable RNA promoters (Paul et al., 2005) and reduce the life time of 
RNAP/promoter open complexes, which can either be advantageous or disadvantageous 
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depending on the promoter (Molodtsov et al., 2018). Aside from transcription initiation, DksA 
has been identified as an elongation factor (Zhang et al., 2014). ChIP experiments reveal that 
DksA co-localises at both promoters for transcription initiation (with σ70 and RNAP) and 
downstream regions which eluded to a possible function during elongation (Zhang et al., 2014). 
Amino acid starvation causes stalling of RNAP at mRNA by uncoupling of transcription and 
translation, promoting backtracking of RNA and DNA through RNAP (Zhang et al., 2014). DksA 
prevents backtracking by arresting elongation complexes in vivo (Zhang et al., 2014). 
 
1.1.7.4 RapA (HepA) 
RapA is 110 kDa protein which consistently co-eluted with RNAP preparations in E. coli and is 
as abundant as σ70. This contaminating protein is the product of the rapA gene and was 
classified as a member of the SNF2 family of putative helicases (Muzzin et al., 1998). The early 
in vitro experiments showed RapA binds to core RNAP but not holoenzyme, this was later 
followed up and showed RapA and σ70 compete for RNAP. Members of the SNF2 family are 
associated with DNA repair processes, therefore upon UV exposure, ΔrapA demonstrated 
reduced survival (Muzzin et al., 1998) and inhibits growth at high salt concentrations 
(Sukhodolets et al., 2001). RapA shares high sequence similarity to ATPases and the solved 
crystal structure of RapA confirmed an ATP binding domain and dsDNA-binding site (Shaw et 
al., 2008). RapA is believed to play a role in back translocation of transcription, 
backtranslocation can have a negative impact on genome stability, however RapA is believed 
to have low affinity for DNA and can easily be dissociated from DNA by RNAP during 
transcription in the forward direction (Liu et al., 2015).  
 
1.1.7.5  RNA polymerase binding protein, RbpA 
RbpA is a 14 kDa RNA polymerase binding dimeric protein that is conserved across the 
Actinobacteria phylum (Fig. 1.7) and the was first detected through consistent co-elution with 
S. coelicolor RNAP during affinity chromatography and gel filtration (Newell et al., 2006; Paget 
et al., 2001). Additionally, ChIP-qPCR has shown the presence of RbpA in a RNAP-
σHrdB/promoter- complex (Tabib-Salazar et al., 2013) and is essential for the growth of S. 
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coelicolor and M. tuberculosis (Hu et al., 2014). RbpA (RbpASc and RbpAMtb) was found to 
activate transcription from promoters that are recognised by the principal sigma factors, σHrdB 
or the orthologue σA in M. tuberculosis (Newell et al., 2006; Tabib-Salazar et al., 2013). 
Structural studies have shown RbpA binds specifically to the σ2 domain and the β subunit of 
RNAP to initiate transcription (Tabib-Salazar et al., 2013).  
 
Figure 1.6. Multiple sequence alignment of selected RbpA homologues. ClustalW analysis of the 
amino acid sequences from selected RbpA homologues. The RbpA core domain (RCD) is 
highlighted green and shows all four of the β strands, whilst the C-terminal Sigma interaction 
domain (SID) is highlighted blue with both α-helices annotated. Residues with a black box 
represent identical whilst the grey box indicates similar amino acids amongst the organisms. 
STRCO-Streptomyces coelicolor, FRASC-Frankia spp, MYCTU-Mycobacterium tuberculosis, 
NOCFA-Nocardia farcinica, BIFAD-Bifidobacterium adolescentis. 
 
1.1.7.5.1 Structure of RbpA  
The RbpA N-terminus is an unstructured 26 amino acid tail that is highly conserved within the 
Actinobacteria, and the function of this region remains largely unknown. A cryo-EM structure 
of the RbpA-NTT (N-terminal tail) has recently been solved, positioning RbpA-NTT into the 
RNAP active site cleft between β zinc-binding domain (ZBD) and σA4 domains and snakes 
towards the RNAP active cleft Mg2+ (Boyaci et al., 2018; Fig. 1.8). The RbpA-NTT interacts with 
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the σ3.2 and the RNAP ZBD and β’ lid. The interactions between RbpA-NTT and the σ-finger 
suggests that it plays a role in RNAP initiation, although not in RPo formation (Boyaci et al., 
2018). Deletion of the RbpA-NTT does not appear to have deleterious effects on the phenotype 
(Prusa et al., 2018), however RNA-sequencing has shown changes in the transcriptome, 
strongly suggestive that the NTT may be important for regulation of specific promoters (Hubin 
et al., 2017a). The designated RbpA core domain (RCD) forms a β barrel, which is composed of 
four β strands (Tabib-Salazar et al., 2013). The C-terminus comprises of two α-helices 
considered to be involved in the binding of σHrdB or σHrdA in S. coelicolor, and σA or σB in M. 
tuberculosis; it is therefore designated the sigma interaction domain (SID). Complete removal 
of the C-terminal domain renders RbpA incapable of binding the σ factor (Tabib-Salazar et al., 
2013). In the absence of core RNAP, RbpA is still capable of binding to the σ2 domain of the 
principal σ factor, HrdB (Bortoluzzi et al., 2013; Hu et al., 2014). Two critical arginine residues, 
R89 and R90 are essential for σ binding and are well conserved across the Actinobacteria (Prusa 
et al., 2018; Tabib-Salazar et al., 2013). Between the RCD and SID exists a 15-amino acid lysine-
rich basic linker (BL) which consists of four positively charged amino acids K73, K74, K76 and 
R79 in M. tuberculosis (K74, K75, K77 and R80 in S. coelicolor). RbpAR79 in M. tuberculosis is 
positioned to interact with -13 and -14 negatively charged non-template DNA whilst RbpAK73, 
RbpAK74 and RbpAK76 are positioned to make long-range electrostatic interactions with -18/-19 
and -17/-18 of the template DNA (Hubin et al., 2015; Hubin, et al., 2017a). The RbpAR79 




Figure 1.7. The cryo-EM structure of M. tuberculosis σA/RbpA/up-stream fork DNA. The non-
template DNA strand is shown in dark grey, template DNA in light grey, RbpA in red with the 
N-terminal tail (NTT), RbpA core domain (RCD), basic linker (BL) and sigma-interaction domain 
(SID) annotated. Structure downloaded from RCSB PDB, accession number 6C04 and visualised 
with PyMOL (version 2.0.7; Boyaci et al., 2018). 
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1.1.7.5.2 Functions associated with RbpA 
Many of the initial studies on RbpA eluded to a stabilisation role of the transcription initiation 
bubble and holoenzyme complex or activation of transcription (Tabib-Salazar et al., 2013). This 
has been assessed in vitro by testing the stability of RNAP-σA holoenzyme and RbpA increases 
the retention of σA and σB at the holoenzyme (Hu et al., 2014). The holoenzyme complex 
without RbpA was unable to form stable promoter complexes and thus unable to initiate 
transcription (Hu et al., 2014). RbpA is also important for the stabilisation of the RPo complex 
and mutations that affect DNA and σ binding do not affect overall promoter opening driven by 
RbpA (Prusa et al., 2018). RbpA has also been shown to rescue transcription activation from 
promoters with a poorly conserved -35 promoter DNA (Hubin et al., 2017). RbpA is induced by 
disulphide stress and rifampicin treatment whilst the ΔrbpA exhibits 15-fold increased 
sensitivity to rifampicin (Newell et al., 2006). Many theories were suggested for the increased 
sensitivity to rifampicin, firstly RbpA may directly compete with rifampicin for the RNAP binding 
site, secondly RbpA may change the binding site of rifampicin-RNAP and thirdly, RbpA may 
affect downstream processes by changing expression of cell proliferation genes (Hu et al., 
2014). However, another study shows that RbpA can rescue the in vitro activity of RNAP even 
in the presence of 100 µM rifampicin (Dey et al., 2010). 
Interestingly, a study has shown that M. tuberculosis can produce a small percentage of INH-
tolerant cells in response to INH treatment, and σB is important for tolerance to several drugs 
(Wang et al., 2018). RbpA can bind to group II sigma factors, such as σB, deletion of σB does not 
change the MIC but does decrease the fraction of cells tolerant to INH. The σB-dependant gene, 
ppk1, responsible for polyP biosynthesis is proportionate to σB levels. The RbpA- σB-ppk1 
complex is believed to be important for INH tolerance in M. tuberculosis, any deletions of the 
key players of this complex reduce the number of cells tolerant to INH (Wang et al., 2018). 
Additionally, a antimicrobial RNAP inhibitor, Fidaxomicin (Fdx) used for the treatment of 
Clostridium difficile infection has shown activity against multi-drug resistant M. tuberculosis 
RNAP in vitro (Boyaci et al., 2018). Cryo-EM structures have revealed that the binding site of 
Fdx is independent to the rifampicin binding site on RNAP and involves interactions with RNAP 
β’-σA-RbpA-NTT (Boyaci et al., 2018). The RbpA-NTT has been shown to play a role in high 




1.1.7.6 RNAP binding protein, CarD 
CarD is a well-conserved RNAP-binding protein originally described in Mycobacterium in 2009 
and is present in a wide range of Gram-positive and Gram-negative bacteria (Fig. 1.9). CarD is 
not found in E. coli and it has not been investigated in any other Actinobacteria (Rammohan et 
al., 2015). Attempts to delete carD in M. tuberculosis and M. smegmatis were unsuccessful 
suggesting that it is essential for viability (Stallings et al., 2009).  
 
Figure 1.8 Multiple sequence alignment of CarD homologues. A multiple sequence alignment of 
the CarD homologues from the actinobacteria phylum, performed using BLASTP to look at 
similar sequences and clustalW, a multiple sequence alignment tool. BOX shading analysis was 
performed using BOXSHADE (version 3.21). Identical amino acid residues are shaded in black 
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and similar amino acids are shaded grey. The RNA polymerase interacting domain (Red) and 
the C-terminal domain (blue). β strands as arrows and α helices as cylinders. The amino acids 
highlighted black are identical in each homologue, and grey represents similar amino acids. 
STRCO= Streptomyces coelicolor, FRASC= Frankia spp, MYCTU= Mycobacterium tuberculosis, 
NOCFA= Nocardia farcinica, BIFAD= Bifidobacterium adolescentis, RHOD= Rhodococcus spp, 
CUAC= Cutibacterium acnes, MILUT= Micrococcus luteus 
 
1.1.7.6.1 Structure of CarD 
CarD is composed of two domains, the Tudor-like fold of the N-terminal domain known as the 
RNAP interaction domain (RID) and the C-terminal domain (CTD) (Srivastava et al., 2013). More 
recently synchrotron-based small angle X-ray scattering experiments suggest that CarD exists 
in two states, as a oligomer in solution and as a homodimer in solution at higher µM 
concentrations (Kaur et al., 2018). Bacterial two-hybrid assays confirmed that the N-terminus 
of CarD in T. thermophilus interacts with the β1 lobe of RNAP (Garner et al., 2017; Stallings et 
al., 2009; Fig. 1.10). The N-terminus of CarD shares sequence and RNAP binding similarity to 
the RID of the transcription-repair coupling factor (TRCF) which is encoded by mfd (Srivastava 
et al., 2013; Stallings et al., 2009). The CarD-CTD has no sequence or structural similarity to any 
other previously characterised proteins. The CTD is composed of five alpha helices which 
appear to make direct contact with position -10 of promoter DNA on the opposite face of RNAP 






Figure 1.9. Structural model of the RPo/CarD complex in T. thermophilus.  Molecular surfaces 
shown for RNAP holoenzyme. CarD-RID (pink), CarD-CTD (green) and W86 (Red). DNA non-
template strand (dark grey), template strand (light grey) and promoter positions -35 and -10 
(yellow). RNAP β1 lobe (cyan), β (light blue), σA (gold). Left and right images are two different 
views of the complex. Permission: creative commons licence (Srivastava et al., 2013).  
 
1.1.7.6.2 Functions associated with CarD 
CarD is up-regulated (~3 to 20-fold) in response to double strand breaks induced by treatment 
with Ciprofloxacin, Bleomycin and alkylating agent methyl methanesulphonate and nutrient 
stress (Stallings et al., 2009). This suggested that CarD is necessary for survival during oxidative, 
DNA damage and nutrient limitation. Whole genome transcriptional profiling indicated that in 
the absence of CarD, 193 genes were upregulated >2 fold whilst 176 genes were 
downregulated >2 fold (Stallings et al., 2009). The most significant up-regulation in the absence 
CarD was the up-regulation of rRNA levels, therefore CarD may play a role in the transcription 
of rRNA operons during stress conditions. CarD is proposed to play a role in M. tuberculosis 
persistence and bacterial replication in vivo. Mice infected with a wild-type and conditional 
doxycycline-dependant CarD knock-down strain received doxycycline at day 1 and 56. The 
carD-depletion infections were unable to replicate even after day 1 compared to the wild-type 
strain infection (Stallings et al., 2009). Most importantly, CarD modulates transcription through 
direct contact with DNA. ChIP experiments reveal the failure of CarD to bind across the genome 
in the absence of RNAP and co-localised at most promoters with σA (Srivastava et al., 2013). 
The CTD includes a well conserved tryptophan, W86 in M. tuberculosis (W85 in S. coelicolor) 
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surrounded by a basic patch which is reportedly important for binding to DNA. CarD is 
predicted to interact around the dsDNA (-12) -ssDNA (-11) interface of a transcription bubble, 
at positions -11 to -15. As a result, W86 interacts with the minor groove of the dsDNA and the 
attraction is further supported by the basic patch (Srivastava et al., 2013). CarD can bind to 
RNAP in vivo and activate transcription in vitro, despite the alanine substitution of W85. Many 
kinetic studies have also shown CarD has been elucidated in stabilisation of open complexes 
like RbpA (Davis et al., 2015; Rammohan et al., 2015). Additionally, CarD has been the first 
cytosolic transcription factor in M. tuberculosis to produce amyloid-like fibrils in vivo and in 
vitro, whilst the function of this still remains unknown (Kaur et al., 2018).  
 
1.1.7.7 Relationship between RbpA and CarD 
We now understand that RbpA (Dey et al., 2010) and CarD (Stallings et al., 2009) are both 
essential in S. coelicolor and M. tuberculosis. RbpA and CarD bind to distinct regions of RNA 
polymerase however both form RNAP-holoenzyme complexes and are both known to stabilise 
RP0 individually (Rammohan et al., 2016). Structural modelling suggested that CarD contacts 
DNA from the opposite side of the DNA double helix to RbpA and there are no steric clashes 
(Hubin et al., 2015). Recently, an X-ray crystal structure of RbpA-TIC complex has superimposed 
CarD onto the structure to show the proximity of both transcription factors (Fig. 1.11). Since 
CarD and RbpA are found at all RNAP-σA transcription initiation complexes, it could suggest an 
overlapping function between both. Disrupting the RbpA/CarD/RNAP complex could be an 
important source of drug discovery. The M. tuberculosis RNAP open complex is less stable 
compared to a fast-growing organism such as E. coli and therefore the combination of RbpA 
and CarD provides better stability of transcription initiation bubbles and enables transcription 
activation (Garner et al., 2017; Hu et al., 2012; Rammohan et al., 2016).  
Fluorescence assays to investigate the transcription open complexes using a Cy3-labeled 
promoter showed that the fluorescence fold change of RbpA and CarD is lower individually 
compared to the presence of both transcription factors in the holoenzyme (Rammohan et al., 
2016). Additionally, a study investigated abortive transcription using two well characterised M. 
tuberculosis promoters, vapB10p and rrnAP3. Full length RbpA and truncations excluding the 
N-terminal tail were capable of activating transcription of the vapB10p in vitro by 2-fold, CarD 
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alone also increased transcription by 3-fold.  The addition of RbpA to M. bovis RNAP 
holoenzyme complexed with CarD activated transcription by 6-fold (Hubin et al., 2017).  
 
 
Figure 1.10. X-ray crystal structure of RbpA-transcription initiation complex with superimposed 
CarD. RbpA-TIC complex in M. smegmatis, PDB accession ID: 5VI5 (Hubin et al., 2017b) and 
superimposed CarD in T. aquaticus (Bae et al., 2015), PDB accession ID: 4XLR. RbpA shown in 
red (basic linker amino acids highlighted in green and yellow),  RNAP β’ subunit is in magenta, 
σA in blue, CarD in orange, non-template DNA in dark grey, template DNA in light grey and the 









1.1.8    Project aims 
The focus of this project was to gain a better understanding of the mechanism of action and 
biological importance of RbpA and CarD in Actinobacteria, S. coelicolor and M. tuberculosis. 
The aims of this thesis are outlined below: 
 
1) Understand the biological importance of the RbpA basic linker in S. coelicolor 
2) Understand the biological importance of the RbpA basic linker in M. tuberculosis 
3) Investigate the mechanism and biological importance of rbpA in S. coelicolor 
4) To develop a co-depletion strain of both rbpA and carD to investigate a possible 













































2.1 Chemicals and reagents  
• Agar (Sigma-Aldrich) 
• Agarose (Melford) 
• Ammonium Persulfate (APS; Sigma-Aldrich) 
• Ampicillin (Melford Laboratories) 
• Antifoam (Sigma-Aldrich) 
• Apramycin (Duchefa Biochemie) 
• Bromophenol Blue (Amersham Biosciences) 
• Casamino Acids (Difco) 
• Chloramphenicol (Melford Laboratories) 
• Chloroform (Sigma-Aldrich) 
• D (+) maltose monohydrate (Fisher Scientific) 
• Deoxyribonucleotide phosphates (dNTPs; New England Biolabs) 
• Diamide (Sigma-Aldrich) 
• Dimethylsulphoxide (DMSO; Sigma-Aldrich) 
• Dithiothreitol (DTT; Melford Laboratories) 
• GelRed (Biotin) 
• Glycerol (Fisher Scientific) 
• HEPES (Sigma-Aldrich) 
• Iodoacetamide (Sigma-Aldrich) 
• Isopropyl-β-D-thiogalactopyranoside (IPTG; Melford Laboratories) 
• Kanamycin (Melford Laboratories) 
• Malt extract (Oxoid) 
• Mannitol (Sigma-Aldrich) 
• MOPS (Fisher Scientific) 
• Nalidixic acid (Duchefa Biochemie) 
• N, N-dimethyl-formamide (Fisher Scientific) 
• Nutrient agar (Difco) 
• Peptone (Bacto) 
• Phenol (Fisher Scientific) 
• Phenylmethylsulfonyl Fluoride (PMSF; Sigma-Aldrich) 
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• Polyethylene glycol 6000 (Sigma-Aldrich) 
• Polyethylene glycol 8000 (Sigma-Aldrich) 
• Ponceau C solution (Sigma-Aldrich) 
• Protease Inhibitor Cocktail tablets (Sigma-Aldrich) 
• Protein A magnetic beads (New England Biolabs) 
• Protein G magnetic beads (New England Biolabs) 
• P-40 substitute (Calbiochem) 
• Rifampicin (Sigma-Aldrich) 
• Sigmacote® (Sigma-Aldrich) 
• Sodium chloride (Fisher Scientific) 
• Sodium hypochlorite (Sigma-Aldrich) 
• Sodium deoxycholate (Sigma-Aldrich) 
• Sodium dodecyl sulphate (SDS; Fisher Scientific) 
• Soya flour (Infinity Foods) 
• Sucrose (Sigma-Aldrich) 
• TES (N-Tris(hydroxymethyl)methyl-2-aminoethane sulfonic acid; Fisher Scientific) 
• Tetramethyl-ethylenediamine (TEMED; Fisher Scientific) 
• Thiostrepton (Sigma) 
• Trichloroacetic acid (TCA) (Sigma) 
• Tris (2-Amino-2-hydroxymethyl-propane-1,3-diol; Fisher Scientific) 
• Triton X-100 (Sigma-Aldrich) 
• Tryptone (Difco) 
• Tween 20 (Sigma-Aldrich) 
• Ultra Pure Sequagel® Urea Gel™ Concentrator (national diagnostics) 
• Ultra Pure Sequagel® Urea Gel™ gel diluent (national diagnostics) 
• Ultra Pure Sequagel® Urea Gel™ buffer (national diagnostics) 
• X-gal (Melford Laboratories) 
• Yeast extract (Difco/Oxoid) 
• 7H9 




• Phusion High-Fidelity DNA Polymerase (New England Biolabs) 
• Taq polymerase (New England biolabs) 
• GoTaq DNA Polymerase (qPCR Master Mix; Promega) 
DNA modifying enzymes 
• Antarctic Phosphatase (New England Biolabs) 
• T4 DNA Kinase (New England Biolabs) 
• T4 DNA Ligase (New England Biolabs) 
• DNAse/RNAse free herring sperm DNA (Promega) 
DNA/RNA restriction enzymes 
• DNA endonucleases (New England Biolabs) 
• S1 nuclease (Life Technologies) 
• RNase A from bovine pancreas (Sigma-Aldrich) 
• RiboShredder™ RNase Blend (Cambio) 
 
2.1.1 Antibodies  
• anti-FLAG M2 monoclonal antibody, from mouse, Sigma F18041MG. 
• anti-σHrdB polyclonal antibody, from rabbit, a gift from P. Doughty. 
• anti-RNAP β subunit monoclonal antibody, from mouse, Abcam ab12087. 
• Anti-SigE polyclonal antibody, from rabbit, a gift from M. Hutchings. 
 
2.1.2 Buffers and solutions 
DNA Manipulation 
TE buffer (pH 8.0):  10 mM Tris-HCl (pH 8.0), 1 mM EDTA 
10X TAE electrophoresis buffer (1 L): 48.4 g Tris base, 11.4 mL glacial acetic acid, 3.7 g EDTA, 
dissolve in 1 L dH2O 
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10X TBE electrophoresis buffer (1 L):  108 g Tris base, 55 g boric acid, 9.3 g Na2EDTA, dissolved 
in 1 L dH2O 
5X DNA loading buffer: 40% sucrose, 0.25% orange G dye, dissolved in dH2O 
Alkaline lysis solution I: 50 mM Tris-HCl (pH 8.0), 10 mM EDTA 
Alkaline lysis solution II:  0.2 N NaOH, 1% (v/v) SDS,  
Alkaline lysis solution III:  3 M potassium acetate (pH 5.5) 
2X Kirby mix (100 mL):  2 g TPNS, 12 g sodium 4-aminosalicilate, 5 mL 2M Tris-HCl (pH  8.0), 6 
mL equilibrated phenol (pH 8.0), up to 100 mL with dH2O 
Phenol:Chloroform:Isoamyl Alcohol (P:C:IAA; 50 mL): 25 mL equilibrated phenol (pH 8.0), 24 
mL chloroform, 1 mL isoamyl alcohol 
 
Protein purification 
Nickel purification column : 
Ni-NTA charge buffer : 50 mM NiCl2.6H2O 
Ni-NTA binding buffer : 50 mM Tris-HCl pH 7.9, 0.5 M NaCl, 5 mM imidazole 
Ni-NTA Wash buffer : 50 mM Tris-HCl pH 7.9, 0.5 M NaCl, 20 mM imidazole 
Ni-NTA elution buffer : 50 mM Tris-HCl pH 7.9, 0.5 M NaCl, 1 M imidazole 
Ni-NTA strip buffer: 50 mM Tris-HCl pH 7.9, 0.5 M NaCl, 100 mM EDTA 
 
AKTA purification: 
Buffer A: 5 mM imidazole, 500 mM NaCl, 20mM Tris-Cl 5 mM β-mercaptoethanol pH 7.9, 
protease inhibitor tablet 
Buffer B: 2 M imidazole, 500mM NaCl, 20mM Tris-Cl pH 7.9, 5 mM β-mercaptoethanol 




Dialysing buffer: 10 mM Tris-HCl pH 7.9, 200mM NaCl, 0.1 mM EDTA, 1 mM MgCl2, 20 μM ZnCl2 
and 10 mM DTT 
Dilution buffer: 20 mM Tris-HCl pH 7.9, 5 mM β-mercaptoethanol, 200 mM NaCl and 5% 
glycerol 
Gel Filtration (GF) buffer: 20 mM Tris-HCl pH 7.9, 200 mM NaCl, 5% (w/v) glycerol, 5 mM β-
mercaptoethanol 
Anion-exchange binding buffer: 50 mM Tris-HCl pH 7.9, 50 mM NaCl, 5% (v/v) glycerol, 5 mM 
β-mercaptoethanol 
Anion-exchange elution buffer: 50 mM Tris-HCl pH 7.9, 1 M NaCl, 5% (v/v) glycerol, 5 mM β-
mercaptoethanol 
 
Cobalt purification column: 
Equilibration/ Wash buffer: 50 mM sodium phosphate, 300 mM sodium chloride, 10 mM 
imidazole pH 7.4 
Elution buffer: 50 mM sodium phosphate, 300 mM sodium chloride, 1 M imidazole pH 7.4 
Phenylmethylsulfonyl fluoride (PMSF): 10 mg/mL in isopropanol and stored at -20°C 
 
Western blot 
1.5 M Tris-HCl pH 8.8: Tris-Base 90.855 mL pH 8.8 and 350 mL distilled water, 500 mL final 
volume 
1 M Tris-HCl pH 6.8: Tris-Base 30.285 mL pH 6.8 and 200 mL distilled water, 250 mL final volume 
Semi-dry transfer buffer (1 L): 5.82 g Tris-Base, 2.92 g glycine, 3.75 mL 10% SDS, 200 mL ethanol 
and make up to 1 L with distilled water 
10 x TBS-Tween buffer: 12 g Tris-HCl, pH 7.6, 40 g NaCl, 5 mL Tween 20™, up to 500 mL with 
distilled water  
Blocking solution: 5% (w/v) skimmed milk in 1 x TBS-Tween buffer, made fresh before use  
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Lamaelli buffer (50mL): 12.5 mL Tris-HCL pH 6.8, 4 g SDS, 5 mL 2-mercaptoethanol, 15 mL 
glycerol, 10 mg Bromophenol blue and make up to 50 mL with distilled water.  
Running buffer: dilute (10X SDS-PAGE buffer, 1 L): 30 g Tris-Base, 144 g glycine, 10 g SDS and 
make up to 1 L with distilled water.  
SDS-PAGE Coomassie Brilliant Blue stain: 0.25% (w/v) Coomassie Brilliant Blue (Sigma), 50% 
(v/v) methanol, 10% (v/v) glacial acetic acid 
SDS-PAGE de-stain solution: 50% (v/v) methanol, 10% (v/v) glacial acetic acid 
 
RNA extraction 
Kirby mix (Kieser et al., 2000): 1% (w/v) sodium-triisopropylnapthalene sulphonate, 6% (w/v) 
sodium 4-amino salycilate, 6% (v/v) phenol made up in 50 mM Tris-HCl pH 8.3.   
3 M sodium acetate, pH 6.0 
5X MOPS buffer: 0.2 M MOPS pH 7.0, 0.0 5M sodium acetate, 0.005 M EDTA pH 8.0 and make 
up to 500mL with distilled water  
Sample buffer: 50% glycerol, 1 mM EDTA, 0.4% bromophenol blue 
 
Chromatin immunoprecipitation buffers 
IP buffer: 50 mM HEPES pH 7.5 with KOH, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% 
sodium deoxycholate, 0.1% SDS 
IP buffer + salt: 50 mM HEPES pH 7.5 with KOH, 500 mM NaCl, 1mM EDTA, 1% Triton X-100, 
0.1% sodium deoxycholate, 0.1% SDS 
Wash buffer: 10 mM Tris pH 8.0, 250 mM LiCl, 1 mM EDTA, 0.5% Nonidet P-40 substitute, 0.5% 
sodium deoxycholate 
5X Elution buffer: TE pH 7.6, 5% SDS 
 
S1 protection assay buffers 
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S1 hybridisation buffer: 2.53 g PIPES in 90 mL distilled water, add 1.67 mL 0.5M EDTA, adjust 
pH 7.0 with 5 M NaOH, then autoclave. Dissolve 93.1 g NaTCA in the PIPES/EDTA solution. 
Make up to a final volume of 167.4 mL with sterile water, mix well and freeze at -80°C in 200 
μL aliquots.  
5X S1 digestion buffer: 1.4 M NaCl, 150 mM sodium acetate pH 4.4, 22.5 mM zinc acetate and 
autoclave, then add 100 μg/mL partially cleave non-homologous DNA (Promega DNAse/RNAse 
free herring sperm DNA) and store in 500 μL aliquots at -20°C. Make 1 X when ready to use 
using sterile water, chill on ice for 5 min and then add 150 units of S1 nuclease per 300 μL, mix 
by vortexing. 
S1 stop mix: 2.5 M ammonium acetate, 0.05 M EDTA 
Formamide loading buffer: 80% formamide, 10 mM NaOH, 1 mM EDTA, 0.1% xylene cyanol, 
0.1% bromophenol blue. 
Urea gel: 16 mL Urea gel concentrator, 29 mL Urea gel diluent, 5 mL Urea gel buffer, 400 μL 
10% APS, 20 μL TEMED.  
 
2.1.3 Strains 
Strain Genotype Source/ reference 
Streptomyces coelicolor M145 SCP1- SCP2- (Hopwood et al., 
1986) 
Streptomyces coelicolor J1981 M145 ΔrpoC::rpoCHIS (Babcock et al., 1997) 
Streptomyces coelicolor S129 J1981 ΔrbpA::aac(3)IV (Newell et al., 2006) 
Streptomyces coelicolor J1915 M145 ΔglkA SCP1- SCP2- (Kelemen et al., 1995) 
Streptomyces coelicolor S115 M145 ΔrbpA ApraR (Aline Tabib-Salazar) 
Streptomyces coelicolor S401 J1915 ΔrbpA ΔrbpB pIJ6902::rbpA, 
pRT802::3XFLAG 
(Aline Tabib-Salazar) 
Streptomyces coelicolor S403 J1915 pIJ6902::sspB (This study) 
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Streptomyces coelicolor S406 J1915 ΔrbpB pIJ6902::sspB (Aline Tabib-Salazar, 
this study) 
Streptomyces coelicolor S407 M145 rbpADAS+4 (This study) 
Streptomyces coelicolor S408 J1915 rbpADAS+4 (This study) 
Streptomyces coelicolor S409 M145 carDDAS+4 (This study) 
Streptomyces coelicolor S410 J1915 carDDAS+4 (This study) 
Streptomyces coelicolor S411 J1915 rbpADAS+4/carDDAS+4 (This study) 
Streptomyces coelicolor S412 rbpA-DAS+4, pIJ6902::sspB (This study) 
Streptomyces coelicolor S413 carD-DAS+4, pIJ6902::sspB (This study) 
Streptomyces coelicolor S414 J1915 ΔrbpB rbpA-DAS+4, pIJ6902::sspB (This study) 
Streptomyces coelicolor S415 J1915 ΔrbpB carD-DAS+4, pIJ6902::sspB (This study) 
Streptomyces coelicolor S416 J1915 ΔrbpB rbpA-DAS+4/carD-DAS+4, 
pIJ6902::sspB 
(This study) 
Streptomyces coelicolor S417 J1981 pSET152::hrdBWT (Chidubem Iwobi) 
Streptomyces coelicolor S418 J1981 pSET152::hrdB4xR (Chidubem Iwobi) 
Mycobacterium tuberculosis 
M233 
H37Rv Tn-pip/pptr::ΔrbpA hygR  
(Himar1 transposon integrated PI pptr inducible 
system, hygR) 
(Bortoluzzi et al., 
2013a) 
Escherichia coli DH5α F-, Φ80lacZΔM15, Δ(lacZYAargF) 
U169, deoR, recA1, endA1, 
hsdR17(rk-, mk+), phoA, supE44, thi-1, 
gyrA96, relA1, λ- 
Invitrogen 
Escherichia coli ET12567 
(pUZ8002) 
dam dcm hsdS 
dam-13::Tn9 dcm-6 hsdM Cmr 
pUZ is a derivative of RK2 with a 
(MacNeil et al., 1992) 
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mutation in the OriT(aph) 
Escherichia coli ET12567 
(pR9406) 
dam-13::Tn9, dcm-6, hsdM, Cmr, pR is a 
derivative of RK2 with a mutation in the oriT 
(amp) 
(Jones et al., 2013) 
Rosetta II BL21 F- ompT hsdSB(rB- mB-) gal dcm (DE3) 
pLysSRARE2 (CamR) 
(Novagen) 
Table 2.1 List of strains used throughout the study. 
 
2.1.4 Plasmids 
Vector Details Source/ Reference 
pBlueScript II SK+ E. coli sub-cloning vector: 
bla, lacZα, AmpR 
Stratagene Ltd. 
(Alting-Mees & Short, 1989)  
pIJ6902 S. coelicolor integrative expression plasmid: 
aac(3)IV, tipAp, oriT, tsr, ΦC31 attP, AprR, ThioR 
(Huang et al., 2005; Molodtsov 
et al., 2018) 
pRT802 S. coelicolor integrative plasmid: 
aphII, oriT, lacZα, ΦBT1 attP, KanR. 
(Gregory et al., 2003) 
pIJ2738 Meganuclease site, I-SceI: 
aac(3)IV, lacZα, oriT, AprR 
(Fernández-Martínez & Bibb, 
2014) 
pIJ2742 Meganuclease: 
oriT, ThioR, aac(3)IV, ermE*p 
(Fernández-Martínez & Bibb, 
2014) 
pMV306 M. tuberculosis integrated plasmid: 
KanR, attP site, oriE, aph, ΦL5 
Addgene 
pSET152 Shuttle plasmid, bifunctional: replicates in E. coli 
and integrates in S. coelicolor, derived from 
pSET152; aac(3)IV -, aadA+, attPøC31, oriTRK2, 
(Bierman et al., 1992) 
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pMT3000::rbpA pMT3000 including rbpA gene with its promoter 
region (735bp) flanked by EcoRI & KpnI 
(Newell et al., 2006) 
pMT3000::rbpA-NdeI pMT3000 including rbpA gene with its promoter 
region (735bp) flanked by EcoRI & KpnI 
rbpA with a NdeI site, replacing the start codon 
(Aline Tabib-Salazar) 
pRM1126 pET28a derivative ori Co1E1, Kan, expressing M. 
bovis rpoC, rpoB, rpoZ, rpoA with His8 tag from a 
T7 promoter. 
(Czyz et al., 2014) 
pSRE3 pRT802 derivative Sven Reisloehner (2017) 
pSU904E A derivative of pRM1126, S. coelicolor rpoB,  
rpoC, rpoZ, rpo. ori Co1E1, Kan, 
Simon Hodges (2016) 
Table 2.2 List of plasmids used in this study. 
 
2.1.5 Antibiotics 
Name Stock concentration Stock made up in Concentration 
used in liquid media 
Concentration used 
in solid media 
Ampicillin 100 mg/mL 60% ethanol 100 μg/mL 100 μg/mL 
Carbenicillin 100 mg/mL 60% ethanol 100 μg/mL 100 μg/mL 
Apramycin 50 mg/mL dH2O (Filter-
sterilised) 
20-50 μg/mL 20 μg/mL 
Chloramphenicol 34 mg/mL 100% ethanol 34 μg/mL 25 μg/mL 
IPTG 1 M dH2O (Filter-
sterilised) 
1 mM 0.5 mM 
Kanamycin 50 mg/mL dH2O (Filter-
sterilized) 
50 μg/mL 25 μg/mL 







N/A 10-15 μg/mL 
X-gal 40 mg/mL N, N-dimethyl-
formamide 
N/A 40 μg/mL 
Diamide 0.5 M dH2O (Filter-
sterilized) 
0.5 mM  
Pristinamycin 3.125 mg/mL  Methanol  0.5 μg/mL 0.5 μg/mL 
Table 2.3 List of antibiotics and additives used in this study including the stock/working 
concentrations in solid and liquid media. 
 
2.1.6 Oligos  
BL mutants in S. coelicolor 
rbpA_Nde_F 5’ ATGAGTGAGCGAGCTCTTCG 
rbpA _Nde_R 5’ ATGTCGTGCCTCCCGGGCTTG 
rbpA3KRA_F 5’ CGCCCGCGGCCACGCACTGGGACATGCTGATG 
rbpA3KRA_R 5’ CGGCCGCCGCCTCCTCAGGGCCGTCGCCGTC  
rbpA3XHind_F 5’ CCAAGCTTCGGCTGCGGCTGCGACGACGGCGAC 
rbpA3XHind_R 5’ GAAGCTTCGCACTCTTGCGGCTGTCTCGCG 
Table 2.4 List of primers designed for the BL mutations in S. coelicolor. 
 
BL mutants in M. tuberculosis 
Rv20503KA_F 5’ GCCCCGCCCCGGACGCACTGGGACATG 
Rv20503KA_R 5’AACGGCGGCCGGCTCGGGCAGGTCGCCCTC 
Rv2050R80A_F 5’ GCCACGCACTGGGACATGCTGCTGGAG 
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Rv2050R80A_R 5’ GGGCGGCTTAACCTTCTTCGGCTCG 
Rv20503KRA_F 5’ GCCCCGCCCGCCACGCACTGGGACATG 
Rv20503KRA_R 5’ AACGGCGGCCGGCTCGGGCAGGTCGCCCTC 
Rv2050_F 5’ GAATTCCTGACAACACGACCGCATC 
Rv2050_R 5’ AAGCTTCGCACGCGCACGACCGGACATTG 
PTRF 5’ GGCGTCACCTTCTACGACCTGA 
RV2050R 5’ GAACTCCTCGCCGTTGTCGGTG 
MTB_F2 5’ CGACCGAGCGCAACGCGTGCGGCCGC 
MTB_R2 5’ GATCGTACGCTAGTTAACTACGTCGACA 
Table 2.5 List of primers designed for the BL mutations in M. tuberculosis. 
 
Multiplex sequencing Illumina RNA-seq adapter oligos 
Illumina multiplexing adapter 1 GATCGGAAGAGCACACGTCT 
Illumina multiplexing adapter 2 ACACTCTTTCCCTACACGACGCTCTTCCGATCT 
Table 2.6 List of multiplex sequencing Illumina RNA-seq adapter oligos  
 
S1 protection assay 
S1_promoter_oligo 5’ GCACCACGCCGGTGAACAGCTCTTCGCCTTTGCTCACCATATCGAAGCTTTGTCGGTG 
SpeI-ypet-for 5’ GAACTAGTACAGCTATGACATGATTACGAA 
EcoRV-ypet-Rev 5’ GCGATATCTCACCTCGAAAGCAAGCTGAT 





In vivo expression of ribosomal promoters in DAS depletion strains 
rrnDp2_nt 5’ GATCCTTCCCGCAAGAGCCGTTGACACGGAGCGAGCGGGGAGGTA 
rrnDp2_t2 5’ AGCTTACTGTTCGAATCTACCTCCCCGCTCGCTCCGTGTCAACGG 
rrnDp3_nt 5’ GATCCCGGAAACGAAGGCCGGTAAGACCGGCTCGAAAGTTCTGAT 
rrnDp3_t2 5’ AGCTTGCGGCTCCGACTTTATCAGAACTTTCGAGCCGGTCTTACC 
rrnDp2-3ch_nt 5’ GATCCTTCCCGCAAGAGCCGTTGACACGGCTCGAAAGTTCTGATA 
rrnDp2-3ch_t2 5’ AGCTTACTGTTCGAATCTACCTCCCCGCTCGCTCCGGTCTTACGG 
rrnDp3-2ch_nt 5’ GATCCCGGAAACGAAGGCCGGTAAGACCGGAGCGAGCGGGGAGGT 
rrnDp3-2ch_t2 5’ AGCTTGCGGCTCCGACTTTATCAGAACTTTCGAGCCGTGTCAACG 
Table 2.8 Primers designed for the in vivo study of the ribosomal promoters in the RbpA/CarD-
DAS depletion system. 
 
σHrdB association with RNAP qPCR targets 
hrdB-double_F 5’ GAGGCCGGTGTCCGCGCCGAGGACAAGCTGGCGAACTC 
hrdB-double_R 5’ GATGCGGGTGGCGAGGCGGACCTCCTGCTCGGCGTTGAG 
3SCO5281_F 5’ GTAGGCGTAGCCTTGATTCC 
3SCO5281_R 5’ CTCGAGTTACTGGGGGACTG 
8SCO5281_F 5’ CGACCTGATCGACAAGAAGC 
8SCO5281_R 5’ GCCTCTTCCAGGGTGATGT 







ChIP-seq adapter  
ChIP Illumina adapter 5’ 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT 
Table 2.10 Adapter using for ChIP-seq library preparation  
 
DAS depletion  
rbpA UF Extension 5’ GTCTACGGTTCCGAGGAACTG 
rbpA INT + Spe1 5’ ACTAGTCCCTGTCCCGCTCCCTGTTC 
rbpA UR 5’ GCGTAGTTCTCGGAGTAGTTCTCGTCGTTGGCGGCCGCACTCTTGCGGCTGTCTC 
rbpA DF 5’ GACGAGAACTACTCCGCGAACTACGCCGACGCCTCCTAGCGGGAAACCGTAGGCGAC 
rbpA DR INT +NOT1 5’ AGCGGCCGCGAGGTGCCGATCACGTTCGTG 
rbpA DR Extension 5’ GGTGGTCAACTGGCCCAAGTC 
carD UF extension 5’ CACGGCGGCGGCAACTCCTTG 
carD UF INT+ SPE1 5’ ACTAGTCTCGTCCGACATTCAGCTATG 
carD UR  5’ GAGCGTAGTTCTCGGAGTAGTTCTCGTCGTTGGCGGCGGAGGCGAGCACCTCGTC 
carD DF  5’ 
GACGAGAACTACTCCGAGAACTACGCCGACGCCTCCTGATCCGACTGGATCCGGGGCGA 
carD DR INT + NOT1 5’ AGCGGCCGCGTGACGTCGTCGGTCACCGTC 
carD DR EXTENSION 5’ GCTCACGCCCGTCCTCGAAGGC 
carD-DAS_F 5’ CGTCGTTACAAGGCAAATCTG 
carD-DAS_R 5’ GTGCGCTGAACCGAGTGGGTG 
rbpA-DAS_F 5’ CGATTCGAGATGCCCTTCTCG 
rbpA-DAS_R 5’ GTTCGGTTGTGTCGCCTACGG 
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pRT802: rbpAF 5’ GAAATCGTTAGTTAGGCTAAGGAGTCGGAACGGGAATCTTTACCGCC 
carD- rbpAR 5’ TTCGCAGGTCCTGCGGGCCGGGCACGGC 
rbpA-carDF 5’ CGGCCCGCAGGACCTGCGAATACTTTCTTCC 
carD-pRT802R 5’ CTATGGTGACGAAGGAACTAGCTGAACCGAGTGGGTGA 
Table 2.11 List of the primers designed for the DAS dependant depletion system. 
 
FLAG-DAS strains 
R/C_FLAGDASinvF 5’ GACATCGACTACAAGGACGATGACGATAAGGGATCCGCCGCCAACGACGAGAAC 
rbpAFLAGDASinvR 5’ ATGGTCTTTGTAGTCGCCGTCGTGGTCCTTGTAGTCAAGCGCACTCTTGCGGCTGTC 
carDFLAGDASinvR 5’ 
ATGGTCTTTGTAGTCGCCGTCGTGGTCCTTGTAGTCAAGGGAGGCGAGCACCTCGTC 
Table 2.12 Primers designed for the FLAG-DAS strains. 
 
Application of the DAS depletion system in vivo 
1-pRT802: rbpA F 5’ GAAATCGTTAGTTAGGCTAAGGGAGTCGGAACGGGAATCTTTACCGCC 
2-carD-rbpA R 5’ TTCGCAGGTCCTGCGGGCCGGGCACGGC 
3-rbpA-carD F 5’ CGGCCCGCAGGACCTGCGAATACTTTCTTCC 
4-carD-pRT802 R 5’ CTATGGTGACGAAGGAACTAGCTGAACCGAGTGGGTGA 
Table 2.13 Primers designed for validation of the DAS system  
 
Recombinant RNA polymerase 
NSB_Link_F 5’ GGCCGCCACACACACTAGTCACCAACCG 
NSB_Link_R 5’ GATCCGGTTGGTGACTAGTGTGTGTGGC 
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RpoA_F 5’ CAATTCCCCTCTAGAGTTTAAACTTTAAGAAGGAGATATACTCATGCTGATCGCTCAGCGTC 
RpoA_R 5’ CTTATATTGTGTTAATTGCTTAATTAAGTTAGTACTGCTCGGTCTCCACGA 
RpoZ_F 5’ CAATTAACACAATATAAGAGGAGGTCCCAGTCGTGTCCTCTTCCATCTCCGCG 
RpoZ_R 5’ CTAGTGTGTGTGGCGGCCGCTTACTGCGCCGGGCCCTCGATG 














Table 2.14 Primers designed for S. coelicolor recombinant RNAP expression.  
 
2.2 Growth selection and storage of bacterial strains 
2.2.1 Liquid and solid media 
L agar (LA): 10 g Difco Bacto tryptone, 5 g Oxoid yeast extract, 5 g NaCl, 1 g glucose, 10 g agar 
made up to 1 L with distilled water. 
Lennox broth (LB): 10 g Difco Bacto tryptone, 5 g Oxoid yeast extract, 5 g NaCl, 1 g glucose, 
made up to 1 L with distilled water. 
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Mannitol soya flour (MS) agar: 20 g agar, 20 g mannitol, 20 g soya flour, made up to 1 L with 
tap water. 
YEME liquid medium: 3 g yeast extract, 5 g Difco Bacto peptone, 3 g malt extract, 10 g glucose 
or glycerol, 100 g sucrose, made up to 1 L with distilled water.  
2 X PG medium; per 100 mL: 1 g Difco yeast extract and 1 g Difco Casamino acids. 5 mL aliquots 
were autoclaved.  
2x YT Broth: 1.6 g Bacto Tryptone, 1 g Bacto Yeast extract, 0.5 g NaCl, pH adjusted to 7.0 using 
5 N NaOH, made up to 90 mL with distilled water.  
Difco nutrient agar (DNA): 4.5 g Difco nutrient agar, distilled water 200 mL, 4.5 g agar.  
Supplemented liquid minimal medium, liquid (SMM):  81.9 mL PEG 6000, 2.5 mL (5mM final) 
MgSO4.7H20, 10 mL (25 mM final) TES buffer (0.25 M, pH 7.2), 1 mL (1 mM final) NaH2PO4 + 
K2HPO4, 2 mL glucose (50% w/v), 1 mL Antifoam 289 (1% w/v), 0.1 mL Trace element solution, 
1 mL Difco casaminoacids (20% w/v), make up to 100 mL with sterile distilled water. 
Supplemented minimal medium, solid (SMMS):  A minimal, solid medium used for production 
of S. coelicolor antibiotics.  2 g Difco casamino acids, 5.73 g TES buffer, dissolved in 1 L dH2O 
and adjusted to pH 7.2 with 5 N NaOH.  Typically divided into 200 mL aliquots in 250 mL 
Erlenmeyer flasks with 3 g agar, stoppered with a foam bung and foil, and autoclaved.  Prior to 
use add 2 mL 50 mM NaH2PO4 + K2HPO4 (1 mM final), 1 mL 1M MgSO4 (5mM final), 3.6 mL 50% 
(w/v) glucose (50 mM final) and 0.2 mL SMM trace element solution (see below). 
SMM trace element solution: 0.1 g/L each of ZnSO4.7H2O, FeSO4.7H2O, MnCl2.4H2O, 
CaCl2.6H2O, and NaCl, made fresh over 2-4 weeks, stored at 4 °C. 
Minimal liquid medium (NMMP): Media used to obtain dispersed cultures with specific carbon 
sources. 2 g Ammonium sulphate, 5 g Difco casaminoacids, 0.6 g Magnesium sulphate, 50 g 
PEG 6000, 1 mL minor elements and 800mL distilled water. 
Minor elements: 1 g Zinc sulphate, 1 g Iron sulphate, 1 g Manganese chloride, 1 g Calcium 
chloride.  
Minimal media: 0.5 g L-asparagine, 0.5 g K2HPO4, 0.2 g MgSO4.7H2O, 0.01 g FeSO4.7H2O and 
make up to 1 L with distilled water, separate into 200 mL aliquots and add 3 g Difco Bacto agar 
to each flask pH 7-7.2 and autoclave, then add 4 mL 50% glucose or glycerol.  
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5X M63 minimal medium: 5 g (NH4)2SO4, 34 g KH2PO4, 1.25 mg FeSO4.7H20, 2.5 mg vitamin B1 
(thiamine) and make up to 500 mL with distilled water, adjust pH to 7.0 with KOH.  
RG-2 media pH 7: 50 mM glycerol, 200 mM sucrose, 5mM K2HPO4, 80 mM KCl, 4 mM MgSO4, 
50 mM TES (KOH), 10% antifoam and 0.75 mL/ of RG-2 media. 
ADC: 10 g Bovine albumin fraction V, 4 g Dextrose, 0.008 g Catalase, 1.7 g sodium chloride, 
make this supplement up to 200 mL with distilled water and filter sterilise. 
OADC: 10 g Bovine albumin fraction V, 4 g Dextrose, 0.008 g Catalase, 1.7 g sodium chloride, 
0.1 g oleic acid, make this supplement up to 200 mL with distilled water and filter sterilise. 
7H9: 1.88 g 7H9, 360 distilled water and 200 µL Tween 80, autoclave and add 40 mL ADC (total 
volume 400 mL). 
7H10: 7.6 g 7H10, 2 mL glycerol, 360 mL distilled water and autoclave, cool to 45°C and add 40 
mL OADC (total volume 400 mL). 
 
2.2.2 Growth and storage  
E. coli 
General growth conditions:  E. coli were grown on solid or liquid media at 37 °C for up to 24 h.  
For liquid culture, E. coli were grown in LB (with selection) in an orbital shaker at 250 rpm.  For 
solid culture, E. coli were grown on LA (with selection) and once colonies formed plates were 
stored at 4 °C for up for 2 weeks. 
Making glycerol stocks:  For long term storage of E. coli strains were stored in a 20% glycerol 
solution and stored at -80 °C. 
 
Streptomyces 
General growth conditions: Streptomyces was grown on solid media at 30 °C for 5-7 days until 
colony formation and sporulation was observed. 
Growing S. coelicolor liquid cultures: Spore stock concentrations were measured using optical 
density and the required volume to give a starting OD450 of 0.05 was added 1 mL 0.05M pH 8 
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TES buffer.  The mixture was briefly centrifuged, the supernatant was removed, and the spore 
pellet was re-suspended in 1 mL of TES buffer.  The spore suspension was heat shocked at 50 
°C for 10 min, mixed with 1 mL 2 X PG media and 2 µL 5 M CaCl2, and incubated in a universal 
tube at 37 °C with vigorous shaking for 3h. Following pre-germination of spores, the culture 
was briefly centrifuged and re-suspended in 1 mL liquid media.  The suspension was used to 
inoculate the S. coelicolor liquid culture which was cultured at 30 °C in an orbital shaker at 300 
rpm.  S. coelicolor were grown in siliconized Erlenmeyer flasks with a stainless-steel spring loop 
in the base of the flask to prevent formation of mycelium clumps and improved aeration. 
Making spore stocks:  A single colony was streaked to confluency on MS agar and incubated at 
30 °C for 5 days until the mycelium turned dark grey, indicating production of mature spores.  
To harvest spores, 9 mL sterile water was added to the plate and scraped with a metal loop 
suspending spores in the water.  The crude suspension was filtered through a "spore tube" (2 
cm of non-absorbent cotton wool in a 10 mL syringe, autoclaved to sterilise) into a 15 mL tube 
and centrifuged at 1,000 x g for 10 min.  The supernatant was discarded, and the pellet was re-
suspended in 1-2 mL sterile 20% glycerol.  Spore stocks were stored at -20 °C and remain viable 
for years, even if repeatedly thawed and frozen. 
 
2.3 DNA manipulation  
2.3.1 PCR  
Each reaction consisted of 10 µL 5X Phusion HF (New England Biolabs), 1 µL 10 mM dNTPs, 2.5 
µL 10 µM of each primer (Eurofins), 100 ng genomic M145 DNA a prototrophic derivative of 
strain A3 (2), 1.5 µL DMSO (100X; Fisher Scientific), 0.5 µL of Phusion DNA polymerase (New 
England Biolabs). The final volume was made up to 50 µL by adding nuclease free water 
(autoclaved) ultra-pure water. 
The thermocycler conditions: 
Initial denaturation: 98° C for 30 sec 
Denaturation: 98 °C for 5-10 sec 
Annealing: Lowest Primer Tm °C for 10 -30 sec 
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Extension: 72°C for 15 sec/kb 
Final extension: 72°C for 5-10 min 
Hold at 4°C 
The thermocycler conditions for the annealing and extension were altered for the optimisation 
of the primers used here.  
 
Inverse PCR 
Primers were phosphorylated by combining 200 pmol oligonucleotides, 1 x T4 DNA kinase 
buffer, 2 mM ATP and 0.005 units T4 DNA kinase. The reaction was left at 37°C for 30 min and 
then heated at 90°C for 2 min to inactivate the enzyme. The primers were used to set up a PCR 
reaction as stated in Section 2.2.1.1, using Accuzyme (Bioline) as the thermostable DNA 
polymerase. 
For large products (>3kb), the following PCR cycle was used: 
• Melting at 96°C for 1 min 
• Annealing at 55-65°C for 45 s  
• Extension at 72°C for 2.5 min per 1 kb 
•  Melting at 96°C for 1 min 
• Annealing at 55-65°C for 45 s 
• Extension at 72°C for 3.5 min per 1 kb  
• Final Extension at 72°C for 15 min  
• Held at 4°C 
The PCR products were then separated on a 0.8 to 1% of agarose gel and the gene of interest 







PCR primers were designed to amplify the upstream and downstream flanks separately, with 
an integrated DAS tag, after the gene sequence (stop codon removed). Once these flanks with 
the DAS tag were amplified separately, these were diluted (1/10), and used as a template for 
the second stage of the PCR. For the second stage, primers were designed internal to the 
external primers from the first stage, with restriction sites attached. The internal primers 
should amplify 1000 bp upstream of the gene + the gene + the DAS tag + 1000 bp downstream 




The strains were cultured in Middlebrook 7H9 medium supplemented with ADC, Tween 80, 
kanamycin, hygromycin and pristinamycin for 7 days. 1mL of this culture was heat killed by 
boiling for 1 h and a FastDNA spin kit for soil was used following the manufacturer’s instructions 
for genomic extractions. The genomic DNA was used for PCR and the resulting PCR products 
were sequenced.  
Alternatively, a Chloroform method was implemented, firstly, M. tuberculosis was heat killed 
by boiling for one h at 99°C. Equal volumes of chloroform was added, vortex and centrifuge for 
one minute at full speed. The aqueous layer was harvested which contains the genomic DNA. 
 
S. coelicolor 
A single colony was picked and re-suspend in 0.5% SDS, the mixture was vortexed vigorously 
and heated to 98°C for 5 min. The mixture was centrifuged, and the supernatant was collected 
into a clean 1.5 mL microcentrifuge tube. To use this genomic preparation, 1:5 dilutions were 
prepared and add to a PCR reaction.  
 
2.3.2 Gibson Assembly  
For 2-3 fragments, 10 μL of Gibson Assembly Master mix (2X; New England Biolabs), 1μL of the 
fragments were added and the final volume was made up to 20 μL. The samples were 
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incubated in a thermocycler at 50˚C for 2 h and store at -20˚C. This mix was then be 
transformed into E. coli DH5α cells. 
 
2.3.3  Restriction digest 
All digests were done in a final volume of 10-40 μL, this includes the appropriate amount of 
DNA, 0.5-1 μL of the restriction enzyme (20,000 units/mL; NEB), restriction buffer (diluted from 
a 10x stock), the final volume was made up with MQ water. The digests were incubated for a 
minimum of 3 h. The digests were confirmed by gel electrophoresis, by running undigested 
DNA. 
 
2.3.4 Gel electrophoresis  
0.8% or 1% agarose (Sigma) gels were used to analyse undigested and digested plasmids. The 
gel was prepared using 100 mL 1X TBE buffer to separate the 1.5 kB flanking regions. The 
samples were run at 150 mA and 75 V against a 1 Kb hyperladder (Bioline). To visualise the 
DNA, gels were stained with GelRed™ Nucleic Acid Gel Stain (Biotium) according to the 
manufacturer’s instructions. The gel was placed onto a rotator (IKA® KS 260 Basic) for 15 min, 
followed by visualisation using a high UV transilluminator.  
The same method from above was used to visualise DNA fragments, however the samples were 
visualised under the low UV transilluminator to limit the mutagenic properties of UV light. The 
desired band was excised and purified using the Gel Purification kit (Qiagen), following the 
manufacturer’s instructions. 
 
2.3.5 Gel purification 
To purify DNA fragments following gel electrophoresis, agarose gel fragments were excised 
with a scalpel and purified with the Wizard® SV Gel and PCR Clean-Up System (Promega) 




2.3.6 DNA dephosphorylation  
DNA was dephosphorylated in 1 X Antarctic Phosphatase buffer with 5 units Antarctic 
Phosphatase (New England Biolabs) and incubated at 37 °C for 15 min (60 min for 3’ 
extensions) before heat inactivation at 70 °C for 5 min. 
 
2.3.7  DNA ligation 
The ligation reaction consisted of 1 µL 10x T4 DNA ligase buffer and 1 μL T4 DNA ligase, 
approximately 100n g of vector DNA with an appropriate concentration of insert, see below:  
Insert (ng) = (100 ng x size of insert (kb))/ (size of vector (kb)) x 3/1 
 
2.3.9.1 Small scale plasmid isolation from E. coli  
To purify plasmid DNA from E. coli, cells were harvested from 3 mL overnight culture at 16,000 
x g for 5 min and the cell pellet was resuspended in 200 µL alkaline lysis solution I. 400 µL 
alkaline lysis solution II was added, mixed by inverting 5 times before addition of 300 µL alkaline 
lysis solution III + 1 µL 10 mg/mL RNase A and incubation for 10 min at room temperature.  The 
mixture was centrifuged at 16,000 x g for 10 min and the supernatant was transferred to a new 
tube.  150 µL P:C:IAA was added, vortexed for 2 min, centrifuged at 16,000 x g for 10 min and 
the upper phase was transferred to a new tube.  600 µL isopropanol was added, chilled on ice 
for 10 min and centrifuged at 16,000 x g for 10 min.  The supernatant was removed, and the 
pellet was washed with 200 µL 70% ethanol before centrifugation at 16,000 x g for 1 minute.  
All supernatant was removed, and the pellet was resuspended in 50 µL dH2O. 
 
2.3.9.2 Large Scale plasmid isolation from E. coli  
To purify plasmid DNA from E. coli on a large scale, the QIAGEN Plasmid Midi Kit (Qiagen) was 




2.3.9.3 Transformation of chemically competent E. coli DH5α 
The transformation protocol (Invitrogen) was used to insert the ligation mix into the competent 
E. coli DH5α cells. 5 µL of the ligation mix was added to a 50 µL aliquot of the competent E. coli 
DH5α cells. This was left to stand on ice for 30 min, followed by heat shocking at 42  ̊C for 20 
sec without shaking. The sample was placed on ice for a further 2 min and 950 μL of pre-
warmed LB was added to the microcentrifuge tube. This was incubated at 37  C̊ for 1 h at 225 
rpm. A 100 uL sample was spread over pre-warmed LA agar plates (with appropriate 
antibiotics) and incubated overnight at 37  ̊C. Typically, transformants were seen 15-17 h post 
overnight incubation. 
 
2.3.9.4 Preparation of chemically competent E. coli (CaCl2 method) 
The preparation of competent E. coli, DH5α cells was performed by following the 
manufacturers protocol (Invitrogen). A single colony was transferred to 5 mL of LB broth with 
appropriate antibiotics and grown for overnight at 37  C̊ shaking. 1:100 of the overnight culture 
was used to inoculate a fresh LB broth flask the following morning and the cells were left to 
culture to an OD600 0.4-0.5. The cells were harvested by centrifugation at 2,000 x g for 10 min 
and the pellet was re-suspended in 20 mL ice-cold 0.1 M MgCl2 10% glycerol. The cell 
suspension was centrifuged at 2,000 x g for 10 min and the pellet re-suspended in 10 mL ice-
cold 0.1 M CaCl2 10% glycerol. The solution was incubated on ice for 30 min before being 
centrifuged for a further 10 min at 2,000 x g. The cell pellet was re-suspended in the residual 
volume, approximately 3 mL and 150 μL aliquots were frozen in dry ice and stored at -80  C̊. 
 
2.3.9.5 Intergeneric conjugation of DNA into S. coelicolor 
Intergeneric conjugation into S. coelicolor was carried out using E. coli strains which contain a 
vector with the oriT, ET12567/ pUZ8002 and ET12567/pR9407. A single colony was used to 
inoculate a 5 mL LB culture with the appropriate antibiotics overnight at 37°C. This culture was 
then used to inoculate a 15 mL culture and grown to an OD600 of 0.4-0.6. The cells were then 
washed twice with cheap muller broth and re-suspended with 0.1 volume of LB broth. In the 
meantime, 5 µL of the appropriate S. coelicolor strain was added to 500 μL of YT broth and 
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heat shocked at 50°C for 10 min. Once cool, 500 μL of the E. coli cells were added to the YT 
broth mixture. The cells were spun, followed by re-suspending the pellet in the residual volume 
(~100 μL). This was then plated onto pre-dried (for one h) MS agar + 10 mM MgCl2 plates. 
After 16-20 h an overlay was poured over the plate which contained 1 mL of sterile water and 
Naladixic acid with other antibiotics for the selection of the plasmids and incubated at 30°C. 
Following 3-4 days, exconjugants were picked off for further plating. 
 
2.3.9.6 Electroporation of M. tuberculosis  
10 mL 7H9-Tween was inoculated with the M. tuberculosis RbpA BL strains were grown to log 
phase. 2 M glycine was added to a final volume of 1.5% v/v and incubated for 16-24 h. The 
cultures were centrifuged for 10 min and the pellet was washed twice with 10 mL 10% glycerol 
followed by 5 mL 10% glycerol. The cell pellet was re-suspended in 1 mL 10% glycerol and 2 µg 
of plasmid DNA was added to 0.2 mL of the M. tuberculosis culture. The culture and DNA were 
mixed thoroughly and transferred to a 0.2 cm electrode gap electroporation cuvette. Cells 
were electroporated with a single pulse of 2.5 kV, 25 µF and 1000 Ω. After the electroporation, 
cells were transferred immediately to 7H9 broth and incubated for a further 16 hours at 37°C. 
The cells were harvested by centrifugation for 3,000 x g for 10 min and the cells were diluted 
to 1:10 and 1:100, 100 µL of these dilutions were plated onto 7H10-OADC supplemented with 
30 µg/mL kanamycin, 50 µg/mL hygromycin and 0.5 µg/mL PI. The plates were dried and 
incubated for 4 weeks at 37°C. 
 
2.4 Setting up cultures  
M. tuberculosis  
The basic linker mutants were cultured in the presence of 0.5 µg/mL Pristinamycin (PI) for 7 
days and harvested at 3,000 rpm for 10 min. The supernatant was removed, and the cells were 
washed twice in PBS (to remove pristinamycin) followed by normalising the amount of cells 
added to a fresh 10 mL Middlebrook 7H9 media (without PI) to ensure that the starting point 
for each culture was similar. The optical density (OD600) was measured at regular intervals and 
colony forming units (CFUs) were measured by plating a dilution series of bacilli onto 
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Middlebrook 7H10 agar supplemented with OADC, 30 µg/mL kanamycin and 50 µg/mL 
hygromycin. The cultures were plated onto LB agar on day 28 to check for contamination, no 
growth was seen on any plates after overnight incubation. Colony PCR was repeated at regular 
intervals through the experiments to check that use of PI had not caused spontaneous PI 
resistance, therefore on each occasion the ptr promoter and Rv2050 downstream of the 
transposon insertion were amplified and sequenced. 
S. coelicolor 
Normalise the spore stocks to OD450 0.05 for all of the spores to ensure that the starting 
number of spores between samples is the same. The spores are added to 1 mL 0.05 M TES 
buffer (pH check), and heat shocked for 10 min at 50°C. The heat shocked spores are added to 
1 mL 2 X PG media and 2 µL 5 M CaCl2 and incubated for 3 h at 37°C shaking. The spores are 
vortexed vigorously and added to a desired amount of media (YEME, NMMP, SMM) and left 
overnight.  
 
2.5 Most probable number assay (MPN) 
MPN is used to estimate the minimal number of cells required for growth, by serially diluting 
the bacterial culture. Firstly, M. tuberculosis was cultured to mid log phase (day 7, 0.2 OD600) 
in the presence of PI (0.5 µg/ml), kanamycin (30 µg/ml) and hygromycin (50 µg/ml). Secondly, 
450 µL 7H9 media supplemented with kanamycin and hygromycin was pipetted into every 24- 
well plate. Thirdly, 50 µL samples from each RbpA BL strain was placed into the first well (10-1) 
and serially diluted to 10-12, this was carried out as four technical replicates and three biological 
replicates for M233 (pMV306::rbpAWT), M233 (pMV306), M233 (pMV306::rbpA3KA), M233 
(pMV306::rbpAR80A) and M233 (pMV306::rbpA3KRA). The plates were incubated for six weeks at 
37°C and then read using a plate reader (OD600). A control plate with no cells was used as a 
measure of no growth. The 12 readings per strain were entered into an MPN calculator to 




2.6 Colony forming units (CFU) for M. tuberculosis 
A serial dilution method similar to the MPN assay was used to determine the colony forming 
units per mL (CFU/ml) of M. tuberculosis. 100 µL of the liquid culture was added to 900 µL of 
sterile PBS (10-1 dilution), vortexed briefly. 100 µL from the 10-1 dilution was further diluted in 
900 µL PBS and so on until a dilution series from 10-1-10-12 was generated. 40 µL samples from 
each dilution series was spotted onto 7H10 agar plates supplemented with kanamycin and 
hygromycin. These plates were incubated for four weeks at 37°C and then the 





𝑛𝑜. 𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 𝑥 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
𝑉𝑜𝑙 𝑝𝑙𝑎𝑡𝑒𝑑 𝑖𝑛 𝑚𝐿
 
 
2.7 Protein purification 
Ni-NTA spin column: Ni-NTA spin column (Qiagen) was used for small-scale purification of His-
tagged proteins according to manufacturer’s instructions.  
TCA precipitation: Mycelium (1.5 mL) were sampled at 3-time points (0, 20 and 40 min), upon 
induction three different stress (Diamide 1 mM, serine hydroxymate 50 mM and sodium 
hypochlorite 2.5 mM), centrifuged at 16,100 x g for 10 min at 4 °C. The pellets were then 
washed with 240 μL ice-cold 0.9% (w/v) NaCl followed by 60 µL of 50% TCA and incubated on 
ice for 20 min. This was then centrifuged again at 16,100 x g for 10 min at 4°C, the TCA was 
removed, and microcentrifuge tubes were spun again as above. The pellets were washed in 
acetone to ensure that all the TCA was removed and spun again as above. The acetone was 
left to evaporate followed by re-suspending the pellet in 100 μL of loading buffer (100 mM 
iodoacetamide, 6 M urea, 200 mM Tris/HCL, pH 7.2, 10 mM EDTA and 0.5% SDS). Samples were 
boiled and loaded on a 12% Bis-Tris non-reducing protein gel. 
Cobalt Histag columns: followed manufacturers protocol (Thermo Scientific) 
HisTrap purification: The HisTrap nickel column was washed with 5 CV distilled water, 5 CV 
buffer A (refer to section 2.2.1 Methods), equilibrate with 5 CV buffer B (Methods section 
2.2.1) and wash with 10 CV buffer A until the UV detector is zero. The sample was loaded onto 
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a 5 mL loading loop using the injection function and loaded, several times until all of the cell 
lysate was injected onto the column. The column was washed with 5 CV buffer A, then the 
protein was eluted into 0.5 mL fractions using the fractionator with an imidazole gradient was 
completed. 10 µL of these fractions were run on an wester gel and the fractions confirming the 
presence of the protein were pooled together and concentrated using a ultracentrifugation 
vivaspin column (Sartorius). The protein sample was dialysed in buffer C (Methods 2.2.1) 
overnight.  
 
2.8.1 Gel filtration 
Gel filtration was performed using a 200 pg 16/600 column (GE Healthcare) and Akta FPLC 
(Amersham PLC). The column was washed with 10 CV of gel filtration buffer overnight, pump 
washed and 2mL of concentrated protein sample was loaded, the program S16/600 
fractionation was run. 10 µL samples for each of the fractions was run on an SDS-PAGE gel and 
the fractions confirming presence of the protein were pooled together and concentrated to 
250 µL and re-dialysed using buffer C overnight at 4°C.  
 
2.8.2 Protein sample analyses via SDS-PAGE 
Every protein sample was normalised to 10 µg, 10% SDS gels Tris-glycine SDS- polyacrylamide 
gel electrophoresis was used to run the protein samples. Protein samples were mixed with the 
appropriate volumes of DTT and loading buffer. The protein samples were boiled at 98°C for 
10 min and centrifuged at full speed for 1 min. Gels were run using a Hoefer SE260, a mini 
vertical gel electrophoresis unit (Amersham Biosciences) at 120 V for 2 h in NuPAGE® MES SDS 
running buffer (Invitrogen). Protein was visualised by staining with Ponceau stain, followed by 
Coomassie Brilliant Blue and washed with de-staining solution. 
2.8.3 Western blot analysis 
The protein samples were separated by SDS-PAGE and transferred onto a Protran® 
nitrocellulose membrane (0.2 μM, Whatman), using a semi-dry transfer method at 20 V for 1 
h. Following this, the membrane was washed with 1x TBS-Tween 3 times for 10 min and 
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incubated with blocking solution at RT for 1-2 h with gentle rocking at 4°C. The membrane was 
washed again 3 x 10 min with 1x TBS-Tween and incubated overnight with primary antibody, 
which was diluted in blocking solution at 4°C with gentle rocking. Following this, the membrane 
was washed for 3 x 10 min with 1 x TBS-Tween and incubated for 1 h with the secondary 
antibody HRP conjugate which was also diluted in blocking solution at 4°C with gentle rocking. 
The membrane was washed for 3 x 10 min with 1 x TBS-Tween and subjected to ECL detection. 
The ECL developer solutions A and B were mixed in a 50:50 ratio and poured onto the 
membrane for 1 min, the membrane is then imaged using the LICOR.  
 
2.9 RNA isolation from S. coelicolor  
The S. coelicolor cultures were grown to OD450 0.6, at which point a stop solution (95:5 ethanol: 
acid phenol) was added to the cultures in a 5:1 ratio (culture: stop solution). 10 mL cultures 
were left at RT for 10 min and centrifuged to remove the supernatant. 2 volumes of RNA 
protect was added to the samples, vortexed for 5 sec and incubated at RT for 5 min. The 
samples were centrifuged for 10 min at 5000 x g and the supernatant was removed. 1 mL of 
TRI reagent was used to resuspend the pellet, before flash freezing. Once all of the samples 
were harvested, the cells in 1 mL TRI reagent were thawed and the nucleic acid extraction 
protocol was followed. 200 µL TRI reagent was added to all of the samples and placed into 0.1 
mm silica beads (Lysing matrix B) and mixed briefly. The bacterial cells were lysed using the 
ribolyser for 45 sec at 6.5 Hz. The samples were left at RT for 10 min and then 200 µL 
chloroform was then added to each cell suspension, vortexed for 30 sec, and incubated at RT 
for a further 10 min to partition the aqueous and phenolic phases before centrifuging at 13,000 
rpm for 15 min at 4°C. The aqueous phase was then transferred to a fresh microcentrifuge tube 
and re-extracted with an equal volume of chloroform. The aqueous phase was transferred to 
a fresh microcentrifuge tube, 0.8 volume isopropanol added and mixed by inverting twice and 
incubated overnight at -20°C to precipitate the nucleic acids. The nucleic acid extractions were 
centrifuged at 13,000 rpm for 20 min at 4°C. A white precipitate should be visible, the 
supernatants were carefully removed and discarded. The pellets were washed by adding 500 
µL cold 70% ethanol, centrifuging at 13,000 rpm for 15 min at 4°C and removing the ethanol, 
the tubes were re-spun to remove any excess ethanol. The pellets were air dried for a few min 
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and re-suspended into 100 µL RNAse free- water. The RNA was cleaned up using a RNeasy 
column (following manufacturer’s instructions). The RNA was stored at -70°C and a 5 µL sample 
was stored separately for bioanalysis of the RNA quality.   
 
2.9.1 RNA isolation from M. tuberculosis  
M. tuberculosis was cultured in 50 mL Middlebrook 7H9 supplemented with ADC, Tween 80, 
30 µg/mL kanamycin and 50 µg/mL hygromycin for 8 days and the OD600 was measured to 
ensure that all of the biological replicates were in the same growth phase. Transcription was 
stopped in the cultures by adding 4 volumes of 5 M GTC (5 M guanidine thiocyanate, 0.5% 
sodium N-lauroyl sarcosine, 25 mM sodium citrate, 1% Tween-80, 0.1 M β-mercaptoethanol; 
Salina et al., 2014). The cultures were centrifuged in 30 mL aliquots for 30 min and the 
supernatant was carefully removed. The process was repeated until the bacilli were combined 
and re-suspended into 1 mL of Trizol and stored at -80˚C. The sterilised samples were removed 
from the CL3 laboratory and each of the samples were made up to 1.2 mL Trizol and added to 
0.5 mL of 0.1 mm silica beads (Lysing matrix B). The bacterial cells were lysed using a ribolyser 
for 45 sec at a speed of 6.5 Hz. The disrupted cells were then left at room temperature for 10 
min. 200 µL chloroform was then added to each cell suspension, vortexed for 30 sec, and 
incubated at RT for a further 10 min to partition the aqueous and phenolic phases before 
centrifuging at 13,000 rpm for 15 min at 4°C. The aqueous phase was then transferred to a 
fresh microcentrifuge tube and re-extracted with an equal volume of chloroform. The aqueous 
phase was transferred to a fresh microcentrifuge tube, 0.8 volume isopropanol added and 
mixed by inverting twice and incubated overnight at -20°C to precipitate the nucleic acids. The 
nucleic acid extractions were centrifuged at 13,000 rpm for 20 min at 4°C. The supernatants 
were carefully removed and discarded, avoiding the white precipitate. The pellets were 
washed by adding 500 µL cold 70% ethanol, centrifuging at 13,000 rpm for 15 min at 4°C and 
removing the ethanol. The tubes were re-spun to remove any excess ethanol. The pellets were 
air dried for a few min and re-suspended into 100 µL RNase free water. The RNA was cleaned 
up using a RNeasy column (Qiagen, following manufacturer’s instructions) which included a 
DNase treatment step on-column method (Qiagen) The RNA was stored at -80°C, storing a 
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separate 5 µL sample for analysis of the RNA quality and yield using the Agilent Bioanalyser 
NanoChip and Nanodrop spectrophotometer.  
 
2.10 Chromatin immunoprecipitation 
Chromatin immunoprecipitation (ChIP) is a technique used to study protein-DNA interactions.  
It involves crosslinking all protein-DNA complexes, precipitating the protein of interest with an 
appropriate antibody and analysing the DNA fragments purified, typically through qPCR or 
high-throughput DNA sequencing. To perform the crosslinking, cultures for S417 and S418 
were cultured in YEME-10 (with glycerol as a carbon source) to mid-late exponential phase 
(OD450 = 1.5–2).  37% formaldehyde solution was added to a final concentration of 1% before 
incubation for a further 20 min at 30 °C.  To quench the remaining formaldehyde, glycine was 
added to a final concentration of 0.5 M before incubation for 5 min at room temperature.  For 
each immunoprecipitation, 70 mL aliquots of cells were harvested by centrifugation at 
6,000 x g for 2 min at 4 °C, washed twice with 25 mL ice-cold PBS and cell pellets were stored 
at -80 °C until required. 
Keeping frozen in liquid nitrogen, pellets were cryogenically ground for 3 x 90 s before 
resuspension in 2.2 mL IP buffer (with 0.1 mg/mL RNase A + protease inhibitor).  Cells were 
further disrupted, and DNA fragmented by sonication using a Diagenode Bioruptor.  To do this, 
each pellet suspension was divided into 6 x 400 µL aliquots and sonicated for 35 cycles of 
sonication (30 s on, 30 s off) at 4 °C.  Samples were centrifuged at 16,000 x g for 30 min to 
remove cell debris and the supernatant transferred to a new tube.  To visualise the degree of 
DNA fragmentation, a 20 µL sample of the supernatant was treated with 2 µL Riboshredder 
RNase Blend at room temperature for 30 min followed by 2 µL proteinase K at 55 °C for 2 h 
and de-crosslinked at 65 °C for 6 h.  This sample was run on a 1.2% agarose gel to check DNA 
fragment size; a smear ranging from ~150 bp to 600 bp was seen and judged suitable for 
sequencing. To perform the immunoprecipitation, the chromatin samples were first pre-
cleared with the appropriate Protein A/G magnetic beads; this is a process that reduces 
non-specific binding by removing proteins that may bind immunoglobulins.  Protein G magnetic 
beads (New England Biolabs) were used for RNAP and 3XFLAG immunoprecipitations. Pre-
clearing was performed with 50 µL magnetic beads incubated at 4 °C for 1.5 h rotating at 20 
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rpm.  Following incubation, the magnetic beads were immobilised with a magnetic rack and 
the cleared supernatant was transferred to a new tube.  100 µL of this pre-cleared chromatin 
was removed and stored at -20 °C as an "input" control.  1–5 µg of the following antibodies 
was added to the remaining cleared chromatin and incubated at 4 °C for 2.5 h rotating at 20 
rpm: 
• 7 µL anti-FLAG M2 monoclonal antibody (Sigma F18041MG)  
30 µL of appropriate magnetic beads were added and incubated for a further 1.5 h.  The beads 
were immobilised with a magnetic rack and the spent supernatant was discarded.  The beads 
were gently resuspended in 750 µL ice-cold IP buffer, transferred to a new tube and incubated 
at 4°C for 10 min rotating at 20 rpm.  The same wash procedure was performed with 1 mL ice-
cold IP + salt buffer, IP wash buffer and finally pH 8 TE buffer.  After washing, the magnetic 
beads were resuspended in 100 µL 1 x IP elution buffer + 5 µL RiboShredder RNase blend and 
incubated at room temperature for 30 min.  At this point, the “input” control sample was 
thawed and incubated with 5 µL RiboShredder RNase blend at RT for 30 min before de-
crosslinking both the IP and input samples in a 65°C water bath overnight.  The following day 
the beads were immobilised and washed with an additional 50 µL pH 7.5 TE buffer.  50 µL 
pH 7.5 TE buffer was added to the input sample.  150 µL IP and input samples were finally 
purified through a Qiagen MinElute PCR purification kit and eluted with 22 µL MQ water. 
 
2.10.1 qPCR 
qPCR was performed in a 96-well PCR plate using a StepOnePlus Real-Time PCR system (Applied 
Biosystems).  A dilution series for genomic M145 DNA was prepared, ranging from 30-
3,000,000 copies. The primers were prepared to a 1/20 dilution and the input control DNA was 
diluted to 1/1000, immunoprecipitated DNA in 1/10 dilution. A 12X GoTaq qPCR master mix 
was prepared for each primer set. 23 μL of the master mix was added to each well followed by 




2.11 S1 nuclease protection assay 
2.11.1 Preparing the gel 
The glass plates and comb were washed with detergent and polished with 70% ethanol. The 
glass plates were mounted onto the stand. The gel was made using 16 mL UreaGel concentrate, 
29 mL UreaGel diluent, 5 mL UreaGel buffer, 400 µL 10% APS and 20 µL TEMED to a total 
volume of 50 mL. The gel was poured into the mould making sure not to avoid bubbles. The 
comb was added, and the stand was rotated to position the glass plates vertical. The gel was 
left to polymerise for 1 h and thereafter the comb was removed. The gel-glass plates were 
placed into the gel tank and 1X TBE was poured gently into the wells to remove any bubbles, 
additionally a syringe was used to remove any urea from the wells. The pump in the gel tank 
was switched on and set to 55°C and the gel was pre-run for 45 mins. Finally 3 µL samples were 
loaded.  
 
2.11.2 S1 nuclease protection assay 
To create the probe, the reverse primer (downstream from the 5’ end) was first labelled with 
32P as follows: 2 μL oligonucleotide (5 pmol/μL), 4 μL 10 X T4 polynucleotide kinase buffer, 5 
μL ATP [γ-32P], 1 μl T4 polynucleotide kinase and made up to 40 μL with RNAse free water.  
Then incubated for 30 min at 37°C and heated to 80°C for 10 min followed by cooling on ice. 
The oligonucleotide was purified using a Sephadex matrix. The Sephadex column was placed 
into a clean 1.5 mL microcentrifuge tube and centrifuged at 1000 x g for 1 min at RT. The eluted 
buffer was discarded and placed into a clean tube again. 300 μL RNAse free water was placed 
into the column and centrifuged at 1000 x g for 2 min at RT. The oligonucleotide was mixed 
carefully and applied to the prepared Sephadex column and centrifuged at 1000 x g for 4 min 
at RT, this purified column was stored at -20°C.   
To perform S1 mapping, 30 µg RNA was mixed with 5-10 ng of probe and lyophilised with a 
SpeediVac.  The dried pellet was re-suspended in 20 µL 1X S1 hybridisation buffer, incubated 
in a water bath at 70 °C for 10 min before allowing the temperature to fall to 42 °C overnight.  
300 µL S1 digestion mix was forcibly added to the mixture, thoroughly mixed and placed in ice 
water until all samples were ready.  The digest mix was incubated in a water bath at 37 °C for 
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45 min until the reaction was stopped by addition of 75 µL S1 stop buffer.  1 µL glycogen and 
400 µL isopropanol was added, mixed and incubated at -20°C for 1 h.  The mixture was 
centrifuged at 16,000 x g at 4°C for 15 min and all supernatant was removed.  The pellet was 
washed with 70% ethanol and air-dried for 10 min.  The pellet was then re-suspended in 6 µL 
S1 formamide loading buffer, heated at 95 °C for 2 min and 3 µL was run on an 8% UREA-PAGE 
sequencing gel at 600 V for 1 h 20 min with 1 X TBE running buffer. The gel was dried onto 
Whatman paper and exposed overnight in a phosphorimaging cassette before visualisation the 
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role of the RbpA basic linker in 











3.1.0 Overview  
The RbpA-Sigma Interaction Domain (SID) has been the most extensively studied region of 
RbpA and has been shown to interact with the σ2 domain of the principle sigma factors in both 
S. coelicolor and M. tuberculosis. However the functions of the N-terminal tail, RbpA core 
domain (RCD) and basic linker (BL) are less well defined. This chapter focuses on elucidating 
the function of the RbpA basic linker in S. coelicolor.  
At the outset of this investigation, mutagenesis had revealed that the RbpA BL residue R80 
played an important role in RbpA function in vivo and in vitro.  An X-ray crystal structure and 
subsequently cryo-EM structural studies positioned the RbpA BL to interact with the extended 
-10 promoter element (Boyaci et al., 2018; Hubin et al., 2015; Hubin et al., 2017a) (Fig 3.1). 
The positively charged R79 residue in M. tuberculosis (RbpAR80 in S. coelicolor) is positioned 
closely to interact with the negatively charged positions -13 and -14 on the DNA backbone 
(Hubin et al., 2017a). Further, truncations of RbpA lacking the BL-SID (residues 1-79) were 
unable to activate transcription in vitro, suggesting that key elements for activation are in the 
BL-SID (Hubin et al., 2015). Formaldehyde cross-linking analysis using full length RbpA and BL-
SID truncations suggested a DNA binding role (Hubin et al., 2015). However, the roles of the 
three conserved lysines in the BL (K74, K75 and K77) were less clear. Preliminary work (A. Tabib-
Salazar and M. Paget, personal communication) revealed that mutants lacking all three lysine 
residues fully restored normal growth to a ΔrbpA mutant, while such a mutant could not cross-
link DNA nor activate transcription in vitro. Although apparently contradictory, these data 
suggest a role for the lysine BL residues, possibly overlapping with that of R80. Residues K74, 
K75 and K77 and R80 (S. coelicolor) are very well conserved across the actinobacteria and 
therefore suggestive of an important role for RbpA-BL in the overall function of RbpA, possibly 
DNA binding or enhancing transcription activation. Therefore, the first section of this chapter 
investigates the phenotypes of the RbpA BL mutant alleles in the ΔrbpA conditional mutant 
S401 using solid and liquid media. The second section of this chapter uses RNA-seq to identify 







Figure 3.1. Cryo-EM structure of RNAP-σA holoenzyme with RbpA and complexed with upstream 
fork DNA in M. tuberculosis. The RNA polymerase subunits, β, β’, α1, α2, ω and Fdx have been 
removed from the structure to focus on the position of the RbpA BL. RbpA in red and σA in 
blue, nt-DNA in dark grey and t-DNA in light grey. The basic linker residues in RbpA, lysines K74, 
K75 and K77 in green and arginine R80 in yellow. The structure was downloaded from RCSB 
PDB, accession number 6C04 and visualised with PyMOL (version 2.0.7; Hubin, et al., 2017a). 
 
3.1.1 Construction of the basic-linker mutants in S. coelicolor  
A ΔrbpA mutant strain in S. coelicolor exhibits a small colony morphology, because of its 
paralogous rbpB. RbpB is not essential in S. coelicolor and a ΔrbpB mutant does not have a 
growth phenotype. However, a ΔrbpA ΔrbpB mutant strain fails to grow, therefore all 
experiments were performed in rbpA null mutant backgrounds in which the paralogous rbpB 
was also knocked out as it might mask the effects of certain alleles (A. Tabib-Salazar and M. 
Paget, unpublished).  
The RbpA-BL mutants were introduced into S401 strain (A. Tabib-Salazar and M. Paget, 
unpublished), in which the only copy of rbpA is induced by thiostrepton. In this background the 
phenotypes of mutants can therefore be fully established when cultured in the absence of 
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thiostrepton. As previously (Tabib-Salazar et al., 2013), alanine substitution was used to 
minimize unwanted structural effects.  
The starting plasmid for constructing the mutations was pMT3000::rbpA-NdeI (created by Aline 
Tabib-Salazar), which includes 150 bp rbpA upstream DNA and an NdeI restriction site inserted 
at the start codon of the rbpA gene, to enable sub-cloning into expression vectors. The 
pMT3000::rbpA-NdeI was previously shown to fully complement an ΔrbpA mutant (Tabib-
Salazar et al., 2013). This plasmid was used as a template to engineer the BL mutant PCR 
products, rbpAK74A, rbpAK77A, rbpAR80A, rbpA3KA (K74A, K75A and K77A) and rbpA3KRA (K74, K75, 
K77 and R80 substituted with alanine) using inverse PCR and confirmed by sequencing.   
PCR primers were designed to insert flanking HindIII sites 135 bp upstream of the rbpA start 
codon and immediately upstream of the stop codon, allowing the creation of an in-frame 
fusion with the 3xFLAG epitope tag in the integrative plasmid pRT802::3XFLAG (Methods, Table 
2.1). pRT802, like pIJ6902 (integrates at the φC31 site), integrates in the genome of S. 
coelicolor, in this case at the φBT1 attachment site (Gregory et al., 2003). PCR products for the 
rbpAWT, rbpAK74A, rbpAK77A, rbpAR80A, rbpA3KA and rbpA3KRA containing the engineered HindIII 
sites were cloned initially into pBluescript II SK+, checked for SNPs by DNA sequencing, and 
then subcloned as HindIII fragments into pRT802:: 3XFLAG tag, where fusions and between the 
rbpA reading frame and the 3XFLAG tag were confirmed using SpeI/BamHI diagnostic digests. 
Following this, recombinant plasmids were transformed into E. coli ETR competent cells 
followed by conjugation into S. coelicolor S401 selecting for the incoming plasmid (KmR) and 
supplementing with thiostrepton to ensure that the WT rbpA was expressed (Fig. 3.2).  
Thiostrepton was included in all sub-culturing media to reduce the incidence of suppressor 
development. 
 
3.1.2 Phenotype of RbpA BL mutants in S. coelicolor  
S. coelicolor S401 (pRT802::rbpAWT) along with strains expressing the equivalent  BL mutants 
(K74A, K77A, 3KA, 3KRA) or vector only control, were plated to single colonies on MS and 
SMMS agars to test for the effects of the mutagenesis on morphology and antibiotic 
production. Strains were cultured with/without thiostrepton for 4-5 days at 30°C (Fig. 3.3). As 
expected S401 (pRT802::rbpAWT) grew equally well in the presence and absence of 
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thiostrepton because there was at least one copy of rbpA expressed in either condition. Whilst, 
S401 (pRT802) formed very small colonies in the absence of the inducer which is consist with 
an S101 (ΔrbpA) background. Consistent with previous observations, S401 (pRT802::rbpA3KA) 
fully complemented the S401 -Thio phenotype on MS and SMMS agar (Fig. 3.3-3.4), confirming 
that the three lysine residues are not required for normal growth in vivo, despite being 
required to activate transcription in vitro. Strains expressing RbpAR80A and RbpA3KRA produced 
a considerable amount of ACT but grew significantly better than S401 (pRT802) in the absence 
of thiostrepton. These data indicated that although RbpA appears to be essential, the BL itself 
is not essential for growth. Interestingly, although expression of RbpAR80A leads to elevated ACT 
production, the additional substitution of all of the lysine residues (RbpA3KRA) displays a more 
profound effect on ACT production, both on MS agar and SMMS; this is the first indication of 





Figure 3.2. Engineering of the RbpA BL mutants in S401. S401 pIJ6902 (orange) integrated at 
phiC31 site and the tipA promoter is dependent on the inducer thiostrepton. pRT802::FLAG 
(blue) integrates at the φattp site and uses the native rbpA promoter. (A) Presence of 
thiostrepton activates tipA promoter (green) and thus expresses rbpA. (B) In the absence of 
thiostrepton rbpA in pIJ6902 is not expressed, allowing pRT802::rbpA and the rbpA BL mutant 
allele phenotypes to be investigated. The green filled in arrows represent the copy of rbpA 





Figure 3.3. Phenotype of the RbpA BL mutants on MS agar. S401 (pRT802::rbpAWT) (RbpA), S401 
(pRT802) (pRT802), S401 (pRT802::rbpAR80A) (R80A), S401 (pRT802::rbpA3KA) (3KA) and S401 
(pRT802::rbpA3KRA) (3KRA) have been plated onto MS agar +/- 15 µg/mL thiostrepton and 

















Figure 3.4. The phenotype of RbpA BL mutants on SMMS agar. (A) S401 (pRT802::rbpA3KA) (3KA), 
S401 (pRT802::rbpAK77A) (K77A), S401 (pRT802::rbpAK74A) (K74A), S401 (pRT802) (pRT802), 
S401 (pRT802::rbpAWT) (RbpA). (B) S401 (pRT802::rbpAWT) (RbpA), S401 (pRT802) (pRT802), 
S401 (pRT802::rbpAR80A) (R80A) and S401 (pRT802::rbpA3KRA) (3KRA) have been plated onto 
SMMS agar – /+ (right and left respectively) 15 µg/mL thiostrepton and incubated at 30°C for 






3.1.3 Growth curves for the BL mutants in S. coelicolor 
The BL mutants show well defined phenotypes on solid media therefore this was investigated 
in further detail by culturing in liquid media. The strains were cultured in an enriched YEME 
liquid media to test the difference in the rate of growth between the RbpA BL mutants. No 
thiostrepton was added to the cultures to prevent expression of the chromosomal conditional 
rbpA allele, kanamycin was included in the media to support stable expression of the BL mutant 
alleles in pRT802. Samples for optical density (OD450) readings were taken over a period of 44 
h (Fig. 3.5).  
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Figure 3.5. Growth curves of the RbpA  BL mutants in S. coelicolor. S401 (pRT802::rbpAWT; blue), 
S401 (pRT802; red), S401 (pRT802::rbpAR80A; purple), S401 (pRT802::rbpA3KA; green) and S401 
(pRT802::rbpA3KRA; orange) were cultured in YEME supplemented with glycerol at 30°C, 300 
rpm without addition of thiostrepton. The results represent three biological replicates for S401 
(pRT802::rbpAWT) and S401 (pRT802::rbpA3KA). The results of two biological replicates shown 
for S401 (pRT802::rbpAR80A) at 21, 24, 35, 38 and 41 h, S401 (pRT802::rbpA3KRA) at 24, 26, 38 





The growth curve using OD showed that the S401 (pRT802::rbpA3KA) and S401 
(pRT802::rbpAWT) grew at a similar rate whereas S401 (pRT802::rbpAR80A) and S401 
(pRT802::rbpA3KRA) showed an extended lag phase compared to the RbpAWT and delayed entry 
into exponential phase. Despite this, both were still viable in liquid media, which supports the 
phenotype seen on solid media. It is difficult to draw many conclusions from this growth curve 
as the negative control, S401 (pRT802) grew at a similar rate to S401 (pRT802::rbpA3KRA). During 
the growth curves, it was observed that the BL mutant flasks were changing the colour of the 
media with the production of secondary metabolites. Therefore, the levels of the blue pigment, 
actinorhodin was quantified. The RbpA BL mutants were pre-germinated for 3 h and cultured 
in RG-2 media nitrogen limited (Bystrykh et al., 1996). The detection assay for actinorhodin 
was performed to analyse the intracellular ƴ-actinorhodin. The cells were re-suspended in 1N 
KOH and incubated at room temperature for 1 h and centrifuged, the supernatant was 
collected and the A640 was measured (Fig. 3.6). The quantification of ACT showed that the S401 











Figure 3.6. Actinorhodin production in the RbpA BL mutants. Spores for the BL mutants, 
(pRT802::rbpAWT; blue), S401 (pRT802; red), S401 (pRT802::rbpA3KA; green), S401 
(pRT802::rbpAR80A; purple) and S401 (pRT802::rbpA3KRA; orange) were normalised and pre-
germinated for 3 h following addition to RG-2 media containing no nitrogen and samples were 
collected at 72 h. This result is from one biological replicate (3 technical replicates) and the 
error bars denote mean with standard deviation. Unpaired T-tests: RbpA vs pRT802 p-value= 
<0.0001, RbpA vs 3KA p-value= 0.0016, RbpA vs R80A p-value= 0.249, RbpA vs 3KRA p-
value=<0.0001.  
 
3.1.4 Expression levels of the BL mutants in S. coelicolor 
The growth curve and the solid media provide evidence of a phenotype for S401 
(pRT802::rbpAR80A) and S401 (pRT802::rbpA3KRA) and a functional role of the RbpA BL in growth. 
However, it is possible that the more severe phenotype seen in these BL mutants is not 
decreased DNA interaction but rather decreased protein stability. To address this, this section 
investigates the expression levels of rbpA in each of the strains.  
The spore stocks for S401 (pRT802::rbpAWT), S401 (pRT802), S401 (pRT802::rbpAR80A),  S401 
(pRT802::rbpA3KA) and S401 (pRT802::rbpA3KRA) were all 3XFLAG (Table 2.2) were normalised 
and cultured in enriched YEME media. At OD450 0.8, 10 mL samples were harvested (Methods; 
2.4) and the protein concentrations of the cell lysate were quantified using the Qubit protein 
assay kit and each loading sample was subsequently normalised to 15 µg before running on a 
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10% SDS gel. The membrane was blotted for RbpA using the primary anti-FLAG antibody. The 
secondary antibody for RbpA was anti-mouse anti-HRP and the membrane was subsequently 
imaged using the LI-COR. The expression levels of the RbpA BL mutants were quantified relative 
to rbpAWT using median signal values from the LI-COR. All three of the BL mutant alleles, 
rbpA3KA, rbpAR80A and rbpA3KRA showed lower protein levels compared to the rbpAWT (Fig. 3.7).  
Despite the lower expression levels of all three BL mutants, rbpA3KA has the same colony 
morphology and growth rate as rbpAWT. This indicates that the over-production of actinorhodin 
in rbpAR80A and rbpA3KRA may be due to the loss of the BL-DNA interactions, as the expression 
level of rbpA3KA is consistent with the other BL mutants however does not produce 
actinorhodin. Therefore, the strains were taken forward for futher experiments.  
 
Figure 3.7. Expression levels of the RbpA BL mutant alleles in S. coelicolor. S401 
(pRT802::rbpAWT), S401 (pRT802), S401 (pRT802::rbpAR80A), S401 (pRT802::rbpA3KA ) and S401 
(pRT802::rbpA3KRA) were cultured in YEME supplemented with glycerol to OD450 0.8, 10mL 
samples were harvested and prepared for western blot analysis. This data is compiled from 3 
biological replicates and the expression of the BL mutants were analysed relative to rbpAWT. 




3.1.5 Susceptibility of the RbpA BL mutants to rifampicin 
Rifampicin has been used as a first-line drug for the treatment of active tuberculosis disease 
caused by M. tuberculosis since 1968 (Campbell et al., 2001). Rifampicin targets RNA 
polymerase, specifically the β subunit encoded by rpoB and may prevent the entry of 
elongating RNA into the active site of RNA polymerase (Campbell et al., 2001). The ΔrbpA strain 
exhibits a 15-fold lower MIC (µg mL-1) to rifampicin compared to rbpAWT, this increase in 
susceptibility to rifampicin is poorly understood (Newell et al., 2006). Therefore, this section 
investigates the effect of the BL mutant alleles on rifampicin resistance.  
Spore dilutions containing 1 million spores per 10 µl for each of the RbpA BL strains was plated 
onto minimal media with increasing concentrations of rifampicin, 0-5 µg/mL and incubated at 
30°C for 3 days (Fig. 3.8). The rbpAWT showed a gradual decrease in rifampicin resistance, whilst 
the ΔrbpA (pRT802) shows an increased sensitivity to rifampicin even at the lower 
concentrations (1 µg/mL) of rifampicin, which is consistent with previous findings. The S401 
(pRT802::rbpA3KA) strain demonstrates a similar profile to pRT802::rbpAWT up to 2 µg/mL. The 
S401 (pRT802::rbpAR80A) and S401 (pRT802::rbpA3KRA) show sensitivity to rifampicin at very low 
concentrations, 0.5 µg/mL and share a similar sensitivity profile to ΔrbpA (pRT802). This would 
suggest that the mutant allele’s rbpAR80A and rbpA3KRA are implicated in rifampicin resistance of 
S. coelicolor. Alternatively, the ΔrbpA strain is more susceptible to rifampicin because of less 
active RNA polymerase. RbpA could be important for recovery of the cell from the stress 
caused by rifampicin. However, it was difficult to conclude that RbpA may require a fully 
functional BL to resist rifampicin without protein expression levels post rifampicin treatment. 
Therefore, western blot analysis was implemented to investigate the effect of rifampicin 
treatment on the expression levels of the BL mutants. However, rifampicin is capable of 
activating sigR, which goes onto activate the SigR regulon. RbpA is a member of the SigR 
regulon and thus is induced by rifampicin, therefore the western blots to investigate the 







Figure 3.8. Sensitivity of the BL mutants in S. coelicolor to rifampicin. The spore stocks for S401 
(pRT802::rbpAWT), S401 (pRT802), S401 (pRT802::rbpA3KA), S401 (pRT802::rbpAR80A), S401 
(pRT802::rbpA3KRA) were normalised to 1 million spores per 10 µl and spotted onto minimal 
media with 0-5 µg/mL rifampicin. The plates were incubated at 30°C for 3 days.  
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3.1.6.1 RNA extractions in S. coelicolor  
The rbpA BL mutant, S401 (pRT802::rbpA3KRA) demonstrated increased production of ACT and 
reduced growth both on solid agar and liquid culture. Therefore, to investigate the significance 
of the S401 (pRT802::rbpA3KRA) in vivo, the technique for RNA extraction was optimised so that 
RNA-seq analysis of the S401 (pRT802::rbpAWT) could be compared to S401 (pRT802::rbpA3KRA) 
and S401 (pRT802).  
Traditionally Streptomyces RNA is prepared by flash freezing the cell pellet and grinding using 
a pestle and mortar (Jeong et al., 2016). This method was tested for the purpose of extracting 
RNA from S401 (pRT802::rbpAWT). However, the method involved large time lags between 
times taken from centrifugation of cultures to addition of TRI reagent. There was also long 
periods of extensive handling and processing of the samples which increased the likelihood of 
RNAse contamination. Therefore, an RNA extraction method from M. tuberculosis was 
modified for use in S. coelicolor. The spores for S401 (pRT802::rbpAWT), S401 (pRT802) and 
S401 (pRT802::rbpA3KRA) were normalised and pre-germinated for 3 h. The spores were 
cultured in 60 mL YEME supplemented with glycerol to OD450 0.8. At this point, 12 mL samples 
were added to stop solution at a 5:1 culture: stop solution followed by RNA protect and 
immediately centrifuged as a precautionary measure to prevent transcriptional changes during 
the handling of samples. The sample pellets were suspended in TRI reagent and ribolysed, the 
same protocol method of nucleic acid extraction, precipitation and RNA clean-up was followed 
as described in Methods; 2.6. The bioanalysis and nanodrop results all provided an indication 
that the RNA quality was good shown by the presence of two peaks for the 16S and 23S 




Figure 3.9. Bioanalyzer results of the RbpA BL RNA samples from S. coelicolor. The RNA samples 
were analysed using the Agilent 2100 Bioanalyzer NanoChip® systems. A-C S401 
(pRT802::rbpAWT), 3 biological replicates. D-F S401 (pRT802), 3 biological replicates. G-I S401 
(pRT802::rbpA3KRA) 3 biological replicates. 
 
3.1.6.2 Sample preparation and the library preparation at Oxford genomics 
centre 
The quality of the samples was checked at the Oxford genomic centre, Wellcome Trust for 
Human genetics (UK) by running the samples on a Tapestation and qubit for RNA 
quantification. The gel image (Appendix. 1) shows that all the samples had bright band for both 
ribosomal subunits, 16S and 23S, which is a good indication of the quality of the RNA samples. 
The library preparation of the 9 S. coelicolor samples (three biological replicates for S401 
(pRT802::rbpAWT), S401 (pRT802::rbpA3KRA) and S401 (pRT802) was commenced after the 
quality control checks were completed using the Truseq Stranded mRNA library prep kit from 
Illumina and the sequencer, Illumina Hiseq 4000. The library was prepared using 0.1- 4 µg total 
RNA, which was purified and fragmented to 150 bp to increase the mapping ability of the reads 
to the reference genome (Fig. 3.10). The first strand synthesis began with a SuperScript II 
reverse transcriptase which uses the RNA fragments randomly primed using random primers 
91 
 
to produce the first strand of complementary DNA. The second strand synthesis incorporates 
dUTP in place of the dTTP to produce a double stranded blunt ended cDNA molecule. The 
highly expressed ribosomal RNA, 16S, 23S and 5S, were removed from the total RNA samples, 
by using a ribodepletion kit (Ribozero Universal bacterial kit). This step ensures that the highly 
expressed ribosomal RNAs do not take up a high proportion of the sequencing reads and 
therefore the subtle changes in other genes can be analysed. This technique uses probe-
hybridization to the ribosomal subunits which are removed using magnetic beads, the resulting 
supernatants are rRNA depleted.  Indexing adapters were ligated to the double stranded cDNA 
to allow hybridisation of the cDNA to the flow cell. The cDNA was end repaired and the uridine 
was depleted. The double stranded cDNA which ligates the indexing adapters on both ends 
was enriched for use in the PCR, this was achieved by using a wide array of primers which 
anneal to the adapters and amplified both strands. The number of PCR cycles was kept to a 
minimum to prevent introducing errors. The subsequent library produced was validated, 
normalised and multiplexed. Multiplexing of the samples involved attaching unique bar codes 
to each cDNA molecule and pooling the samples into a single reaction, which produced millions 
of reads per sequence making this method quick and less expensive. Paired-end sequencing 
occurs over 100-300 bp, making the 5’ and 3’ sequenced ends of a poor quality generally but 






Figure 3.10. Overview of the library preparation carried out by the Oxford genomics centre. The 
RNA-seq library preparation was carried out by Oxford genomics centre, Wellcome trust for 
human genetics, UK. The Truseq Stranded mRNA library prep kit from Illumina was used to 
prepare the library. Total RNA was fragmented, and the first strand of cDNA was synthesised 
following random oligo priming. The second strand synthesis of cDNA was incorporated with 
dUTP. The ribosomal RNA was selectively removed using the Ribozero universal bacterial kit 
(NEB). Indexing adapters were added to the ends of the cDNA, and the cDNA was end repaired 




3.1.7.1 RNA-sequencing bioinformatic analysis  
RNA-seq requires the alignment of cDNA fragments to a reference genome, which minimises 
bias created during assays such as microarrays (Croucher & Thomson, 2010). RNA-seq is 
commonly used now for the study of transcriptomes because of its high sensitivity and 
accuracy. There are several pipelines that can be used to process raw sequencing files, this 
chapter focuses on the implementation of Cufflinks to obtain a differential gene expression list 
for the investigation of the importance of the RbpA BL (Fig. 3.12; Trapnell et al., 2011).  
 
3.1.7.2 FastQC and trimming of the reads 
The High-Performance computer (HPC) cluster at the University of Sussex was used to carry 
out the bioinformatic analysis of the FASTQ files. Each FASTQ file was uploaded onto WINSCP 
(version 5.10.4) and subsequently onto the module. To improve the alignment across the 
genome it is important to remove the adapters, this is DNA sequences which are not 
complementary to the reference genome (Table 2.6). Next the quality of the reads from the 
HiSeq 4000 sequencer was visualised using FastQC (version 0.11.5). FastQC processed the 
samples in the FASTQ format and provided a preview of GC%, quality of the base reads and 
potential adapter contamination. The FastQC analysis of the samples showed one peak for GC 
content at 66% which correlates with S. coelicolor. The overrepresented sequences indicated 
no hits for the adapters.  However, the adapter sequences were checked independently in each 
sample using Text manipulation (Grep; Galaxy Tool version 1.0.0), which showed some 
matches. Therefore, Scythe (version 0.993b) was used to remove the 3’ adapter sequences 
which can give poor quality bases, Table. 3.1, shows very little contamination of the reads with 
the adapter sequences. Reads usually consist of a deteriorating quality at the 3’-end therefore 
the reads were trimmed using Sickle (version 1.29) which trimmed the reads at the 3’ end to 
remove the poor base quality (Table 3.2). A genome alignment of the samples was carried out 
before and after running Scythe and Sickle, this showed that by quality controlling the reads, 





Sample Contaminated reads Contamination rate (%) 
 PE1 PE2 PE1 PE2 
RbpA (1) 413601 537690 0.016 0.020 
RbpA (2) 358563 487059 0.014 0.018 
RbpA (3) 413077 510781 0.015 0.018 
pRT802 (1) 1055316 1236762 0.032 0.037 
pRT802 (2) 793136 933858 0.026 0.031 
pRT802 (3) 1711324 1869721 0.047 0.051 
3KRA (1) 1785212 1927009 0.044 0.047 
3KRA (2) 2475563 2713199 0.055 0.060 
3KRA (3) 732426 2710286 0.034 0.071 
 
Table 3.1. The number of reads contaminated with adapters. Scythe (version 0.993b) detected 
adapters at the 3’ end of the reads for the RNA extracted from S401 (pRT802::rbpAWT), S401 
















Table 3.2. The number of reads kept and discarded after trimming of the S. coelicolor RNA 
samples. The reads from samples S401 (pRT802::rbpAWT), S401 (pRT802), S401 
(pRT802::rbpA3KRA) were trimmed using Sickle (version 1.29).  
 
Sample Paired reads kept Paired reads 
discarded 
RbpA (1) 25932388 430 
RbpA (2) 25505589 454 
RbpA (3) 27341400 631 
pRT802 (1) 32630986 774 
pRT802 (2) 29628027 634 
pRT802 (3) 35755658 990 
3KRA (1) 39911505 1152 
3KRA (2) 44604080 1279 




Figure 3.11. FastQC results of sample S401 (pRT802::rbpAWT) (replicate-1, paired read 2) before 
and after trimming. FastQC (Galaxy tool, version 0.11.5) was used to check the quality of the 
reads. (A) Raw FASTQ file for S401 (pRT802::rbpAWT) (1) (B) FASTQ file for S401 
(pRT802::rbpAWT) (1) processed using Scythe (version 0.993b) to remove any present adapters. 
(C) FASTQ file for S401 (pRT802::rbpAWT) (1) trimmed using Sickle (version 1.29).  
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3.1.7.3 Mapping to the Streptomyces coelicolor A3 (2) genome  
The reference genome, Streptomyces coelicolor A3 (2) NCBI: NC_003888.3 was downloaded 
from NCBI in GTF and FASTA format, the GTF file provides gene annotation whilst the FASTA 
file is the base sequence of the whole genome. The genome FASTA file was loaded in the HPC 
cluster using HISAT2 (version 2.1.0). HISAT2 is an alignment program which was used to map 
the sequencing reads to the S. coelicolor genome, this program has been developed from the 
HISAT and Bowtie2 genome builders. The trimmed paired end sample reads were aligned to 
the reference genome and the output file was in SAM format. The results of the alignment are 

















Table 3.3. Overview of the mapping ability of the sample reads to the S. coelicolor genome. The 
reads for S401 (pRT802::rbpAWT), S401 (pRT802), S401 (pRT802::rbpA3KRA) have been mapped 



































































(28.43%)  96.65% 
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3.1.7.4 Assembling the transcriptome using Cufflinks 
The mapped reads to the S. coelicolor genome using HISAT2 produced SAM files which were 
converted into their binary BAM files using SAMtools (version 0.1.19) and the subsequent BAM 
file was sorted using the same index and aligned to the reference genome. Cufflinks (version 
2.2.1) is a suite of tools which assemble, merge, quantify and measure the differences in two 
conditions (Trapnell et al., 2011). The Cufflinks (version 2.2.1) algorithm was implemented to 
assemble individual transcripts from each of the RNA-seq reads that are aligned with the 
reference genome. Next the transcripts from the biological replicates were merged to improve 
the assembly quality and to reduce the read depth. The FPKM (fragments per kilobase of 
transcript per million mapped reads) is calculated after the merger of the biological replicates 
against the reference genome. The cuffmerged files were loaded into Cuffquant to calculate 
the transcript abundances by using the merged.gtf and BAM files, the output file was named 
abundances.cxb. Next, Cuffdiff was used to compare two conditions, RbpA3KRA vs RbpAWT or 
RbpAWT and pRT802. The comparison between RbpA3KRA vs RbpAWT produced a gene_exp.diff 
file which can be viewed in Microsoft excel. The gene list provided FPKM values from the 
Cuffmerge application of the three biological replicates, log2 fold change, uncorrected p-value 
and false discovery rate (FDR) adjusted p-value of the test statistic using Benjamini-Hochberg 
correction for multiple testing. The differential gene expression data can all be viewed in R 
studio (version 1.0.153) using the CummeRbund package (version 2.0.0), this provides the 
individual replicate FPKM values for each replicate which can be used to identify anomalous 







Figure 3.12. Overview of the RNA-sequencing pipeline. RNA-seq FASTQ files processed using the 
pipeline to obtain quantified differential transcript levels between RbpAWT and RbpA3KRA or 





3.1.8 Analysis of the differential gene expression between RbpAWT and 
RbpA3KRA  
The differential gene expression between rbpAWT and pRT802 (ΔrbpA) has been analysed in 
results chapter III 5.4.1, more extensively whilst this chapter focuses on the impact of rbpA3KRA 
on gene expression identifying genes that were differentially expressed between S401 
(pRT802::rbpA3KRA) and S401 (pRT802::rbpAWT). The up-regulated genes in S401 
(pRT802::rbpA3KRA) have also been discussed further in chapter III. The gene list was sorted 
according to significance (yes or no), resulting in 3788 significant genes (1432 up-regulated and 
2356 down-regulated) out of 7069. CummeRbund was used to check the quality of the RNA-
seq RbpAWT and RbpA3KRA samples. Boxplots showed that the log10 (FPKM) was generally 
uniform between the three biological replicates (Fig. 3.13A). The dendogram demonstrated 
that the three biological replicates for each sample, and RbpA3KRA vs RbpAWT cluster together 
based on the different genetic backgrounds (Fig. 3.13B). Lastly, the heatmap clustered 3277 
genes (unable to load some of the genes) significantly different between rbpA3KRA and rbpAWT 





Figure 3.13. Quality of the RNA-seq comparing S401 (pRT802::rbpAWT) and S401 
(pRT802::rbpA3KRA). (A) Boxplots show the uniformity of the biological replicates for S401 
(pRT802::rbpAWT) and S401 (pRT802::rbpA3KRA). (B) Dendogram shows the clustering of the 







Figure 3.14. Heatmap generated using FPKM values for S401 (pRT802::rbpAWT) and S401 
(pRT802::rbpA3KRA). The FPKM values for three biological replicates from the rbpAWT and 
rbpA3KRA samples were loaded into Gene Cluster 3.0. The genes were clustered, centred using 
the mean and average linked. The heatmap was viewed in Java TreeView (version 3.0). Red= 












3.1.8.1 Growth related genes are down-regulated in S401 pRT802::rbpA3KRA 
As S401 (pRT802::rbpA3KRA) strain demonstrated a growth phenotype in both liquid and solid 
media, it was important to explore the transcriptome for growth-related genes to explain the 
reduced growth of S401 (pRT802::rbpA3KRA).  The RNA-seq data revealed that 46 ribosomal 
protein genes out of 52 were down-regulated by 1.48-135.2 fold in S401 (pRT802::rbpA3KRA) 
compared to S401 (pRT802::rbpAWT). Most interestingly, datasets comparing S401 
(pRT802::rbpA3KRA) and S401 (pRT802) revealed that 44 ribosomal protein genes are down-
regulated in S401 (pRT802::rbpA3KRA) and S401 (pRT802; Fig. 3.15).  
Next, KEGG pathways were used to identify other groups of growth related genes. This 
revealed 20 amino acyl tRNA synthetase (out of a possible 29; (Fig. 3.16A) and 12 peptidoglycan 
biosynthesis genes (out of a possible 21; Fig. 3.16B) were down-regulated in S401 
(pRT802::rbpA3KRA) and S401 (pRT802). In addition to this, all RNAP subunits were also down-
regulated in (pRT802::rbpA3KRA) but not in S401 (pRT802; Fig. 3.17). It is unclear why the RNAP 
subunits are all down-regulated S401 (pRT802::rbpA3KRA), it could suggest that global down-
regulation of the growth related genes signals down-regulation of RNAP, however the lack of 
down-regulation in S401 (pRT802), disproves this theory.  Nevertheless, the down-regulation 
of growth related genes supports the growth phenotype of the S401 (pRT802::rbpA3KRA) shown 
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Figure 3.15. Down-regulation of ribosomal protein genes in S401 (pRT802::rbpA3KRA) and S401 (pRT802). The ribosomal protein gene FPKM values 
were comparing S401 (pRT802::rbpAWT) vs S401 (pRT802::rbpA3KRA) vs S401 (pRT802). This data is compiled from three biological replicates and 




Figure 3.16. Growth-related genes are down-regulated in S401 (pRT802::rbpA3KRA) and S401 
(pRT802). (A) Aminoacyl tRNA biosynthesis genes and (B) peptidoglycan biosynthesis gene log 
FPKM values comparing S401 (pRT802::rbpAWT; blue circles) to S401 (pRT802::rbpA3KRA; red 
squares) and S401 (pRT802; green triangles). The results are compiled from three biological 





Figure 3.17. The down-regulation of RNAP subunits in S401 (pRT802::rbpA3KRA). FPKM values 
comparing S401 (pRT802::rbpAWT) to S401 (pRT802::rbpA3KRA). The results are compiled from 
three biological replicates and the error bars represent mean with standard deviation. 
SCO4729 = α subunit, SCO4655= β’ subunit, SCO4654= β subunit and SCO1478= ω subunit.  
 
The number of ribosomal protein genes that are down-regulated in the S401 
(pRT802::rbpA3KRA) and S401 (pRT802) suggested that they may be dependent on RbpA. 
Therefore, the promoters for the 26 available TSS for the ribosomal protein genes were aligned 
in order to identify features of the promoter which could indicate possible dependency on 
RbpA (Jeong et al., 2016). The alignment of the ribosomal protein gene promoters showed a 
good -10 consensus (TAnnnT) sequences for the majority, whilst the -35-promoter element is 
not identifiable (Fig. 3.18A). The promoter elements were compared to ribosomal genes which 
were unchanged, only two of the four have TSS annotated (Fig. 3.18A), SCO4735 and SCO1998. 
Additionally, the ribosomal gene promoters significantly down-regulated in S401 
(pRT802::rbpA3KRA) consist of multiple thymine residues upstream from the -35 element which 




Figure 3.18. Alignment of the 22 ribosomal protein gene promoters downregulated in S401 
(pRT802::rbpA3KRA) and S401 (pRT802). The TSS were identified using supplemental data, 
datasheet S2 (Jeong et al., 2016). (A) Position +1 from TSS is shown in grey, -10 and -35 
promoter elements are underlined, the extended -10 elements are shown in red. The 
consensus -10 and -35 promoter elements are shown in bold and have been aligned based on 
the -10 and -35 HrdB dependant conservation (Kang et al., 1997). (B) Motif conservation 
created using WEBLOGO (version 2.8.2), position 1 represents -52 and position 52 at the 3’ 
presents +1 of the promoter.  
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The TCA cycle also referred to as the ‘Krebs cycle’ is used by aerobic organisms to generate 
energy. Thus far, most of the growth related genes are downregulated in S401 
(pRT802::rbpA3KRA) and S401 (pRT802), which could be a result of reduced ATP generation from 
the TCA cycle. Therefore, the RNA-seq data was used to group the TCA cycle genes together, 
which confirmed that 27 (out of 48) are all downregulated in S401 (pRT802::rbpA3KRA). The 
S401 (pRT802::rbpA3KRA) was compared to S401 pRT802, which matched the downregulation 
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Figure 3.19. The down-regulation of the TCA cycle genes in S401 (pRT802::rbpA3KRA) and S401 
(pRT802). The FPKM values are comparing S401 (pRT802::rbpAWT) to S401 (pRT802::rbpA3KRA) 
and S401 (pRT802). The results are compiled from three biological replicates and the error bars 
represent mean with standard deviation.  
 
Ribonucleotide reductase (RNR) are involved in the biosynthesis of deoxyribonucleotides, the 
precursor for DNA synthesis (Reichard & Ehrenberg., 1983). Class Ia RNRs consist of two 
homodimeric proteins, α2β2, the large α subunit is encoded by nrdA and the β subunit is 
encoded by nrdB. Class II uses vitamin B12 and generally operates in an oxygen-independent 
process. The Streptomyces spp. can encode for both class I and class II RNRs and are oxygen 
dependant or independent, this section focuses on the class I RNR (Borovok et al., 2002). The 
S. coelicolor, nrdA (SCO5226) and nrdB (SCO5225) are part of the class Ia RNR and are oxygen 
dependent. The highest oxygen concentrations are present during early exponential phase 
compared to mid or late exponential phase (Borovok et al., 2002). Immediately upstream of 
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nrdA is an ORF encoding a 91-amino acid protein, nrdX (SCO5227). The nrdA, nrdB and nrdX 
operon is down regulated in S401 (pRT802::rbpA3KRA) and S401 (pRT802), Fig.3.20 
demonstrates the reduction in FKPM value for both RNA-seq datasets. The S. coelicolor nrdJ 
belongs to the class II oxygen independent ribonucleotide reductase (Borovok et al., 2002). 
nrdJ mRNA levels generally remain constant over the entire exponential phase and may play 
an important role during vegetative growth. The nrdJ S. coelicolor gene is co-transcribed in an 
operon with nrdR and is vitamin B12 dependant, ΔnrdJ fails to grow in the presence of vitamin 
B12. The RNA-seq data shows down-regulation of nrdJ (SCO5805) in S401 (pRT802::rbpA3KRA) 
and S401 (pRT802) strain by 2.4 and 1.9-fold respectively (Fig. 3.21).  
 
Figure 3.20. Down-regulation of class Ia RNR, nrdABX operon. (A) The FPKM values of rbpAWT 
and rbpA3KRA, (p-value = 0.0009). (B) The FPKM values of rbpAWT and pRT802, (p-value = 
0.0004). This data is compiled from three biological replicates and the error bars denote mean 





Figure 3.21. Vitamin B12 dependant ribonucleotide reductase, nrdJ is down-regulated in S401 
(pRT802::rbpA3KRA) and S401 (pRT802).  (A) Visualisation of the RNA-seq reads at the SCO5805 
location using IGV (version 2.4.9) with TSS of SCO5805 shown using TSS data from Jeong et al 
(2016) (B) FPKM values for rbpAWT and pRT802, this data is compiled from three biological 






3.1 Discussion  
3.2.1  The RbpA BL does not have an essential function   
RbpA together with RbpB confers an essential function in S. coelicolor. The RbpA BL is highly 
conserved across the Actinobacteria and therefore the first key aim of this section was to 
determine whether the BL-DNA interactions are the essential role of RbpA. The BL residues are 
required in vitro for transcription activation, but it is not clear whether they are essential in 
vivo. The RbpAR79A failed to activate transcription in vitro and produced a small colony 
phenotype in vivo (Hubin et al., 2015; 2017). The S. coelicolor RbpAR80 mutant reduces growth 
compared to the RbpAWT but the growth phenotype does not appear to be as severe as a ΔrbpA 
null mutant. This could be because the lysines contribute to RbpA function, perhaps playing an 
overlapping role when R80 is deleted. Additionally, a crystal structure of RbpA/TIC in M. 
smegmatis has shown that the highly conserved RbpAR79 makes polar interactions with 
negatively charged -13 and -14 bases of the non-template promoter DNA (Hubin et al., 2017a). 
The highly conserved RbpAK76 (K77, S. coelicolor) makes long electrostatic interactions with -
17/-18 of the template strand (Hubin et al., 2017a). This provides evidence of a potential role 
of the RbpA BL in promoter binding (Hubin et al., 2017a; Prusa et al., 2018). Therefore, the 
RbpA3KRA mutant was engineered which substitutes all three lysines (K74, K75 and K77) and 
R80 with alanine. The mutants were tested in the conditional mutant S401 which, would reveal 
the activity of the mutants without the complication of rbpB. The S401 (pRT802::rbpA3KRA) 
demonstrated a small colony phenotype with ACT production compared to S401 
(pRT802::rbpAWT) but again the phenotype was not as severe as a ΔrbpA null mutant. This 
shows that the BL, and by extension BL-DNA interactions, do not constitute the essential 
function of RbpA. Importantly, this result eludes to additional roles that are independent of 
the essentiality of RbpA. Next, the RbpA BL strains were cultured in liquid media to identify an 
effect on growth. The S401 (pRT802::rbpA3KA) grew at a similar rate to S401 (pRT802::rbpAWT) 
whilst S401 (pRT802::rbpAR80A) demonstrated some reduction. Most interestingly, S401 
(pRT802::rbpA3KRA) demonstrates delayed entry into log phase and reduced growth rate overall 
compared to S401 (pRT802::rbpAWT). This provided further evidence of a potential combined 
function of the three lysine residues and R80.  
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Additionally, during the period of this study several studies were published providing an insight 
into the possible role of the RbpA BL. The BL residues were annotated onto a M. tuberculosis 
RbpA-SID RPo structural model and provided the first evidence of the RbpA BL residue 
interactions with DNA (Hubin et al., 2015). This was later followed up by a RbpA-transcription 
initiation X-ray crystal structure  (Hubin et al., 2017) and subsequently the cryo-EM RNAP-σA-
RbpA-Fdx structure confirmed that the RbpA BL residues are positioned closely to the DNA 
phosphate backbone upstream of the -10 element (Boyaci et al., 2018). In vivo studies showed 
that RbpAR79A is not morphologically different to RbpAWT despite the slow growth phenotype. 
Finally, kinetic studies show that RbpA stabilises RPo complexes (Rammohan et al., 2015) and 
the RbpAR79A delays transition of RPc to RPo (Hubin et al., 2017), and is unable to stabilise the 
RPo complex (Prusa et al., 2018). Most interestingly, the cryo-EM structure showed that the 
RbpA-NTT threads into the RNAP active site and interacts with conserved residues of the σ 
finger (σ3.2 linker; Boyaci et al., 2018).  
 
3.2.2  Increased susceptibility of RbpA BL mutants to rifampicin treatment  
The S. coelicolor ΔrbpA mutant S101 exhibits a 15-fold increase in susceptibility to rifampicin 
compared to rbpAWT, although over-expression of RbpA did not further increase rifampicin 
resistance (Newell et al., 2006). Therefore, this study investigated the contribution of the RbpA 
BL to the susceptibility to rifampicin compared to the previous study on the ΔrbpA mutant. In 
support of the previous study, S401 pRT802 did show increased susceptibility to rifampicin 
compared to S401 (pRT802::rbpAWT). The S401 (pRT802::rbpAR80A) and S401 
(pRT802::rbpA3KRA) also show increased susceptibility but not as severe as S401 (pRT802). The 
RbpA NTT does thread through to the active site of RNAP, therefore direct contact between 
RbpA and rifampicin cannot be ruled out (Boyaci et al., 2018). Alternatively, RbpA may bind 
more tightly to RNAP through conformational changes in the presence of rifampicin, however 
abortive initiation assays prove that RbpA does not affect the binding of rifampicin to RNAP 
(Hu et al., 2014). We know that, rifampicin causes the activation of SigR, thus causing the 
activation of SigR regulon. RbpA consists of a sigR-dependant promoter which results in the 
up-regulation of RbpA, which would ensure survival of the cells in response to rifampicin. The 
increased susceptibility of ΔrbpA to rifampicin remains unclear. One possible solution for this 
is to construct a sigR mutant or alternatively to delete the sigR dependant rbpA promoter.  
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Fidaxomicin (Fdx) is an RNAP inhibitor used clinically for C. difficile infection and has now been 
shown to have inhibitory effects against M. tuberculosis in vitro (Boyaci et al., 2018). Cryo-EM 
structures show RNAP-RbpA interacting with Fdx. Fdx acts like a doorstop which jams RNAP in 
an open complex, preventing promoter DNA from entering the RNAP active site (Boyaci et al., 
2018). The Fdx binding site is independent of rifampicin and there is no cross-resistance with 
rifampicin. Resistance to Fdx increases 35-fold when the RbpA-NTT is truncated (Boyaci et al., 
2018) and therefore it is quite plausible that RbpA-NTT occupying the RNAP active-site, 
prevents binding of rifampicin to the active site thus resulting in resistance. Although, the 
RbpA-NTT is not required for viability, changes in the other RbpA domains may affect the 
positioning of the NTT within the RNAP active site. Similarly, a recent publication characterises 
a regulatory pathway for isoniazid tolerance in M. smegmatis (Wang et al., 2018). RbpA binds 
to the stress induced group II sigma factor, σB and in turn activates the transcription of a 
polyphosphate kinase gene, ppk1. This resulted in an increase in intracellular polyphosphates 
and drug tolerance to isoniazid  (Wang et al., 2018). The problem with such studies is that RbpA 
is an essential protein and thus has pleiotropic effects on the cell, it is therefore no surprise 
that this pathway has been identified but does not prove that RbpA is directly responsible for 
isoniazid tolerance.  
 
3.2.3 The RbpA BL mutant and ΔrbpA cause down-regulation of growth related 
genes  
This study has found that S401 (pRT802::rbpA3KRA) and S401 (pRT802) cause down-regulation 
of growth related genes, these include ribosomal protein genes, TCA cycle genes, aminoacyl-
tRNA biosynthesis and peptidoglycan biosynthesis genes. This could be because S401 
(pRT802::rbpA3KRA) and S401 (pRT802) fail to grow at the same rate as S401 (pRT802::rbpAWT), 
thus failure to grow causes global transcriptional down-regulation. Alternatively, the loss of the 
essential gene rbpA could be responsible for the global down-regulation of growth related 
genes. Upon closer inspection of the ribosomal protein genes, genes that were down-regulated 
mostly lack a -35-consensus sequence, which suggests that RbpA may be important for 
promoters that lack a consensus -35 sequence.  
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Ribonucleotide reductases (RNRs) which catalyse the conversion of ribonucleotides to 
deoxyribonucleotides are also down-regulated in S401 (pRT802::rbpA3KRA) and S401 (pRT802). 
The oxygen dependent ribonucleotide reductases may contribute to the slow growth 
phenotype of S401 (pRT802::rbpA3KRA) and S401 (pRT802). The global ribonucleotide reductase 
regulator, nrdR can bind to the promoters of both class Ia and II RNRs (Borovok et al., 2006). In 
addition to this, the B12 riboswitch provides regulation of the class Ia RNR and serves as a 
cofactor for the class II RNRs (Borovok et al., 2002; 2006). Therefore, in summary it is difficult 
to comment on whether the RbpA BL and ΔrbpA cause the changes in the transcriptome which 
lead to down-regulation of growth-related genes or whether slow growth causes the 
transcriptomic changes. Finally, the results of the RNA-seq indicate that the RbpA BL is required 
for efficient gene expression.  
 
3.2.4 Future work  
Firstly, the potential RbpA3KRA targets identified from the RNA-seq have not been confirmed 
with qRT-PCR yet. The ribosomal protein genes will also be confirmed using in vitro 
transcription assays to investigate the dependency of promoters on RbpAWT and RbpA3KRA. The 
optimisation and purification of core RNAP and σHrdB has been completed, therefore RbpAWT 
and RbpA3KRA remains to be purified (Appendix. 2). Secondly, to establish a link between the 
genes involved in ACT production, the S401 pRT802::rbpA3KRA and S401 pRT802 strains need to 
be cultured for 72-120 h before RNA is extracted for qRT-PCR examination of actII-ORF4, adpA, 
dasR, absA2 and atrA. Lastly, this study has provided preliminary evidence that RbpA may 
compensate for the loss of a consensus -35 promoter sequence, therefore these need further 
validation. The RbpADAS+4 and CarDDAS+4 depletion system (Results chapter IV) could be 
implemented in this study by incorporating promoters with a ‘good’ or ‘poor’ -35 into a GFP 
expression plasmid to test the level of expression of the promoters using S1 nuclease 














Results chapter II: Investigating the 













4.0   Overview of the RbpA basic linker in M. tuberculosis 
RbpA (Rv2050) is an essential protein in M. tuberculosis and shares 56% end-to-end amino acid 
similarity with the S. coelicolor RbpA (Bortoluzzi et al., 2013; Sassetti et al., 2003). Structural 
studies suggest that the key role of RbpA is to contact DNA upstream of the -10 elements, 
stabilising promoter open complexes (Hu et al., 2012). This is hypothesised to be critical for the 
action of some promoters and therefore disruption of this essential function affects 
mycobacterial viability. However, mutagenesis of the RbpA basic linker residues in S. coelicolor 
demonstrated that removal of this DNA binding interaction does not impact viability, 
suggesting that this function may be compensated for or that RbpA plays a different role. RbpA 
in S. coelicolor exists in tandem with its paralogue, RbpB thus far no such paralogue has been 
found in M. tuberculosis. Since RbpA is an essential gene in M. tuberculosis, we investigated 
the role of RbpA in transcription initiation in M. tuberculosis by constructing strains in which 
the only expressed copy of rbpA contained a series of mutations of the basic linker. This study 
identified that the M. tuberculosis RbpA3KRA was unable to grow on solid media compared to 
wild type or other basic linker mutants, however the growth defect was not observed in liquid 
culture. This differential culturability has been associated with persister phenotypes in M. 
tuberculosis (Mukamolova et al., 2010; Salina et al., 2014). To investigate this phenotype 
further and to understand the impact of modifying the RbpA basic linker on the M. tuberculosis 
transcriptome, we compared RbpA3KRA to RbpAWT using RNA-sequencing. This chapter 
therefore focuses on addressing the biological importance of the RbpA basic linker (BL) in M. 
tuberculosis.  
 
4.1.0 Construction of RbpA BL mutants in M. tuberculosis 
To identify essential genes in M. tuberculosis a study constructed a transposon library using 
the Streptomyces Pristinamycin I-inducible ptr promoter in a Tn-pip/pptr system. Pristinamycin 
inhibits ribosomes and the pristinamycin resistance gene promoter, ptr encodes for a 
multidrug efflux pump (Ehrt & Schnappinger, 2014). The ptr promoter is repressed by the 
transcription factor Pip and can be activated by pristinamycin (Ehrt & Schnappinger, 2014). The 
transposons were inserted into the mycobacteriophage phAE87, transduced into M. 
tuberculosis, which created a transposon insertion library (Forti et al., 2011). This screening 
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confirmed the essentiality of rbpA in M. tuberculosis with the insertion of the Tn-pip/pptr 
system 45 bp upstream of the rbpA open reading frame  by sequencing (Forti et al., 2011; 
kindly gifted by Dr Helen O’Hare, University of Leicester). The rbpA transposon mutant is 
stabilised with hygromycin and pristinamycin (PI) to maintain native rbpA expression, this strain 
will be referred to as M233. The objective was to express a series of RbpA basic linker mutant 
alleles in this PI-inducible system by integrating these mutated RbpA alleles into the genome 
at the mycobacteriophage L5 attB site using the integrative E. coli-Mycobacterium shuttle 
plasmid pMV306. The addition of PI causes expression of the inducible wild type chromosomal 
copy of rbpA, however when PI is removed only the integrative rbpA allele (from pMV306) 
should be expressed. This allowed investigation of the functional significance of the RbpA BL 
mutants in an essential M. tuberculosis gene.  The coding region of rbpA together with the 357 
bp upstream promoter region (743 bp in total) was cloned into EcoRV-digested pBluescript II 
SK+ and confirmed by sequencing. The resulting plasmid, pMV306::rbpAWT was used as a 
template for inverse PCR mutagenesis to create the BL mutations 3KA (K74, K75 and K77 
substituted with alanine), R79A (R79 substituted with alanine) and 3KRA (K74, K75, K77 and 
R79 substituted with alanine). The inverse PCR mutagenesis primers are listed in Table 2.5. 
Following DNA sequence analysis confirming the expected nucleotide sequences, the three 
rbpA-mutant sequences along with wild-type rbpA  and empty vector (containing no rbpA 
sequence) were cloned as EcoRI-HindIII fragments into pMV306. The constructs were 
confirmed by sequencing and electroporated into M. tuberculosis M233 (Tn-pip/pptr ΔrbpA). 
The recombinants were plated onto Middlebrook 7H10 agar supplemented with OADC (Oleic 
acid-Albumin-Dextrose-catalase), kanamycin, pristinamycin I and hygromycin. Insertion of the 
mutant alleles at the attB site were confirmed by colony PCR (Methods; 2.3.2) using primers 
MTB2_F and MTB2_R (Table 2.5) that amplify 8 bps from pMV306 into the ORF of RbpA of the 
integrated pMV306::rbpA. The recombinant strains were cultured for 7-days with kanamycin, 
hygromycin and PI (to express the inducible chromosomal wild type rbpA allele that is essential 
for growth). Thus, in the presence of PI, Pip is no longer able to repress pptr allowing expression 
of the native WT rbpA. In the absence of PI, pip is expressed from the pfurA102 promoter that 
represses ptr inhibiting the expression of that native WT rbpA (Fig.4.1). This scenario allowed 
the impact of the integrated pMV306::rbpAWT, pMV306::rbpA3KA, pMV306::rbpAR80A, and 
pMV306::rbpA3KRA to be assessed.  
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Figure 4.1. The regulatory control of the rbpA conditional mutant in M. tuberculosis. The 
transposon rbpA conditional mutant strain was created by Francesca Forti (Forti et al., 2011), 
the pMYT829 construct consists of the hyg resistance cassette (black, marked hyg), pip (ptr 
repressor, in purple) controlled by the promoter pfurA102, pptr, hyperactive transposase and 
the left and right inverted repeats of the Himar1 transposon. The transposon has inserted at 
the TA site 43 bases upstream of the translational start site of rbpA. The pfurA102 promoter 
(arrow with black outline) and pip (purple) are integrated at the ΦL5 att site on the M. 
tuberculosis chromosome.  pMV306 (orange) is an integration plasmid, carrying kanamycin 
cassette and recombinant rbpA mutant alleles integrated at the attP site. In the absence of PI, 
the only rbpA copy expressed is the pMV306 integrated copy (green arrow represents the 
activated pfurA102 and prbpA promoters, pip is expressed which represses the rbpA promoter, 
pptr. The presence of PI prevents pip expression from the pfurA102 promoter and allows 





4.1.1 Growth curves of the BL mutants in M. tuberculosis 
The RbpA BL mutants in the absence of RbpB in S. coelicolor exhibited a growth phenotype 
displayed by small colony formation and ACT production, therefore growth curves were 
performed for the RbpA BL mutants in M. tuberculosis. To investigate the impact of the RbpA 
BL mutants on M. tuberculosis growth, optical density and CFUs (colony forming units) were 
measured over 28 days. The strains were cultured for seven days in the presence of PI (allowing 
WT rbpA expression), then washed with PBS to remove all PI. The cells from the RbpA BL strains 
were normalised using optical density to ensure that each recombinant growth curve was 
started with the same number of cells. Cultures were plated onto LB agar and inoculated into 
liquid LB media to check for contamination; the results of which confirmed no contamination. 
The stability of the inserted transposon and the absence of point mutations in the 
pristinamycin I gene in the engineered strains was checked by designing primers 52 bp 
upstream of the TA insertion site (PTRF) and the reverse primer at the C-terminus of native 
rbpA (Table 2.5). These primers amplified the pptr, transposon insertion site and the 
chromosomal copy of rbpA to check for spontaneous mutations. The sequencing results 
confirmed the presence of the transposon insertion of the Tn-pip-pptr system and showed no 
SNPs. The integrated pMV306::rbpAWT and BL mutants were also PCR-amplified and 
sequenced, using primers MTB2_F and MTB2_R (Table 2.5). Similarly, the sequencing results 
confirmed that pMV306::rbpAWT contained RbpAWT and the mutants contained the relevant 
mutant alleles. Samples were taken through the growth curves at regular intervals to measure 
mycobacterial growth by OD600 (Fig. 4.2). The RbpA BL mutants did not show any growth defect 
compared to RbpAWT as measured by optical density over the 28-day period (Fig. 4.2). 
Unexpectedly, the empty vector control, M233 (pMV306) containing no recombinant rbpA 
grew at a similar rate to M233 (pMV306::rbpAWT). This is likely a result of leaky rbpAWT 
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Figure 4.2. Growth of the rbpA BL mutants alongside rbpAWT and empty vector in M. tuberculosis 
in the absence of PI, measured by optical density. M233 (pMV306::rbpAWT; blue), M233 
(pMV306- empty vector; red), M233 (pMV306::rbpAR79A; green), M233 (pMV306::rbpA3KA; 
purple) and M233 (pMV306::rbpA3KRA; orange) cultured in 7H9 (supplemented with ADC) at 
37°C for 28 days. This figure is compiled from three biological replicates and the error bars 
represent mean with standard deviation. 
 
4.1.2 Confirmation of complementation of the BL strains in M. tuberculosis 
The growth curve (measured by optical density) did not show a phenotype for the RbpA null 
empty vector control, which raised the question of whether the PI inducible system was 
operating effectively. Therefore, complementation of the RbpA BL strains, ± PI, was tested on 
solid agar. The BL strains were cultured for 7 days (OD600 ~0.3) and then the cells were washed 
and normalised followed by serially diluting from neat to 10-3 and plated onto 7H10 in the 
absence/presence of PI (Fig. 4.3). M233 (pMV306- empty vector), M233 (pMV306::rbpA3KA), 
M233 (pMV306::rbpAR79A) and M233 (pMV306::rbpA3KRA) all cultured the same as M233 
(pMV306::rbpAWT) in the presence of PI, demonstrating that the PI inducible system is 
operational from the chromosomal rbpAWT location. In the absence of PI, the M233 (pMV306) 
strain lacking a recombinant rbpA did not grow, showing that there was no expression from 
the pptr inducible rbpAWT allele in the absence of PI. This was expected as rbpA is an essential 
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gene in M. tuberculosis. The M233 (pMV306::rbpAWT) grew in a similar fashion to when PI was 
present, demonstrating that, expression from the integrated pMV306::rbpA successfully 
complemented in the absence of PI (Fig. 4.3). M233 (pMV306::rbpA3KA) grew similarly to M233 
(pMV306::rbpAWT), on solid media. This correlates with the phenotypic data of the same 
RbpA3KA mutations in S. coelicolor. M233 (pMV306::rbpAR79A) also grew in a similar fashion to 
M233 (pMV306::rbpAWT), however M233 (pMV306::rbpA3KRA) demonstrated a difference in 
growth at dilutions 10-2 and 10-3 compared to M233 (pMV306::rbpAWT). These experiments 
measuring growth on solid media suggested that rbpA3KRA may be important for growth in M. 
tuberculosis H37Rv. M233 (pMV306::rbpA3KRA) however was not essential for viability in M. 
tuberculosis as there was more growth than M233 (pMV306), this strongly suggested that 







Figure 4.3. Growth of M. tuberculosis BL strains on solid media. M233 (pMV306::rbpAWT; wt 
control), M233 (pMV306; empty vector), M233 (pMV306::rbpA3KA), M233 (pMV306::rbpAR79A) 
and M233 (pMV306::rbpA3KRA) were plated in the presence of 0.5 µg/mL PI (left) and absence 
of PI (right). Dilution series; neat, 10-1, 10-2 and 10-3 plated onto 7H10 Middlebrook 
supplemented with OADC and incubated for 3 weeks at 37°C. 
 
4.1.3 Characterising the growth phenotype of M233 (pMV306::rbpA3KRA)  
The M233 (pMV306::rbpA3KRA) strain was unable to grow on solid agar as well as M233 
(pMV306::rbpAWT) but was able to grow at a similar rate as M233 (pMV306::rbpAWT) in liquid 
media (as measured by optical density). Therefore, to further explore this differential 
culturability, the growth curves were repeated measuring OD, CFUs and MPN (Most Probable 
Number) count (Fig. 4.4). MPN is a method for estimating the number of bacteria in liquid 
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culture by conducting a series of bacterial dilutions, incubating and then counting the number 
of wells that do not become turbid (Jarvis et al., 2010). Differential culturability has been 
associated with a persister ‘non-culturable’ phenotype in M. tuberculosis therefore the same 
methods were employed in this study (Mukamolova et al., 2010; Salina et al., 2014). As before 
no difference was observed between M233 (pMV306::rbpAWT), M233 (pMV306) and the RbpA 
BL mutants in liquid media measured using optical density, as previously observed. At 0, 7, 14 
and 21 days MPN and CFU counts were performed together on three biological replicates and 
four technical replicates for CFU counting and the same for MPN counts (Fig. 4.4). At day 21, 
no visible colonies on any of the agar plates were present, possibly the result of plate 
formulation errors, therefore the CFU and MPN results for day 21 are not shown. The CFU data 
revealed that M233 (pMV306) failed to grow at day 0 to 14 whilst the MPN values showed that 
there were ~2x107 viable bacteria at day 7 and ~2x107  at day 14. This suggests that the PI- 
inducible system repressing WT RbpA expression is only fully effective on solid media. CFU and 
MPN counts were correlated for M233 (pMV306::rbpAWT) and M233 (pMV306::rbpAR79A), at 
day 7 and 14. MPN was not calculated for M233 (pMV306::rbpAWT) and M233 
(pMV306::rbpAR79A) at day 14 as both strains grew at all of the dilutions from 10-1 to 10-12, and 
therefore no limiting dilution was recorded. This suggests that the R79 residue alone does not 
impact viability. M233 (pMV306::rbpA3KRA) appeared attenuated at day 0 and day 7 by CFU and 
MPN however recovered at day 14. This could be an indication that the cells enter into a non-
culturable state, or are attenuated in some way during lag phase growth after removal of WT 




Figure 4.4. Growth rate assays for the RbpA BL mutants. (A) OD600 readings over a 21 day period, 
(B) CFUs at days 0, 7 and 14, (C) MPN at days 0, 7 and 14 for M233 (pMV306::rbpAWT; blue), 
M233 (pMV306; red), M233 (pMV306::rbpA3KA; green), M233 (pMV306::rbpAR79A; purple) and 
M233 (pMV306::rbpA3KRA; orange) were cultured in the presence of 30 µg/mL kanamycin to 
allow expression of the integrative pMV306 plasmid and 50 µg/mL hygromycin to stabilise the 
transposon insertion. The OD readings are taken from three biological replicates, the CFUs and 
MPN readings represent three biological and four technical replicates. The results for RbpA 
and R79A at day 14 are not shown because all of the dilutions were turbid, absence of dilution 
with no growth. The CFUs for day 21 are not shown as there was no observed colonies on any 
agar plate. The error bars represent mean with standard deviation.  
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4.2.0 Profiling the impact of rbpA3KRA substitutions on global gene expression 
patterns  
The most striking RbpA BL mutant phenotype in S. coelicolor was RbpA3KRA (Results Chapter I). 
This was replicated on solid media in M. tuberculosis where M233 (pMV306::rbpA3KRA) was not 
viable. The incomplete PIP-mediated repression of native WT rbpA in liquid culture meant that 
this attenuated growth phenotype was not replicated in broth culture. This leaky repressor 
system did however present an opportunity to assay the impact of over-expressing the 
rbpA3KRA variant without significantly affecting growth, unlike on solid i.e. to profile comparable 
samples from M233 (pMV306::rbpAWT) and M233 (pMV306::rbpA3KRA) in a system where 
complete repression would result in severe attenuation. Therefore, to explore the impact of 
M233 (pMV306::rbpA3KRA) substitutions, RNA was extracted from mid-log phase M233 
(pMV306::rbpAWT) and M233 (pMV306::rbpA3KRA) at day 8 (OD600=0.6; Fig. 4.2; Methods: 
2.6.1).  RNA was quantified using the Qubit HS assay (Table. 4.1), and the quality of the RNA 
was assessed using the Nanodrop spectrophotometer and Agilent Bioanalyser RNA 6000 Nano 
kit (Fig. 4.5) before commencing RNA-sequencing. The Bioanalyser showed that the quality of 
the ribosomal 16s and 23s subunits were optimum and the RIN scores (>9.6) confirmed this. 
The Nanodrop provided an absorbance ratio of ~2 for the 260/280 and 260/230 wavelength 
ratios, confirming that the RNA was not contaminated with protein or salt.  
 
Figure 4.5. Bioanalyser results of the RbpAWT and RbpA3KRA RNA extractions from M. tuberculosis. 
Agilent 2100 Bioanalyzer NanoChip® systems, prokaryote total RNA nano assay. The 16S and 
23S ribosomal subunits are shown for RbpA (M233 (pMV306::rbpAWT)) and 3KRA (M233 












RbpA (1) 17 82.2 1233 2.11 2.23 
RbpA (2) 17 65.6 984 2.10 2.36 
RbpA (3) 17 67.2 1008 2.11 2.32 
3KRA (1) 17 55.6 834 2.12 2.33 
3KRA (2) 17 52 780 2.11 2.31 
3KRA (3) 17 65 975 2.12 2.37 
 
Table 4.1. Quality control results and quantification of the M. tuberculosis RNA samples. The RNA 
concentration for RbpA (M233 (pMV306::rbpAWT)) and 3KRA (M233 (pMV306::rbpA3KRA)) was 
measured using the Qubit RNA HS assay kit. The 260/280 and 260/230 ratios were measured 
using the Nanodrop spectrophotometer. This table represents the RNA samples sent for 
sequencing.  
 
4.2.1 Sample preparation and library preparation at Oxford genomics 
centre 
Library preparation of the 6 M. tuberculosis samples and sequencing was carried out at the 
Oxford Genomics Centre, The Wellcome Trust for Human Genetics (UK) using an Illumina HiSeq 
4000. The samples were quality controlled again by the Oxford Genomics Centre before strand-
specific paired-end sequencing was commenced. The gel image (Fig. 4.6) showed that all the 
samples had distinct bands for both ribosomal subunits and the RIN scores >9.6, demonstrating 
that the RNA quality is high. The electropherograms from the Tapestation did however indicate 
DNA contamination in all of the M233 (pMV306::rbpA3KRA) biological replicates (Fig.4.6D) which 
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was not identified using the Bioanalyser. Therefore, all 6 of the samples were re-run through 









Figure 4.6. Agilent 4200 Tapestation quality control results for the M. tuberculosis BL RNA 
samples performed by the Oxford Genomics Centre. A. Reconstructed gel image of the RNA 
profiles. B. RNA concentrations and RNA integrity number equivalent (RINe) of the RNA 
samples. C. RNA profile of RbpA1 showing the ribosomal subunits 16S and 23S. D. RNA profile 
of 3KRA1 showing the ribosomal subunits 16S and 23S, the DNA contamination is shown 
upstream of the 23S subunit as it is higher molecular weight.  
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4.2.2 FastQC and trimming of the reads 
The raw FASTQ files delivered from the Illumina HiSeq 4000 sequencer were processed as 
mentioned in described Results I: 3.1.7.2. The reads were trimmed from the 3’ using Sickle 
(version 1.29) because sequencing at the periphery of the reads is usually poor, Table. 4.2 
shows the number of paired end reads discarded. The quality of the RNA reads was improved 











Table 4.2. The number of reads kept and discarded after trimming. Sequences were trimmed 








Sample PE reads kept PE reads discarded % discarded 
RbpA (1) 21637030 353 0.0016 
RbpA (2) 25006892 607 0.0024 
RbpA (3) 21412374 573 0.0027 
3KRA (1) 24456552 657 0.0027 
3KRA (2) 21656757 522 0.0024 




Figure 4.7. FastQC results of M233 (pMV306::rbpAWT) replicate 1 before and after trimming. 
FastQC (version 0.11.5) provides the base quality of the reads. (Left) before trimming, (right) 
after trimming using Sickle (version 1.29). 
 
4.2.3 Mapping to the M. tuberculosis reference genome 
The reference genome, Mycobacterium tuberculosis H37Rv, was downloaded from NCBI 
(NC_000962.3) in GTF and FASTQ formats, the GTF file contained information regarding the 
gene structure. The reads were aligned to the M. tuberculosis H37Rv reference genome FASTA 
file using HISAT2 (version 2.1.0).  The reads for each sample demonstrated an overall alignment 
rate above 96% which eliminated any issues surrounding contamination (Table. 4.3). The 
number of reads mapping multiple times was also minimal (~0.15%). The discordant rate was 
low in all the samples which meant that both strands of the paired end sequencing mapped 
uniquely. The concordant rates of all the samples was ~92.6%, which suggested that the paired 


















Table 4.3. Overview of the sample reads using HISAT2. The table shows the total number of 
reads, mapped once, reads mapped multiple times and the overall alignment rate for 3 
independent biological replicates of RbpA (M233 (pMV306::rbpAWT)) and 3KRA (M233 
(pMV306::rbpA3KRA)). The average overall alignment rate is 94.75%. A very small number of the 
reads mapped to the genome multiple times, averaging 0.24%.  
 
4.2.4 Assembling the transcriptome using Cufflinks 
The mapped reads in SAM format were converted into their binary BAM files using SAMTOOLS 
(version 0.1.19), and the subsequent BAM files were sorted using the same index and aligned 
to the reference genome. Cufflinks (version 2.2.1; Fig. 4.9), a suite of tools was used to 
assemble (Cuffquant), merge (Cuffmerge), quantify and measure the differences (Cuffdiff) 
between M233 (pMV306::rbpAWT) and M233 (pMV306::rbpA3KRA; Results I; 3.1.7.4; Trapnell et 










RbpA (1) 21656757 
19788345 
(91.37%) 33617 (0.16%) 96.58% 
RbpA (2) 21412374 
19909299 
(92.98%) 34004 (0.16%) 97.12% 
RbpA (3) 24665222 
22976737 
(93.15%) 38986 (0.16%) 97.24% 
3KRA (1) 21637030 
20277461 
(93.72%) 30141 (0.14%) 97.18% 
3KRA (2) 24456552 
22535682 
(92.15%) 32815 (0.13%) 96.30% 
3KRA (3) 25006892 
23092678 




Figure. 4.8. Pipeline for the processing of the RNA-sequencing samples in M. tuberculosis. The 
arrows direct the pipeline steps. The white boxes represent the tools used to carry out the 
functions described in the orange boxes, whilst the blue boxes represent the input and output 




4.2.5 Differential gene expression between M233 (pMV306::rbpAWT) and M233 
(pMV306::rbpA3KRA) 
To identify the significantly differentially expressed genes, Cuffdiff from the Cufflinks 
application was implemented which provides one FPKM value for three biological replicates 
for each of the strains, M233 (pMV306::rbpAWT) and M233 (pMV306::rbpA3KRA; Fig. 4.9). To 
plot the individual replicate expression data, triplicate values were obtained by loading the 
differential gene expression list into R studio (version 1.0.153) using the CummeRbund package 
(version 2.0.0), this provided the individual FPKM values for each biological replicate. Cuffdiff 
was applied to identify significantly differentially expressed genes between M233 
(pMV306::rbpAWT) and M233 (pMV306::rbpA3KRA). Cuffdiff presented genes that were 
statistically significant when the p value was lower than the FDR after Benjamini-Hochberg 
correction for multiple testing. 1236 genes (522 up-regulated and 714 down-regulated) were 
differentially expressed between M233 (pMV306::rbpA3KRA) and M233 (pMV306::rbpAWT) from 
a total of 4112 gene transcripts. The replicate values for all genes (FPKM) have been 
represented in a box plot and dendrogram (Fig. 4.9). The pattern of log 2 (FPKM) shown in the 
box plots was consistent across the replicates, whilst the dendrogram showed that the 
biological replicates cluster closely based on genetic background, therefore the samples were 
comparable. The significantly up-regulated and down-regulated genes in M233 
(pMV306::rbpA3KRA) compared to M233 (pMV306::rbpAWT) were clustered and displayed as a 
heatmap, which highlighted good correlation of gene expression across biological replicates 








Figure 4.9. Comparison of the biological replicates FPKM for M. tuberculosis. (A) A boxplot 
showing the overall distribution of the gene expression of all three biological replicates for WT 
and 3KRA represented as log10 FPKM for all 4112 genes. (B) A dendrogram showing the 
clustering of the biological replicates of, WT and 3KRA (KRA3) relative to each other based on 






Figure 4.10. Differentially expressed genes in RbpA3KRA compared to RbpAWT in M. tuberculosis. 
Heatmap of significantly differentially expressed genes generated in Gene Cluster (version 3.0) 
using log transformed mean-centred data clustered by average linkage clustering and 
displayed with Java TreeView (version 1.1.6r4). Genes in red show log2 fold change between 
1.2-3.5 relative to the mean, genes shown in blue represent log2 fold change from -2.8-8.3. 




4.2.6 Minimal leaky expression from the repressed WT rbpA allele in M233 
(pMV306::rbpA3KRA) in the absence of PI 
Empty vector, pMV306 that did not contain a plasmid- borne copy of rbpA did not grow on 
solid media, as expected, since rbpA is essential. However, this strain did grow in liquid culture 
raising concerns that the PIP repression system may be leaking expression in the absence of 
PI. To confirm this, the transcript levels of inducible rbpA versus the integrated 
pMV306::rbpA3KRA copy in the M233 (pMV306::rbpA3KRA) samples was assessed using Galaxy 
project tools. The FASTQ files for two biological replicates (was unable to load all three as a 
result of the size of the files) of M233 (pMV306::rbpAWT) and M233 (pMV306::rbpA3KRA) were 
uploaded into Galaxy (usegalaxy.org) and a 20 bp discriminatory sequence between the wild 
type rbpA and rbpA3KRA was searched for using the Search in ‘textfiles’ (grep; Galaxy version 
1.0.0). The output provided the number of reads which matched the two discriminatory 20 bp 
sequences. M233 (pMV306::rbpAWT) averaged 804 reads for rbpAWT, whilst the M233 
(pMV306::rbpA3KRA) averaged 71 reads for inducible rbpAWT  allele and 825 copies for 
integrated rbpA3KRA, in the absence of the PI (Fig. 4.11). This showed that the level of rbpA3KRA 
transcripts far exceeded the leaky expression of rbpAWT transcripts in the absence of PI at a 
ratio of ~12:1. RbpA is an essential gene in M. tuberculosis therefore, it is possible that the low-
level expression of rbpAWT may be sufficient to maintain growth of the M233 
(pMV306::rbpA3KRA) comparable to M233 (pMV306::rbpAWT) in liquid culture.  
 
Figure 4.11. Quantified RbpAWT and RbpA3KRA reads from the M233 (pMV306::rbpA3KRA) strain. 
Galaxy tool was used to search the reads for a discriminatory 20 base sequence for RbpAWT or 
RbpA3KRA to assay the stringency of the PI-inducible system. (Galaxy version 1.0.0). Results from 
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two biological replicates, error bars represent mean with standard deviation. Unpaired T-test 
p-value 0.0452.  
 
4.2.7 Biological insights from transcriptome profiling of the RbpA BL mutant    
Hypergeometric probability testing was performed to identify the biologically relevant patterns 
of gene expression by comparing the genes significantly induced and repressed in M233 
(pMV306::rbpA3KRA) vs M233 (pMV306::rbpAWT) against 465 published and unpublished 
transcriptional signatures maintained in the Waddell lab. The list of genes as it stood were too 
large to obtain any real meaningful analysis from. The hypergeometric analysis (p value <0.05) 
was implemented to provide insight into the different pathways that RbpA may be implicated 
in.  
 
4.2.7.1 Hypergeometric analysis of genes induced in M233 (pMV306::rbpA3KRA)  
This section focuses on the signatures enriched in the 256 genes induced (1.5 fold change filter 
was applied to the list of 523 significantly induced genes) in M233 (pMV306::rbpA3KRA) vs M233 
(pMV306::rbpAWT). A further filter for p value 0.005 was applied that resulted in a list of 16 
significantly overlapping pathways, Table 4.4. Firstly, 190 genes from the RNA-seq data 
matched the non-essential genes from a transposon mutagenesis study which identified genes 
that are required for optimal in vitro growth in M. tuberculosis (Sassetti et al., 2003). RbpA has 
been shown to be present at almost all promoters therefore it is not surprising that a large 
number of genes transcribed by RbpA are non-essential. Secondly, 82, 54 and 27 genes 
overlapped with the Lsr2 binding sites (Gordon et al., 2010; Minch et al., 2015). Lsr2 is found 
in almost all sequenced Actinobacteria (Gordon et al., 2008) and has been known to bridge 
DNA together non-specifically (Chen et al., 2008). Therefore, it is expected that such a large 
number of genes are recognised as Lsr2 binding sites. Thirdly, a number of different datasets 
all investigating a non-culturable or persister state in M. tuberculosis were matched to the 
induced genes by M233 (pMV306::rbpA3KRA). The first study showed that potassium depletion 
induced a non-culturable state which was resuscitated with the re-introduction of potassium 
(Salina et al., 2014). This dataset showed an overlap of 49 repressed genes for 2 days vs non-
culturable (NC) state. Additionally, 18 genes were induced during -K vs log +K, these are 
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probably growth-related genes during the resuscitation of cells from a NC state. The second 
example shows that 40 induced genes in M233 (pMV306::rbpA3KRA) map to genes induced in a 
nutrient starvation model at 4-96 h, during which growth is arrested (Betts et al., 2002). 
 





Non-essential genes. Sassetti et al., 2003 190 2.92E-08 
Lsr2 binding sites (intensity ratio of 1.5) Gordon et al. 2010 PNAS 82 1.95E-07 
Acid shock Induced M.tuberculosis, Golby et al 2007 19 1.94E-06 
sigD putative regulon, Balazsi et al 2008 6 1.30E-05 
All predicted and previously published secreted proteins Wiker et al., 
2000 10 1.38E-05 
Induced in log -K vs log +K t-test B+H p<0.05 >2 fold Salina 2014 18 1.69E-05 
Repressed in Res 2d vs NC (high MPN:high CFU) Salina 2014 49 2.72E-05 
PhoP regulon genes induced in WT v mutant Walters et al 2006 11 2.81E-05 
Upregulated in vitro vs granuloma, pericavity, distant lung (Sup T14) 
Rachman et al., 2007 33 0.000109 
Lsr2 binding sites (intensity ratio of 2.0) Gordon et al. 2010 PNAS 54 0.000185 
Lsr2 repressed KO vs WT H37Rv in ANY Condition (Bartek et al., 2014) 27 0.000201 
Predicted Secreted Proteins Top208-TM1 Gomez et al., 2000 10 0.000659 
a BALBc at 14 days vs BALBc at 45 days Repressed Talaat et al 2007 3 0.00177 
Nutrient Starvation Induced 4 or 24 or 96 h Betts et al., 2002 40 0.00228 
sigL putative regulon, Balazsi et al 2008 3 0.00339 
THP-1 Induced 24h, Fontan et al 2008 27 0.00374 
Table. 4.4. Hypergeometric analysis of genes induced RNA-seq gene list comparing RbpAWT and 
RbpA3KRA. 256 significantly induced genes identified after applying a q-value cut-off 0.01, were 
run using the hypergeometric function. P-value cut-off (<0.05) was applied. 
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4.2.7.2 Hypergeometric analysis of genes repressed in M233 (pMV306::rbpA3KRA) 
A 1.5 fold change filter was applied to the list of 714 significantly repressed genes resulting in 
a list of 373 genes for M233 (pMV306::rbpA3KRA), were matched to the hypergeometric analysis 
and further filtered by applying a p-value 0.0001 cut-off. This filter resulted in 21 significantly 
enriched gene expression signatures (Table. 4.5). Firstly, a number of datasets again 
overlapped with genes involved in non-culturable M. tuberculosis states. Secondly, a study 
aimed to understand the transcriptional changes of host-microbe interaction showed an 
overlap of 128 genes induced by M. tuberculosis inside dendritic cells and macrophages 
(Tailleux et al., 2008). Thirdly, the DosR regulon identified by multiple studies was significantly 
enriched in the genes down-regulated by the RbpA BL mutations in M. tuberculosis (Section: 
4.2.7.2.1).  
 





NRP or Stationary phase Induced genes Voskuil et al., 2004 62 1.96E-37 
Induced DC 1 or 4 or 18 h AND M 1 or 4 or 18 h Tallieux et al., 
2008 128 2.60E-29 
dosR Regulon Park 2003 36 1.53E-28 
Induced NRP-2 vs log phase ttest p<0.05 B+H >1.5 fold Tudo et 
al., 2010 131 3.11E-25 
Intracellular_Murine Macrophage Induced Schnappinger et al., 
2003 104 4.95E-24 
2.5 fold induced NRP2 v Aerobic ANOVA p0.05 B+H, Garton et al 
2008 36 1.31E-17 
dosR putative regulon, Balazsi et al 2008 22 4.10E-17 
2.5 fold induced 70:30 v Aerobic ANOVA p0.05 B+H, Garton et 
al 2008 19 7.73E-17 
RNI Induced genes Ohno et al., 2003 23 9.25E-17 
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NRP or Stationary phase Induced genes Voskuil et al., 2004 62 1.96E-37 
THP-1 Induced 24h, Fontan et al 2008 27 0.00374 
Induced DC 1 or 4 or 18 h AND M 1 or 4 or 18 h Tallieux et al., 
2008 128 2.60E-29 
Overexpressed Dendritic Cell v Macrophage Tallieux et al., 2008 66 1.10E-25 
Induced NRP-2 vs log phase ttest p<0.05 B+H >1.5 fold Tudo et 
al., 2010 131 3.11E-25 
dosR-dependent genes induced in vitro Kendall et al., 2004 26 3.57E-15 
Low Oxygen Induced Bacon et al., 2004 31 1.46E-14 
Bedaquiline Induced 30 mins 30x MIC top20 genes only, Koul et 
al 2013 15 1.76E-13 
Repressed Res 192h vs NC ANOVA p<0.05 >1.5 fold Salina et al., 
2014 132 2.36E-13 
Induced by BTZ043 4h exposure at  x10 MIC Makarov et al., 
2009 26 2.66E-13 
Table 4.5. Hypergeometric analysis of the genes repressed in RbpA3KRA compared to RbpAWT. 373 
genes after applying a q-value cut-off 0.01, were run using the hypergeometric function. p-
value cut-off (<0.0001) was applied and some of the overlapping datasets are represented in 
this table.  
 
4.2.7.2.1 Down-regulation of the DevR regulon by M233 (pMV306::rbpA3KRA) 
The hypergeometric analysis revealed that the repressed genes in M233 (pMV306::rbpA3KRA) 
overlapped with the DosR regulon. Therefore this section focuses on the status of the DosR 
regulon. The DevR (also known as DosR) regulon is induced by conditions that inhibit aerobic 
respiration and prevent bacillus replication, important for a non-culturable state (Sherman et 
al., 2001). DevR is a response regulator and DevS is a sensor kinase which binds to respiration-
impairing gases such as NO and CO, and thus is activated upon oxygen deprived conditions 
(Kumar et al., 2007). There is a gene upstream of devR, Rv3134c which has no known function, 
the stop codon of Rv3134c provides a gap of 27 bp before the start codon of devR. The ORFs 
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of devR (Rv3133c) and devS (Rv3132c) overlap by one base, the TGA stop codon of devR shares 
the TG of the start codon of devS, ATG. It is believed that Rv3134c-devR-devS are co-transcribed 
as an operon (Dasgupta et al., 2000; Fig. 4.12B). The RNA-seq data of this study showed down-
regulation of the devR/devS two component system in M233 (pMV306::rbpA3KRA) by 6-fold (Fig 
4.12A). The first gene of this co-transcribed operon, Rv3134c was also highly down-regulated 







Figure 4.12. The devS/devR/Rv3134c operon visualisation. (A) displays the average FPKM values 
of the devS/devR/Rv3134c operon in 3KRA (blue) and WT (red); t-test comparing RbpAWT and 
RbpA3KRA Rv3134c p-value 0.0329 and devS/devR p-value 0.0554. (B) Visualisation of the FPKM 
values for three biological replicates for devS/devR/Rv3134c using IGV (version 2.4.5), the log 
scale has been normalised between the RbpA and 3KRA tracks, the overlap between devS and 




Interestingly, a recent paper investigated the change in gene expression of various RbpA 
truncations, RbpA28-114 (CD, BL and SID), RbpA72-114 (BL and SID) and RbpAWT in M. smegmatis 
(Hubin, et al., 2017a). These RNA-seq data was accessed through Gene Expression Omnibus 
database (accession number GSE89773) and processed through the RNA-sequencing pipeline 
(Figure 4.8).  Three comparisons were made from this dataset, RbpAWT vs RbpA28-114, RbpAWT 
vs RbpA72-114 and RbpA28-114 vs RbpA72-114. The homologue of the devR/devS two-component 
system, MSMEG_3944/ MSMEG_3943 respectively is up-regulated in the RbpA72-114 mutant by 





























Figure 4.13. devS/devR FPKM values of the RbpA truncations, in M. smegmatis. FPKM values 
devS/devR (MSMEG_3944/ MSMEG_3943) in M. smegmatis with the Gene Expression 
Omnibus database (GEO: GSE89773; Hubin et al., 2017a) comparing RbpAWT, RbpA28-114 and  
RbpA72-114.  This data was compiled from two biological replicates.  
 
Whilst the devR/devS operon itself was down-regulated in M233 (pMV306::rbpA3KRA), it was 
important to identify the status of the DosR regulon. Studies have shown that in M. tuberculosis 
H37Rv exposed to low oxygen caused the induction of 47 genes from the DosR regulon in 
response to the hypoxic stress (Sherman et al., 2001). The RNA-seq data from this study 
confirmed that 36 out of these 47 genes of the DosR regulon were significantly down-regulated 
in M233 (pMV306::rbpA3KRA) compared to M233 (pMV306::rbpAWT; Fig. 4.14). The heat shock 
protein, hspX (Rv2031c) is a member of the DosR regulon and encodes α-crystallin (Acr), a 
major antigen found during latent infection of M. tuberculosis (Verbon et al., 1992). The 
145 
 
transcript levels of acr in the BL mutant were downregulated by 5-fold suggesting that the 
RbpA BL may be implicated in the host-microbe response during infection, particularly in the 
macrophage where bacilli encounter a multitude of stresses.  
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Figure 4.14. The DevR regulon genes down-regulated in M233 (pMV306::rbpA3KRA) compared to M233 (pMV306::rbpAWT). The FPKM values from 
two biological replicates of M233 (pMV306::rbpAWT) and M233 (pMV306::rbpA3KRA) have been plotted on a log scatter plot , the error bars 
represent mean with standard deviation. 
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4.2.7.2.2 RbpA3KRA down-regulates the DosR target, class II ribonucleotide 
reductase 
Class II RNRs modulate deoxynucleoside triphosphate biosynthesis in an oxygen independent 
manner and utilises adenosylcobalamin (vitamin B12) to generate radicals. Rv0570, nrdZ 
encodes for a class II RNR and transcription is dependent on devR/devS (Dawes et al., 2003). 
Deletion mutants of nrdZ have been shown to be dispensable for growth of M. tuberculosis 
(Dawes et al., 2003). The RNA-seq data showed that nrdZ was down-regulated in rbpA3KRA by 
8.8-fold (Fig. 4.15).  
 
Figure 4.15. Down-regulation of nrdZ in by RbpA3KRA. (A) Differential gene expression for nrdZ 
FPKM values for RbpAWT and RbpA3KRA, 652 and 167 respectively. The data is compiled from 
two biological replicates and the error bars represent mean with standard deviation (p 
=0.0065). (B)  RNA-seq data visualised using IGV (version 2.4.10).
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4.2.8 The RNAP subunits are up-regulated in M233 (pMV306::rbpA3KRA) 
RbpA interacts extensively with σA and the RNAP β subunit (rpoB) during transcription initiation 
(Hu et al., 2012; Tabib-Salazar et al., 2013), so it was important to identify any changes in the 
expression levels of RNAP caused by M233 (pMV306::rbpA3KRA). Thus far, this study has shown 
a down-regulation of the RNAP subunits for S401 (pRT802::rbpA3KRA) in S. coelicolor. However, 
the differential gene expression comparing M233 (pMV306::rbpA3KRA) to M233 
(pMV306::rbpAWT) revealed an up-regulation of rpoB, rpoC and rpoZ in M. tuberculosis by 2, 
1.8 and 1.5-fold respectively (Fig. 4.16). The up-regulation of the RNAP subunits may suggest 
that RbpA plays some modulatory function for RNAP. Explanations for the up-regulation of 
rpoB specifically could be because the RbpA3KRA is not fully functional and thus a general stress 
response is launched by the cell, or alternatively rpoB may be induced to increase the chances 
of holoenzyme formation that contains σA, because the expression levels of sigA remain the 
same in both strains.  
 
 
Figure 4.16. The up-regulation of RNAP subunits in M233 (pMV306::rbpA3KRA). The data is 
compiled from three biological replicates and the error bars represent standard deviation with 
mean. The unpaired t-test p-value of rpoB <0.001, rpoC p value= 0.0002 and rpoZ p value= 




The up-regulation of the RNAP subunits raised the question of why more RNAP is required in 
the cell for the M233 (pMV306::rbpA3KRA) compared M233 (pMV306::rbpAWT). Could this be a 
reflection of the greater rate of transcription/translation that is required during growth? 
Additionally, as bacterial cells increase in size with increasing growth rate the expression of 
ribosomal protein genes also increases to meet the demand for protein synthesis (Cortes & 
Cox, 2015). The RNA-seq results revealed that only five (out of 35) ribosomal protein genes 
were significantly differentially expressed between M233 (pMV306::rbpA3KRA) and M233 
(pMV306::rbpAWT). Three genes, rpsJ, rpmE and rpsO, were up-regulated, and two genes, rpsT 
and rpsP, were down-regulated (Fig. 4.17). The rpsJ is one of the large classified ribosomal 
operons which consists of 11 ribosomal protein genes (Cortes & Cox, 2015). rpsJ was the only 
member of the operon that was significantly up-regulated, by 1.5-fold (Fig. 4.18), whilst the 
expression of rplC, rplD, rplW, rplB, rpsS, rplV, rpsC, rplP and rpsQ remained unchanged 
between RbpA3KRA and RbpAWT. The known TSS for the rpsJ operon was aligned to identify 
features of the promoter which would explain why rpsJ is the only member of the operon to 
be up-regulated (Cortes et al., 2013; Sachdeva et al., 2010). The alignment revealed that rpsJ 
was the only member of the operon to consist of a -10 and -35-element consensus sequence 
compared with the other members of the rpsJ operon (Fig 4.18B). Whilst the promoter 
alignment of the up-regulated ribosomal protein genes, rpsJ, rpmE and rpsO, and the down-
regulated genes rpsT and rpsP revealed consistent conservation of the -10 and -35 promoter 
consensus sequence (Fig. 4.18C).  From the promoter alignments, it was difficult to link RbpA 
and promoter dependency as the promoters from the up-regulated genes in M233 
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Figure. 4.17. The FPKM values for the ribosomal protein genes in M. tuberculosis. This data is compiled from three biological replicates and the error 







Figure 4.18. The rpsJ ribosomal protein operon. (A) The rpsJ ribosomal protein operon 
viewed in IGV (version 2.4.10), RbpA (RbpAWT, blue) and 3KRA (RbpA3KRA, red) showing the 
number of reads aligning at the rpsJ operon. (B) The TSS   for the rpsJ operon genes (C) the 
promoters of the rpsJ, rpmE and rpsO which were up-regulated and rpsT and rpsP were 
down-regulated ribosomal protein genes using the Cortes et al., 2013, genome TSS 
annotations, the -10 and -35 elements are shown in bold and underlined, the extended -10 
element is shown in bold. Motif conservation created using WEBLOGO (version 2.8.2), 
position 1 represents -48 and position 48 at the 3’ presents +1 of the promoter. The sigA-
dependant promoter consensus sequence is shown in bold (Sachdeva et al., 2010). +1 of 
the TSS is annotated in red. The promoter TSS were not available for rpsS and rplV.  
 
4.3 Identification of potential transcription factors involved in response 
to BL mutation in M. tuberculosis  
A recent study in M. tuberculosis mapped transcription factor interactions by 
overexpressing transcriptional factors to define TF regulons using microarrays alongside 
ChIP-seq experiments to define TF binding patterns (Rustad et al., 2014). Hypergeometric 
probability was used to identify enriched TF regulons in the M233 (pMV306::rbpA3KRA) vs 
M233 (pMV306::rbpAWT) signature (log fold change=1 and p-value=0.01 filters were 
applied). Identification of large overlaps between these datasets could identify TFs that are 
specifically modulated by the RbpA BL.  
 
4.3.1 Analysis of the overlapping genes induced in M233 
(pMV306::rbpA3KRA) to transcription factor over expression datasets 
The 256 up-regulated genes in M233 (pMV306::rbpA3KRA) were compared to TFOE database 
and sorted by significance (Ind.Sig p-value 0.05; Table 4.6). Several sigma factor regulons 
were significantly enriched in the genes induced after RbpA BL mutation, SigI, SigJ, SigG, 
SigF and SigH.  SigI  is one of ten ECF σ factors in M. tuberculosis and is up-regulated during 
stationary growth phase and during heat shock (Lee et al., 2012). SigJ is also expressed 
during stationary phase and ΔsigJ null mutants demonstrated increase susceptibility to 
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hydrogen peroxide (Yanmin et al., 2004). The RNA-seq data comparing M233 
(pMV306::rbpA3KRA) to M233 (pMV306::rbpAWT) showed that sigI and sigJ were the only 
sigma factors up-regulated 4 and 2-fold respectively in M233 (pMV306::rbpA3KRA).  
Although the number of transcripts aligning to the principal sigma factor, sigA was 
extremely high in both M233 (pMV306::rbpAWT) and M233 (pMV306::rbpA3KRA), FPKM 
values of 600 and 719, respectively (Fig. 4.19C). The SigE expression data from Results 
chapter I indicates that despite the high expression levels of HrdB in S. coelicolor, the levels 
of SigE which is an ECF sigma factor are unchanged, but more SigE associates with RNAP. 
Therefore it is quite possible that the ECF sigma factors up-regulated in the RNA-seq data 



















TF Name TF.Ind Ind.Sig 
Rv3328c sigJ 3 2.64E-04 
Rv3416 whiB3 255 1.56E-03 







Rv1189 sigI 2 4.13E-03 











Rv3676 crp 43 1.84E-02 
Rv3557c kstR2 4 2.27E-02 
Rv3260c whiB2 104 3.35E-02 
Rv3223c sigH 95 3.99E-02 
Rv3765c tcrX 54 5.58E-02 
Rv0212c nadR 7 6.99E-02 




Table 4.6. Significantly enriched TF reulons in those genes up-regulated in M233 
(pMV306::rbpA3KRA) vs M233 (pMV306::rbpAWT). TF.Ind refers to the number of genes 






Figure 4.19. Significant up-regulation of SigI and SigJ in M233 (pMV306::rbpA3KRA). Comparing 
rbpAWT and rbpA3KRA for sigI and sigA transcript levels using FPKM. Triplicate FPKM values 
for sigI (p value= 0.0003) and sigA (p-value = 0.0864) using GraphPad Prism (version 6.01).  
 
4.3.2 The overlap of the down-regulated genes in M233 (pMV306::rbpA3KRA) 
with the TFOE dataset 
The 373 genes down-regulated in M233 (pMV306::rbpA3KRA) were compared to the TFOE 
and sorted by significance (Rep.Sig p value 0.05; Table 4.7), resulting in a list of 11 genes. 
Again, DosR (DevR) appeared in this list which was been discussed with the down-regulated 
































Rv2788 sirR 72 3.96E-02 








Table 4.7. Significantly enriched TF regulons in those genes down-regulated M233 
(pMV306::rbpA3KRA) vs M233 (pMV306::rbpAWT). TF.Ind is the number of genes repressed by 
overexpression of the TF. Ind.Sig is the significance of the enrichment, p value <0.05.  
 
4.4 Discussion 
4.4.1 RbpA3KRA displays an attenuated growth phenotype on solid agar 
This study focused on dissecting the function of the RbpA BL in M. tuberculosis. To study 
the effect of the RbpA BL mutations. RbpA BL mutants were constructed using a transposon 
inserted PI inducible system. The growth curve generated using OD readings in liquid 
culture over a period of 28 days, showed that the RbpA BL mutants were not attenuated. 
Checking the complementation of each of the RbpA BL mutant strains on solid media 
demonstrated, that M233 (pMV306::rbpA3KRA) did influence growth on solid agar. This 
suggested that Pip may have been ineffective in completely repressing pptr in the absence 
of PI since the empty vector control containing no RbpA (an essential gene in M. 
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tuberculosis) still grew. RNA-seq was used to quantify the expression levels of rbpA 
expressed from the native PI inducible system in the absence of the inducer and the 
rbpA3KRA allele in M233 (pMV306::rbpA3KRA). This showed that there were 71 copies of rbpA 
vs 825 copies of rbpA3KRA in this strain. As RbpA is essential in M. tuberculosis, even minimal 
expression of rbpA in the absence of the inducer could be enough to mask the true 
phenotype of the RbpA3KRA allele. However, it is assumed that this same strain leaks rbpA 
expression in the absence of the inducer on solid media too, yet we observed an 
atennuated growth phenotype. To further investigate the non-culturability hypothesis, an 
MPN assay was performed alongside CFUs and OD readings. The OD readings consistently 
showed that the RbpA BL mutants did not influence growth rate in liquid media, whilst the 
CFU assays consistently demonstrated that M233 (pMV306::rbpA3KRA) failed to grow as well 
as M233 (pMV306::rbpAWT). Most strikingly, the MPN showed that the M233 
(pMV306::rbpA3KRA) required higher dilutions to identify the absence turbidity whilst the 
CFUs counts required lower dilutions for growth to be observed. This pattern of growth for 
high MPN vs low CFU has been associated with M. tuberculosis persister phenotypes 
(Mukamolova et al., 2010; Salina et al., 2014). However, the more likely explanation is that 
the Pip repression system is leaking expression of rbpA from the native loci, this is mainly 
because M233 (pMV306) does not grow on solid agar but does in liquid media. Most 
inducible systems in mycobacteria are known to be leaky and therefore it is difficult to 
estimate the extent of the leaky expression that masks the true phenotype of the RbpA BL 
mutants (Ehrt & Schnappinger, 2014). To address the possible instability of the transposon 
insertion, the RbpA-BL strains were sequenced after the initial transformations and after 
every growth curve. All sequencing confirmed the presence of the integration of RbpA BL 
mutants and the transposon insertion.  
 
4.4.2 Impact of RbpA3KRA mutation on M. tuberculosis transcriptome  
Differential gene expression profiling comparing RbpA3KRA to RbpAWT demonstrated that 
the RbpA BL caused global transcriptional changes in the cell despite the absence of an 
attenuated growth phenotype in liquid culture (Hubin et al., 2017a). Hypergeometric 
analysis was performed to identify biological pathways enriched in the RbpA3KRA vs RbpAWT 
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gene list. This highlighted that RbpA was responsible for the induction of a large proportion 
of ‘non-essential’ genes (Sassetti et al., 2003). Both the up-regulated and down-regulated 
genes comparing the transcriptome of RbpA3KRA vs RbpAWT revealed a large overlap with 
persister/non-culturable phenotypes (Betts et al., 2002; Salina et al., 2014).  This suggested 
that the RbpA3KRA may cause global gene expression changes which signal for the bacterium 
to enter a non-replicating or persister phenotype. Additionally, it was found that the down-
regulated genes in M233 (pMV306::rbpA3KRA) overlapped with 43 DosR regulon binding 
sites. Closer inspection of the RNA-seq data from this study, highlighted that the co-
transcribed devR/devS/Rv3134c operon and 36 DosR targets out of 47 were down-
regulated in M233 (pMV306::rbpA3KRA). Therefore, this pattern of transcriptional changes 
suggested that the RbpA BL residues could play a role in the M. tuberculosis response to 
hypoxic conditions, found in macrophages and lung lesions. 
Additionally, the RNAP subunits were all induced by RbpA3KRA, which could suggest that the 
loss of the full length RbpA signals a global stress response. The RNA-seq data also 
highlighted the up-regulation of multiple ECF sigma factors, thus more RNAP availability 
could result in the ECF sigma factors out-competing SigA for holoenzyme formation. Other 
classes of growth-related genes such as the ribosomal protein genes were investigated, this 
showed only 5 out of 35 to be affected by the BL residue mutations suggesting that this BL 
phenotype is more specific than a general slowing of growth. However, rpsJ was up-
regulated in M233 (pMV306::rbpA3KRA), upon closer inspection of the rpsJ operon, 
promoter alignments revealed that rpsJ was the only affected member of the operon that 
consisted of ‘good’ -10 and -35 promoter elements. Additionally a promoter alignment of 
all the ribosomal protein genes up/down-regulated in M233 (pMV306::rbpA3KRA) consisted 
of highly conserved -10 (TANNNT) and -35 (TTGCGA) promoter elements. It may well be 
that RbpA controls promoters with specific -10 and -35 promoter features and could 
function as a repressor of some ribosomal protein genes. Other studies have demonstrated 
that differences between mycobacterial and E. coli promoter structures affects the overall 
stability of transcription initiation. Mycobacterial promoters require conservation of -10 
and -35 promoter elements for the initiation of transcription, whilst E. coli promoter can 
activate transcription initiation from a conserved -10 promoter element (Agarwal & Tyagi, 
2006). This study investigated the optimum -35 sequence required for optimal activity by 
base substitution of the -35 to -30 sequence, this showed that, TTGCGA, was required for 
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optimum activity (Agarwal & Tyagi, 2006). Additionally some studies have shown that a 
conserved -35 sequence is not required for transcription initiation in mycobacteria and 
streptomyces (Bashyam et al., 1996). Interestingly, rpsJ was the only member of the operon 
up-regulated by M233 (pMV306::rbpA3KRA). Closer inspection of the promoter revealed that 
rpsJ was the only member of the operon to consist of a good -10 and -35 promoter 
consensus sequence. The RbpA3KRA residues could increase promoter binding but may not 
necessarily increase transcription. Alternatively, the high binding strength of RbpA3KRA may 
trap RbpA3KRA onto the promoter and thus unable to activate transcription initiation. 
Similarly, RbpA3KRA could activate a stress response such that the ribosomal protein genes 
with a highly conserved consensus -10 and -35 promoter sequence are induced.  
 
4.4.3 Future work 
One of the most striking results for this chapter has been the contradictory RbpA3KRA 
phenotypic results in liquid and solid media, and discrepancies between CFU and MPN 
counts, one possibility may be that the RbpA3KRA induces a non-culturable phenotype. If the 
RbpA BL mutants are entering a persister/ non-culturable phenotype, it will be important 
to show how these cells resuscitate back to a culturable state. A study investigated the 
effect of K+ deficiency on culturability and showed how a high MPN/low CFU count can be 
used as a measure of a non-culturable phenotype, found that M. tuberculosis deficient in 
K+ were capable of resuscitation when supplemented with K+ (Salina et al., 2014). The non-
culturable transcriptome of K+ deficient cells show down-regulation of glycolysis and 
gluconeogenesis pathways, TCA cycle, fatty acid, mycolic acid biosynthetic pathways and 
up-regulation of genes involved in the catabolism of branched chain keto and amino acids. 
The RbpA BL mutant transcriptome affects multiple intermediate metabolism, respiratory 
and lipid metabolism genes. Alternatively, it is an assumption that organisms should behave 
the same in both liquid and solid, so the differences seen in this study may just be a result 
of the state of the culturing media. Finally, key indicator genes identified as significantly 
differentially expressed in RbpA3KRA compared to RbpAWT should be validated using an 

















Results chapter III: Investigating the 












To date, one of the main established functions of RbpA has been contacting the -10 
promoter DNA to help stabilise RPo complexes (Hu et al., 2014; Hubin et al., 2015, 2017). 
Data presented in Results chapter I suggests that the RbpA basic-linker-DNA interactions 
are not the essential role of RbpA, implying that RbpA plays additional functions.  These 
potential roles might include: an essential contact point for other transcription factors; a 
chaperone for holoenzyme formation; or a stabilising role for σHrdB. This chapter focuses on 
the importance of the RbpA SID M85 residue, which was previously recognised as having a 
potentially important role and investigating the binding capacity of a σHrdB mutant that is 
unable to bind RbpA by ChIP-seq analysis. Finally, the global importance of RbpA on the 
transcriptome is investigated in a strain in which RbpA is severely depleted. 
 
5.1.1 The importance of RbpA M85 residue interactions with σHrdB  
Previously, the RbpA-SID was subjected to alanine site-directed mutagenesis (Tabib-Salazar 
et al., 2013), which revealed several key residues involved in interaction (e.g. R89/R90) with 
HrdB.  Although not required for HrdB binding, M85 was also shown to play an important 
role. rbpAM85A only partially complemented the S. coelicolor S129 strain (ΔrbpA) and, unlike 
any other rbpA mutant, appeared to act dominantly by inhibiting the development of the 
wild-type strain (M. Paget, personal communication).  Structural predictions suggested that 
the equivalent residue  in M. tuberculosis (M84) makes non-polar interactions with σA- 
residue K334, which makes contact with the -12 promoter DNA at the beginning of the 
transcriptional bubble, and might itself make van der Waals interactions with the DNA 
backbone (Hubin et al., 2015). In support of a key role,  the M. tuberculosis RbpAM84A 
mutant was less active than WT in in vitro transcription assays (Hubin et al., 2015). 
Therefore, this section focuses on the amino acid substitution of M85 with neutrally 
charged alanine (A), leucine (L) and negatively charged glutamate (E), with the aim of 
potentially enhancing the dominant effect. These RbpA M85 mutant constructs were then 
introduced into S. coelicolor S401 to understand the phenotype in the absence of a possible 




Figure 5.1. The cryo-EM structure of RbpA-σA complex in M. tuberculosis. Cryo-EM structure 
shows RbpA-SID complexed to σA2 domain in M. tuberculosis and the RbpAM84 (RbpAM85 in 
S. coelicolor) is shown in yellow which interacts with σA- residue K334, shown in magenta. 
Accessed from Protein Data Bank using PDB ID: 6C04 and visualised and modified with 
PyMOL (version 1.3; Boyaci et al., 2018).  
 
5.1.1.1 Construction of the RbpA C-terminal M85 mutants  
Previous experiments on the RbpA-SID amino acid M85 mutants have been performed in 
rbpA null mutant backgrounds in which the paralogue rbpB has been deleted as it might 
mask the effects of certain alleles. Therefore, the M85 mutant alleles were introduced into 
S401 strain (A. Tabib-Salazar and M. Paget, unpublished), in which the only copy of 
rbpA/rbpB is an rbpA gene integrated in pIJ6902 such that it is induced by thiostrepton 
(Results I; 3.1.0).  As mentioned previously (Results I: 3.1.0), the starting plasmid for 
constructing M85A, M85E and M85L alleles was pMT3000::rbpA-NdeI. This plasmid was 
used as a template to engineer the M85 mutant PCR products, rbpAM85A, rbpAM85E and 
rbpAM85L using inverse PCR and confirmed by sequencing.  The mutant alleles were 
amplified using primers that incorporated flanking HindIII sites 135 bp upstream of the rbpA 
start codon and replacing the stop codon, allowing them to be fused to the 3XFLAG epitope 
tag in pRT802::3XFLAG tag (Methods; Table 2.4),  pRT802 integrates in the genome of S. 
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coelicolor, in this case at the φBT1 attachment site (Gregory & Smith, 2003). Following 
confirmation of structure using SpeI and BamHI diagnostic digests, recombinant plasmids 
were transformed into E. coli ETR competent cells followed by conjugation into S. coelicolor 
S401 and S129. Thiostrepton was included in all sub-culturing media for the S401 strain to 
reduce the incidence of suppressor development. 
 
5.1.1.2 Phenotype of the RbpAM85 mutants 
The S401 strains were cultured with/without thiostrepton for five days at 30°C (Fig. 5.2A). 
As expected S401 (pRT802::rbpAWT) grew equally well in the presence and absence of 
thiostrepton, whereas S401 (pRT802) formed very small colonies in the absence of the 
inducer. S401 (pRT802::rbpAM85L) grew equivalently to the wild-type in the presence and 
absence of thiostrepton, whereas the M85A and M85E mutations each led to small colonies 
that overproduced ACT in the absence of thiostrepton, particularly the case for M85E. The 
expression of the alleles in S. coelicolor S129 background had only a minimal effect on 
growth, presumably as a result of rbpB suppressing the mutant phenotypes (Fig. 5.2B). The 
data revealed that replacement of M85 with a bulky hydrophobic residue did not 
significantly affect RbpA function, whereas a smaller uncharged residue (Ala) or a negatively 
charged residue (Glu) impacted on RbpA function leading to a growth defect and ACT 
overproduction.  It is possible that a hydrophobic residue plays a key role in positioning 





Figure 5.2. Phenotypes of the RbpA M85 mutants on MS agar. (A) S401 pRT802::rbpAWT 
3XFLAG, S401 pRT802 3XFLAG, S401 pRT802::rbpAM85A 3XFLAG, S401 pRT802::rbpAM85E 
3XFLAG and S401 pRT802::rbpAM85L 3XFLAG have been plated onto MS agar with (A, left) 
/without (A, right) 15 µg/mL thiostrepton and incubated for five days. (B) S129 
pRT802::rbpAWT 3XFLAG, S129 pRT802 3XFLAG, S129 pRT802::rbpAM85A 3XFLAG, S129 







5.2 Analysis of σHrdB mutants that cannot associate with RbpA  
5.2.1 Overview 
RbpA binds to group I sigma factors (S. coelicolor σHrdB and M. tuberculosis σA) and selected 
group II σ factors (S. coelicolor σHrdA and M. tuberculosis σB) but not others (S. coelicolor 
σHrdC and σHrdD). RbpA also does not interact with the more diverse group III (e.g. M. 
tuberculosis  σF) and  group IV  proteins (e.g. S. coelicolor σR) (Hubin et al., 2015; Tabib-
Salazar et al., 2013). A sequence alignment (Fig. 5.3) of the σ2 domain revealed that σHrdB 
and σHrdA share 61% sequence similarity, whilst that between σHrdB vs σHrdC/ σHrdD/ σR is 50%, 
40% and 27%, respectively. The sequence similarity between group I and some group II go 
some way in explaining why RbpA only binds to certain sigma factors.  
The structure of M. tuberculosis σA2/RbpA revealed several amino acids in σA2 that make 
important interactions with RbpA-SID (Hubin et al., 2015). These amino acids were 
substituted for the corresponding amino acids from S. coelicolor σHrdC, which as expected 
disrupted RbpA binding (Hubin et al., 2015). These findings provided an opportunity to 
investigate how σHrdB might behave in vivo when unable to interact with RbpA. Therefore, 
the equivalent substitutions were constructed in a 3XFLAG-tagged copy of σHrdB and the 







Figure 5.3. Amino acid sequence alignment of S. coelicolor Group I, II and the IV sigma factors. 
The sequence alignment of conserved σ regions 1.2-2.3 in σ2 domain. Sequence alignment 
performed using CLUSTALW multiple sequence alignment tool (version 1.2.2), identical 
amino acids have been shaded in black. The red arrows indicate the four amino acids from 
σHrdB that have been substituted with the corresponding σHrdC amino acids.  
 
5.2.2.1 Construction of the σHrdB mutant for ChIP-analysis  
Four amino acids not conserved (Fig. 5.3) between S. coelicolor σHrdB and σHrdC were 
identified for site directed substitutions: 
• σHrdB E235/ σHrdC R59 
• σHrdB K238/ σHrdC T62 
• σHrdB L244/ σHrdC V68 
• σHrdB F245/ σHrdC R69 
 
The hrdB gene with 500 bp upstream DNA and a C-terminal 3XFLAG tag were inserted into 
the blunt ended EcoRV site in pBluescript II SK+ (created by Aline Tabib-Salazar) and was 
used as a template in this study. The σHrdB changes in conserved region 1.2, E235R and 
K238T, and the NCR, L244V and F245R, were generated using inverse PCR site-directed 
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mutagenesis using primers, HrdB-double_F and HrdB-double_R (Table 2.9); the resulting 
mutant was referred to as hrdB4xR. The hrdBWT3XFLAG and hrdB4xR 3XFLAG genes were 
cloned into EcoRV-digested pSET152, and recombinants were digested with BamHI which 
confirmed the correct orientation of the inserts in pSET152, producing two fragments 
~6320 bp and ~1342 bp. The confirmed pSET152::hrdBWT and pSET152::hrdB4xR constructs 
were transformed into E. coli ETZ and conjugated into S. coelicolor J1981 (rpoC::6His).  
 
5.2.2.2 The HrdB mutant association with RNAP using western blot 
analysis 
Initially, tests were performed to investigate whether the HrdB4XR mutant could still 
associate with RNAP, and whether this was affected by a stress response involving the 
activation of an alternative  factor. The best characterised  based stress response in 
Streptomyces is the R response to thiol stress  (Kallifidas et al., 2010) which involves the 
induction of >100 genes in response to thiol oxidation by e.g. diamide. Interestingly, rbpA 
is a member of the R regulon and is therefore also induced in response to diamide stress 
(Newell et al., 2006). Although it is not known why rbpA is controlled by R, one possibility 
is that an increased expression of rbpA might have an important role in maintaining σHrdB 
RNAP levels in the face of increased competition. Therefore, the association of the HrdB4XR 
mutant was investigated under conditions where R levels were induced, providing 
increased competition with σHrdB.  In this assay the J1981 rpoC::6His allele enabled the rapid 
purification of RNAP via immobilised metal affinity chromatography, followed by the 
immunodetection of associated FLAG-tagged HrdBWT or HrdB4xR.  Firstly, spores for J1981 
(pSET152::hrdBWT 3XFLAG) and J1981 (pSET152::hrdB4xR 3XFLAG) were cultured to OD450 
0.8 (Methods; 2.4), 1 mM diamide was applied to the cultures and 10 mL samples at time 
points 0, 20, 40 and 60 min were harvested. The his-tagged RNA polymerase in these strains 
were purified using a cobalt mini-column, and the eluates tested by western blotting using 
an anti-FLAG monoclonal antibody (Methods; 2.8.3) to detect FLAG-tagged HrdB. The 
western blot was normalised by dividing each HrdB signal by the RNAP β subunit, then 
divided by HrdBWT 0 min. Firstly, the time point 0 min for HrdBWT and HrdB4XR showed 
different amounts of immunodetection, this casted doubt on the validity of this western 
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analysis. Upon diamide induction, it was expected that the competition between σHrdB and 
σR would increase resulting in less HrdB associating with RNAP in the presence of oxidative 
stress. However, the amount of HrdB detected in HrdBWT samples was generally the same, 
which could be because RbpA is induced by the SigR regulon (Newell et al., 2006).  
 
 
Figure 5.4. Western blot analysis of HrdB association with RNAP upon diamide stress. Spore 
stocks were normalised and cultured in YEME supplemented with glucose to OD450 0.8, 1 
mM diamide was added to the cultures and at time points 0, 20, 40 and 60 min, 10 mL 
samples were collected. The cell lysate was transferred to the cobalt column following 
manufacturer’s instructions. The primary antibody was anti-mouse anti-FLAG whilst the 
secondary was anti-mouse anti-HRP. The data has been normalised firstly to the RNAP 
subunit control and then to HrdB time point 0 min. This figure is the result of two biological 




5.2.2.3 Chromatin immunoprecipitation of HrdBWT and HrdB4XR 
Chromatin immunoprecipitation (ChIP) is a technique used to study protein-DNA 
interactions.  This involves crosslinking all protein-DNA complexes followed by precipitating 
the protein of interest with an appropriate antibody and then analysing the DNA fragments 
purified, typically through qPCR or NGS. This section focuses on the ChIP-sequencing of 
DNA fragments immunoprecipitated by the anti-FLAG antibody designed to isolate HrdB 
FLAG tagged. The strains J1981 (pSET152::hrdBWT 3XFLAG) and J1981 (pSET152::hrdB4XR 
3XFLAG) were cultured in 80 mL YEME to mid exponential phase (OD450 = 0.8-1). The ChIP 
procedure is detailed in Methods Section 2.10.  
 
5.2.2.3.1 RbpA is not required for σHrdB interaction with SCO5281 promoter 
HrdBWT and HrdB4xR ChIP samples were initially tested for the  association with promoter 
DNA using qPCR to confirm that the C-terminal FLAG tag did not prevent promoter 
association and provide initial assessment of the effect of preventing RbpA binding. A large 
gene, SCO5281 (3819 bp) was chosen to allow resolution between the promoter and 
reading frame probes considering that the ChIP experiment involves shearing DNA to 300-
500 bp fragments. SCO5281 is annotated as a putative 2-oxoglutarate dehydrogenase, an 
important TCA cycle enzyme which converts 2-oxoglutarate to succinyl semi-aldehyde.  The 
‘promoter’ forward primer (3SCO5281_F) was designed 21 bp upstream of the TSS (Jeong 
et al, 2016) and the reverse primer (3SCO5281_R) was designed 73 bp downstream of the 
TSS (Table 2.9). The ‘mid-frame’ forward primer (8SCO5281_F) was designed 2475 bp 
downstream from the TSS and the reverse primer (8SCO5281_R) was designed 1324 bp 
upstream of the stop codon (Table. 2.10).  qPCR revealed a 6.9- and 4.6-fold enrichment at 
the promoter for HrdBWT and HrdB4xR, respectively (Fig. 5.5). The copy number was only 
slightly reduced in the HrdB4xR compared to HrdBWT, providing further evidence that the 
























5 0 0 0 0
1 0 0 0 0 0
1 5 0 0 0 0
2 0 0 0 0 0
2 5 0 0 0 0
H r d B
H r d B 4 x R
 
Figure 5.5. RbpA is not required for σHrdB interaction with the SCO5281 promoter. -21 
represents 21 bp upstream of the TSS of SCO5281 and +2475 represents 2475 bp 
downstream of the TSS. This data is compiled from 2 biological replicates. Error bars 
represent mean with standard deviation. 
 
5.2.2.4 Preparation of the ChIP-seq library 
Samples were quality controlled by quantifying the DNA concentrations using the Qubit 
DNA HS assay kit following manufacturer’s instructions. Additionally, the quality of the DNA 
was measured using the NanoDrop spectrophotometer (Table 5.1). The 
immunoprecipitated and input control DNA was sent to Novogene (Hong Kong) for library 
preparation (Fig. 5.6) and sequencing.  The DNA fragments were extracted to construct the 
Illumina sequencing library. The ends of DNA fragments were end repaired and ligated to 
an adaptor (Table 2.10). The DNA fragments were run on a gel and fragments between 100-
500 bp and extracted from the gel and PCR amplified for 16 cycles. The amplified PCR 
products were quality tested and sequenced. 8 samples were combined and sequenced 
using the Illumina HiSeq 2500 platform with 50 bp singe-end reads via multiplex 







Figure 5.6. Pipeline for the library preparation of ChIP-seq samples. The samples were 
sequenced externally by Novogene (Hong Kong) using Illumina HiSeq SE50. The DNA 
fragments ends were repaired and ligated to an adaptor. The samples were run on a gel to 
enable size exclusion of any fragment above 100-500 bp. PCR of the fragments was 
enabled, and the PCR product was QC’d, denatured to ssDNA, multiplexed and sequenced. 








Table 5.1. Quality control of the ChIP samples in-house. The ChIP samples were QC’d using 
FastQC Read Quality reports (Galaxy version 0.69). WT= hrdBWT, mutant = hrdB4xR and IPC= 
input control.  
 
5.2.2.4.1 Bioinformatic analysis of ChIP-seq data 
The FASTQ files were processed using the Galaxy tool (https://usegalaxy.org). The FASTQ 
files were first converted from Illumina to Sanger format using FASTQ Groomer (Galaxy Tool 
version, 1.0.4). The FASTQ files were quality control checked to ensure the sequencing was 
successful using FASTQC (Galaxy Tool version, 0.63) and highlights any problems with the 





Sample ng/μl Volume 
(μl) 
Total amount (ng) 260/280 260/230 
WT1 0.634 16 10.144 1.1 0.68 
WT2 0.134 16 2.114 1.29 0.63 
WT3 0.27 16 4.32 1.23 0.57 
HrdB4xR1 0.646 16 10.336 1.25 0.54 
HrdB4xR2 0.506 16 8.096 1.51 0.64 
HrdB4xR3 0.55 16 8.8 1.38 0.67 
WT3 IPC 82 16 1312 1.82 1.53 



















Figure 5.7. Quality control of FASTQ files. (A) The quality score across all the bases, shows 
that this sample has passed the QC, the first 6-10 bases have been trimmed to ensure that 
only the ‘very good quality’ bases are included in the analysis. (B) The basic statistics of a 
sample that has a poor GC%. (C) Sequence content across all of the bases provides an 
indication of the number of bp require trimming.  
 
The FASTQ files were trimmed from the first 10 bases using the Trim sequences tool (Galaxy 
Tool Version 1.0.0) to remove the poor sequence quality at the 5’. The FASTQ files were 
aligned to the S. coelicolor A3 (2) genome sequence (NCBI reference sequence: 
NC_003888.3) with Bowtie for Illumina (Galaxy Tool Version 1.1.2, using the settings –q –p 













Sample Mapped Reads Unmapped Reads Total Reads % 
Mapped 
HrdBWT1 21641143 461501 22102644 97.9% 
HrdBWT2 23023728 940501 23964229 96.1% 
HrdBWT3 18435590 426427 18862017 97.7% 
HrdB4xR1 19167262 336947 19504209 98.3% 
HrdB4xR2 25160294 575662 25735956 97.8% 
HrdB4xR3 21006305 355820 21362125 98.3% 
HrdBWT3 IPC 21416330 161127 21577457 99.3% 
HrdB4xR3 IPC 21319715 171094 21490809 99.2% 
Table 5.2. Percentage of reads mapped to the S. coelicolor genome. The number of mapped 
and unmapped read counts were obtained with IdxStats (Galaxy Tool Version 2.0) after 
running the alignment to the S. coelicolor genome using Bowtie (version 1.1.2). 
 
The percentage of mapped reads were obtained using the IdsStats (Galaxy Tool Version 
2.0). This revealed good alignment results to the S. coelicolor genome, averaging 98% (Table 
5.2). The Bowtie Sequence Alignment Map (SAM) file was then converted to an input BAM 
file using SAM-to-SAM (Galaxy Tool Version 2.0). This BAM file is then sorted by 
chromosomal co-ordinates using the Sort BAM dataset (Galaxy Tool Version, 2.0). Finally, 
the BAM files were uploaded to the Galaxy deepTools server (http://deeptools.ie-
freiburg.mpg.de) and bigWig files were generated using bamCoverage Tool (Galaxy Tool 
Version 2.5.0.0). The samples were then normalized using the Normalisation method: 
Normalized to fragments (reads) per kilobase per million (RPKM). These files were then 
uploaded to the Integrated Genome Browser (IGB; Version 8.3.4) to visualize the 
normalized bigWig histograms against the annotated S. coelicolor A3 (2) genome sequence 
















Figure 5.8. bigWig Histogram file visualised using the Integrated Genome Browser. ChIP-seq analysis of the σHrdB association with RNAP in the 













5.2.2.4.2 Analysis of the HrdBWT and HrdB4xR ChIP-sequencing   
A previous unpublished ChIP-seq study using a polyclonal antibody mapped genome-wide 
HrdB binding sites in the presence and absence of rifampicin (which traps RNAP at promoters; 
A. Tabib-Salazar and M. Paget, personal communication). Therefore, the current set of data 
were visually compared with this study to ensure that the anti-FLAG antibody was enriching 
the same promoter DNA. Inspection of two rRNA operons revealed a similar pattern of peaks 
to that obtained with an anti-HrdB polyclonal and anti-FLAG antibody, although there were 
less normalised reads, illustrated by the scale bar (Fig 5.9). The lower read count relative to 
background levels could be caused by many factors including competition between the FLAG-
tagged HrdB proteins and the native HrdB, or deleterious effects caused by the FLAG-tag on 















Figure 5.9. Validation of ChIP-sequencing for this study. (A) Comparing the level of binding of HrdB at the rrnC operon and (B) rrnE operon. HrdB U 
(lilac) and HrdB Rif (lilac) are ChIP-seq datasets from Aline Tabib-Salazar, U represents untreated and Rif represents HrdB binding post Rifampicin 
treatment. HrdBWT (blue) and HrdB4xR (yellow) are comparing the level of HrdB localisation at promoters, HrdB4xR cannot bind RbpA. 
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The RNA-seq in Results chapter I: 3.1.8.1 demonstrated that the S401 (pRT802), empty vector 
control which does not express rbpA, caused global downregulation of growth related genes. 
Therefore, as an initial step the level of binding of the HrdB4xR mutant at the highly active tRNA 
promoters was investigated. For this purpose, 21 5’-mapped promoters for tRNA 
genes/operons were chosen. The enrichment of HrdB at each tRNA promoter was quantified 
using the NGS FASTQ files, this was achieved by uploading the files into Galaxy and searching 
the reads from the HrdBWT and HrdB4XR samples for 20 bp sequence upstream of the +1 
transcription start site of the tRNA promoter using the ‘Text Manipulation’ function and ‘Search 
in textfiles’. These counts were normalised by dividing by the total counts of three control 
sequences for each sample. The control sequences were located within the long gene, 
SCO5281 that were not associated with HrdB peaks and therefore represent background reads 
(Fig 5.10). Almost all of the tRNA gene promoters investigated showed reduced HrdB4XR binding 
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Figure 5.10. The dependency of tRNA genes on RbpA using ChIP-seq. The 20 bp upstream 
sequences from the tRNA +1 was used to search the reads for each sample using the ‘Search 
in textfiles’ (Galaxy Tool version 1.1.0) in Text manipulation (Jeong et al., 2016). The number 
of reads that produced a hit for the 20 bp sequence from tRNA genes in the HrdBWT and HrdB4xR 
samples were quantified and divided by the number of the reads for SCO5281. This data is 
compiled from three biological replicates and error bars represent mean with standard 




Next the annotated TSS were aligned for each of the tRNA gene promoters (Fig. 5.11), in an 
attempt to identify conservation of particular promoter elements (Jeong et al., 2016).  The 
promoter alignments revealed that the -10 element were well conserved to the consensus 
sequence, whilst the -35 element was not recognisable. The -35 promoter element is rich in 
thymine residues, this region is important for binding to the αCTD (Estrem et al., 1999).  
 
Figure 5.11. tRNA gene promoter alignments. The TSS were identified from Jeong et al., 2016, 
bases in grey represent position -1 from the TSS. The -10 and -35 promoter elements are 
underlined and bases in red are the extended -10 element.  Motif conservation created using 




Initial attempts to identify peaks for HrdBWT and HrdB4XR using the input controls in MACS2 and 
then identify differences bioinformatically using bdgdiff (version 2.1.1.20160309.0) failed 
because the differences were small. Additionally, MACS2 is ideal for identifying the 
presence/absence of peaks rather than less/more binding at the same locus. Therefore, 
HrdBWT and HrdB4xR peaks were compared using MACS2 directly without the use of input 
controls. Each biological replicate comparison produced a list of genes, which were pooled 
together, and a 1.5-fold enrichment filter was applied, resulting in a list of 36 genes (Table 5.3). 
This list of 36 genes represented less binding for the HrdB4XR samples vs HrdBWT. The list of 
genes also showed that the vast majority of differences between HrdBWT and HrdB4xR exist at 
the periphery of the chromosome (Fig 5.8).  
 





SCO6032/SCO6033 6622487 6622846 1.55291 8.05193 
Hydrolase/ 
hypothetical protein 





SCO6960 7726906 7727168 1.52833 10.81185 Hypothetical protein 
SCO6468 7157227 7157558 1.52619 10.81185 
phosphatidylserine 
decarboxylase 
SCO6864 7635024 7635264 1.52436 10.7076 hypothetical protein 










rrnc 1471828 1472038 1.51642 10.4136 Ribosomal protein 
SCO6374 7036266 7036543 1.51512 10.61922 sugar transferase 
SCO0297 291595 291853 1.51245 10.26669 secreted protein 
SCO1302 1379640 1379868 1.51245 10.26669 hypothetical protein 









SCO1242 1314390 1314647 1.50054 9.82452 DNA-binding protein 
SCO1544/SCO1543 1652478 1652848 1.50054 9.97343 Hypothetical proteins 
SCO6863 7632947 7633194 1.50054 9.82452 hypothetical protein 
SCO0504 537420 537716 1.64775 14.07565 
DEAD-box RNA-
helicase 
SCO0748 789707 789962 1.57873 11.53981 hydrolase 
SCO0636 676905 677192 1.56003 11.53052 
ABC transporter ATP-
binding protein 




SCO1656 1772625 1772903 1.53856 10.49098 hydrolase 
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SCO6391 7056806 7057424 1.53176 10.6936 
IS110 
transposase/integrase 
SCO7203 8006039 8006283 1.53129 9.74129 
integral membrane 
protein 
SCO7253 8065015 8065237 1.53129 9.74129 hypothetical protein 
SCO7093 7881725 7881978 1.51737 9.42179 
transcriptional 
regulator 
SCO1365/SCO1364 1442621 1442862 1.51403 9.12645 Hypothetical protein 
SCO1491 1594068 1594473 1.51108 10.18576 elongation factor P 
SCO6336/SCO6335 6995657 6995907 1.50972 8.98058 Hypothetical protein 
SCO0233 223713 223920 1.50541 8.82848 DNA-binding protein 
SCO7318 8125286 8125498 1.50541 8.82848 hypothetical protein 





SCO6488 7157250 7157488 1.50041 8.82848 
acyl-peptide 
hydrolase 
Table. 5.3. List of enrichment sites identified as significantly lower for HrdB4xR compared to 
HrdBWT using ChIP-seq. MACS2 provides a list of enrichment at chromosome locations, which 
were then viewed using IGB (version 9.0.0). The gene ID column contains two gene IDs because 
the enrichment could be present for either strand. Start and end refer to the chromosomal 
location. 
 
The promoters from the genes in Table 5.3 were aligned using TSS annotations to identify 
unique elements of the promoters of genes which all demonstrate less binding of HrdB in the 
HrdB4XR compared to HrdBWT (Fig 5.12). RbpA has been shown to activate in vitro transcription 
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of promoters which lack a consensus -35 promoter element so it was important to check the 
quality of the -10 vs -35 promoter sequences (Hubin et al., 2017a; Vishwakarma et al., 2018). 
The alignment of the promoters revealed almost perfect conservation of the -10-consensus 
(TAgaaT) sequence, whilst the -35 (TTGaCA) promoter sequence was poorly conserved. This 








Figure 5.12. Alignment of gene promoters with less HrdB4xR binding. The annotated TSS were 
identified using TSS information from Jeong et al., 2016. The promoter elements -10 (TAgaaT) 
and -35 (TTGaCA) are consensus sequences for HrdB (Kang et al., 1997). Motif conservation 
created using WEBLOGO (version 2.8.2), position 1 represents -42 and position 42 at the 3’ 




5.4  The genes that require RbpA in S. coelicolor 
RbpA is present at all HrdB-dependent promoters in vivo, although it is not clear which 
promoters actually require RbpA for expression. RbpA appears to stimulate most promoters in 
vitro (Tabib-Salazar et al., 2013), although other cellular factors, such as activators, are missing 
from these experiments, and so the actual in vivo dependency on RbpA is unclear.  The 
question of which genes are dependent on RbpA was partially addressed in Results chapter I, 
where the role of the basic linker was investigated. However, considering that the basic linker 
is not essential, RbpA could play additional roles at some promoters. To try to address this we 
used RNA-sequencing to compare the transcriptome of the S401 (pRT802) and S401 
(pRT802::rbpAWT) strains under conditions where the thiostrepton-induced rbpA gene in S401 
was not expressed. Following initial characterisation of the data, the focus was on genes that 
were up-regulated in S401 (pRT802::rbpA3KRA) and differential gene expression between S401 
(pRT802) and S401 (pRT802::rbpAWT).  For information on the library preparation, quality 
control data and the level of adapter contamination and trimming, refer to Results I; sections 
3.1.6.1, 3.1.6.2, 3.1.7.1 and 3.1.7.2. 
 
5.4.1 Analysis of the differential gene expression between S401 (pRT802) 
and S401 (pRT802::rbpAWT)  
A differential gene expression list was generated comparing S401 (pRT802) and S401 
(pRT802::rbpAWT), 3562 genes were significantly different, with 1352 genes up-regulated in 
S401 (pRT802) and 2210 genes down-regulated. The samples were loaded into Rstudio 
(version 1.0.153) using the CummeRbund package (version 2.0.0) to visualise the samples (Fig 
5.13A and Fig 5.13B) biological replicate FPKM values. The FKPM values for the three biological 
replicates for S401 (pRT802) and S401 (pRT802::rbpAWT) were demonstrated using box plots 
and dendograms. The dendograms showed that the biological replicates cluster together 
based on the genetic background (Fig 5.13A), whilst the box plots revealed the conservation of 





Figure 5.13. Quality of the replicate RNA-Seq samples in S. coelicolor. (A) Dendrogram 
demonstrates the hierarchical clustering of the three-biological replicate. (B) Density plot of 
the distribution of FPKM values for all three-biological replicates. All the quality control 





5.4.2 Analysis of genes up-regulated in S401 (pRT802) 
To analyse the up-regulated genes in S401 (pRT802), the differential gene list was stringently 
filtered, firstly by >log2=1 difference in expression level and secondly by filtering out the S401 
(pRT802) FKPM values <20. The resultant list contained 200 genes and was sorted by the 
chromosome location to identify clusters of genes.  
 
5.4.2.1 Genes induced by cell wall antibiotics are induced in S401 (pRT802)  
S401 (pRT802) has shown a clear growth-related phenotype, the absence of rbpA expression 
in this strain may be responsible for the induction of a multitude of stresses. In line with this, 
the bacterial cell wall is a good target for antibiotics as it is crucial for growth. Therefore this 
section focuses on the changes in expression of genes that are upregulated in response to cell 
wall antibiotics. A study by the Hong lab (2011) investigated the genes up-regulated by 
vancomycin, bacitracin and moenomycin which target the cell wall in S. coelicolor (Hesketh et 
al., 2011). This study found 1062 significantly induced genes in response to exponentially 
growing S. coelicolor in response to vancomycin, bacitracin or moenomycin.  The list of 244 
genes induced by all three cell wall targeting drugs were compared to the RNA-seq data from 
this study which revealed a match of 37 genes. This list of 37 up-regulated genes included hrdD, 
which is controlled by SigE. This raised the possibility that the SigE regulon is induced in the 
S401 (pRT802) background. Upon investigations of the SigE regulon, 22 of the SigE-dependant 
genes were identified and matched to the 37 genes cell wall antibiotic targeting genes. SigE 
(SCO3356) is an extra-cellular sigma factor (ECF) which is activated during cell envelope stress 
(Paget et al., 2002). The only known SigE targets to date was σhrdD and the cwgA operon (Paget 
et al., 1999). Next the RNA-seq data comparing S401 (pRT802) and S401 (pRT802::rbpAWT) 
revealed 28 possible SigE targets in total. However, the levels of sigE expression in S. coelicolor 
S401 (pRT802) and S401 (pRT802::rbpAWT) were unchanged, whilst SigE was down-regulated 
in S401 (pRT802::rbpA3KRA) by 1.88-fold. The annotated TSS for 20 up-regulated genes of the 
22 potential SigE targets were aligned to identify the conservation of the -10 and -35 promoter 
elements (Table 5.4; 5.14). The promoter alignments showed conservation of the -35 (GgAAC) 






Table 5.4. Promoter alignments of the SigE targets up-regulated in S401 (pRT802). The 
transcriptional start site data used from Jeong et al (2016) has been used to identify the 
promoters for the SigE genes. The -10 and -35 elements are separated by 18-19 bases and the 




Figure. 5.14 Motif conservation of the SigE targets. The SigE targets motif conservation has been 
generated using WEBLOGO (version 2.8.2), position 1 represents -43 and position 43 at the 3’ 
presents +1 of the promoter 
 
Interestingly, SCO3089-SCO3090 are ABC transport proteins known to be up-regulated in 
response to bacitracin treatment and null mutants demonstrate increased sensitivity. The RNA-
seq data showed that SCO3089-SCO3090 as induced by 11.6 and 12.8-fold in S401 (pRT802), 
respectively. Additionally, SCO3397 is the only lysyl-tRNA synthetase out of a possible 27 that 
is up-regulated by 2.1-fold, it has been also known to play a role in resistance to bacitracin and 
vancomycin (Hesketh et al., 2011). 
 
5.4.2.2 Increased levels of SigE associate with RNAP in ΔrbpA 
The RNA-seq results indicated that the SigE regulon is up-regulated in S401 (pRT802::rbpA3KRA), 
despite the levels of sigE remaining unchanged in both samples. It was hypothesised that 
depletion of RbpA might result in increased accessibility of σE to the RNAP. Therefore, the levels 
of SigE in cell lysate and pull-downs were tested by comparing the S. coelicolor J1981 (rpoC::his) 
and S129 (J1981 ΔrbpA) strains. To test this, firstly, the starting number of spores were 
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normalised between both strains and cultured to OD450 0.8 and the cell lysates were passed 
through the cobalt protein purification column. The pull-down samples were normalised to 
J1981 and run on a 10% SDS gel and imaged using LI-COR. The western blot analysis showed 
the level of SigE in the cell lysates in J1981 and S129 was generally consistent whilst the levels 
of SigE associating with RNAP in the pull-down assays indicated an increase in SigE association 
with RNAP in the S129 strain (Fig 5.15). The anti-SigE antibody appeared to bind to several 
other proteins shown in Fig 5.15A, B. SigE is a 28 kDA protein and this was used to line up the 
band corresponding to SigE (Kang et al., 1997). This data suggested that the expression levels 
of sigE are unchanged in the absence of RbpA, however the levels of SigE associating with RNAP 






Figure 5.15.  Increased association of SigE in the S129 ΔrbpA. Spore stocks for J1981 and S129 
strains were normalised and cultured to OD450 0.8, the cell lysates were passed through the 
cobalt protein purification column following manufacturer’s instructions. The pull-down 
protein concentrations were normalised to J1981 and run on 10% SDS gel. The primary 
antibody anti-rabbit anti-SigE and the secondary antibody anti-rabbit anti-HRP was used to blot 
the membrane and visualised using the LI-COR. Multiple bands on the western blots indicate 
that the anti-sigE Ab is able to detect other proteins (A) Cell lysate (B) Pull-down samples 
visualised and quantified (C). Unpaired T-test compares the J1981 and S129 pull-downs, p-
value 0.0224. This data is compiled from three biological replicates and the error bars denote 




5.4.3 Upregulation of genes in S401 (pRT802::rbpA3KRA) and S401 (pRT802) 
The up-regulated genes in S401 (pRT802::rbpA3KRA) were not discussed in Results Chapter I, 
and therefore has been presented in this section. Investigating genes that are both up-
regulated in S401 (pRT802::rbpA3KRA) and S401 (pRT802) could provide an insight into gene 
regulation by RbpA. Therefore, the list of 2768 genes that are significantly up-regulated in S401 
(pRT802::rbpA3KRA) and S401 (pRT802) was stringently filtered. Firstly, the list was filtered by 
log2=1 (2 fold change) for both datasets, secondly genes with FKPM <20 for both S401 
(pRT802::rbpA3KRA) and S401 (pRT802) were removed. This produced a list of 91 genes which 
were organised based on chromosomal location for the identification of gene clusters.  
 
5.4.3.1 Carotenoid biosynthesis operons, crtEIVB, crtYTU, litRQ and litSAB are 
up-regulated in S401 (pRT802) and S401 (pRT802::rbpA3KRA) 
Carotenogenesis is the production of natural pigments which can provide protection against 
photo-oxidative damage and aids light harvesting (Takano et al., 2005).  The biosynthesis of 
the yellow-pigmented carotenoids in S. coelicolor are light-inducible and the sequenced 
genome enabled identification of the carotenoid biosynthesis gene cluster (Takano et al., 
2005). The carotenoid gene cluster is composed of two convergent operons, crtEIBV and 
crtYTU and the cluster is flanked by the light-induced regulatory divergent operons, litRQ and 
litSAB (Takano et al., 2005). LitR is part of the MerR transcription family of regulators and LitS 
is an ECF sigma factor. LitA is a lipoprotein, LitB is a putative anti-sigma factor and LitQ is a 
possible oxireductase. Transcription at the promoters proceeding crtE, crtY, litR and litS are 
activated upon light illumination (Takano et al., 2005). Sigma factor LitS drives the activation 
of the crt biosynthesis gene cluster upon light activation (Takano et al., 2005). The crtEIVB and 
litS deletion mutants failed to produce the carotenoid yellow-pigment (Takano et al., 2005). 
The RNA-seq from this study showed an up-regulation of the convergent operons crtEIBV and 
crtYTU in S401 (pRT802) by 16 and 15-fold and in S401 (pRT802::rbpA3KRA) by 14 and 12.1-fold, 
respectively. Additionally, litQ, litR, litA and litB are up-regulated 3.6, 1.3, 3.8 and 8.2-fold in 
S401 (pRT802) respectively and litB is up-regulated 3.5-fold in S401 (pRT802::rbpA3KRA). 
Interestingly the expression levels of sigma factor, litS remains unchanged between S401 
(pRT802::rbpAWT), S401 (pRT802) and S401 (pRT802::rbpA3KRA).  
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5.4.4 Down-regulation of genes in S401 (pRT802) 
Results chapter I;3.1.8.1 focused on the growth-related genes which were all down-regulated 
possibly as a direct result of the RbpA null mutant, RbpA3KRA or because the strain simply failed 
to grow. This section focuses on the genes that are significantly down-regulated in S401 
(pRT802) but not in S401 (pRT802::rbpA3KRA). There was a list of 361 down-regulated genes in 
S401 (pRT802) which were stringently filtered by applying a FPKM value <20 for S401 (pRT802) 
which reduced the list to 210 genes and secondly applying a log2=-1 fold cut-off, resulting in a 
final list of 20 genes.  
S. coelicolor encodes two glutamine synthetases, glnA which is regulated by GlnR and GlnII 
(Tiffert et al., 2008). GlnR is a global nitrogen response regulator and binds upstream of the 
amtB-glnK-glnD operon and recognises the GGTCAC-N(5)-CGAAC-N(19-23)-TSS motif of the 
promoters (Fink, 2002). amtB encodes a putative ammonium transporter, glnK is a signal 
peptide and glnD encodes for an adenylyl transferase. A study mined the genome sequence 
for S. coelicolor for the GlnR binding motif in the promoter sequences of genes found upstream 
of the TSS and were confirmed using electrophoretic mobility shift essays (EMSAs) for an 
extensive identification of the GlnR regulon (Tiffert et al., 2008). The putative secreted protein, 
SCO0888 was identified as a member of the GlnR regulon which is down-regulated in S401 
(pRT802) by 2-fold.  Some possible explanations include that, RbpA may regulate the GlnR 
promoter, the absence of RbpA causes global shut-down in transcription which includes the 
GlnR regulon.  
 
5.5 Discussion 
5.5.1 The SID RbpAM85 displays a clear phenotype  
The RbpAM85 residue is very well conserved across the Actinobacteria and is located in the 
RbpA-SID which is important for σHrdB interactions. In this study, the RbpAM85 was substituted 
with leucine, alanine and glutamate. All three substitutions in a ΔrbpA S129 background 
displayed minimal changes whilst introduction of the same constructs into an ΔrbpA ΔrbpB 
genetic background resulted in RbpAM85E and RbpAM85A displaying a small colony phenotype 
and production of ACT. The RbpAM85L does not display a phenotype despite its larger R group 
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compared to RbpAM85A. Previous studies tested the in vitro transcription activation ability of 
the M. tuberculosis RbpAM84A, which has shown partial activation. The corresponding RbpAM85A 
in S. coelicolor was tested in a ΔrbpA S129 background which produces a small colony 
phenotype (Hubin et al., 2015). A crystal structure of the M. tuberculosis RbpA-SID- σA2 
complex, positioned the RbpAM84 residue to bind to the σA -residue K334 which interacted with 
-12 template DNA (Hubin et al., 2015). Together this evidence suggests that the RbpAM85 in S. 
coelicolor is critical for normal rbpA function in vivo.  To further characterise the importance of 
the RbpAM85, growth curves are required to establish the effect of substituting M85 with a 
negative charged amino acid and those with a larger R group on viability.  
 
5.5.2 σHrdB unable to bind to RbpA is still able to associate with RNAP and 
promoters  
Previous work by our group identified several amino acids in σA2 positioned to interact with 
RbpA-SID (Hubin et al., 2015). These amino acids in σA2 were substituted with the 
corresponding σHrdC2 residues which rendered RbpA binding in BACTH assays in M. tuberculosis 
(Hubin et al., 2015). Therefore, this study investigated the effects of σHrdB binding to RNAP by 
substituting the amino acids important for RbpA binding with the corresponding σHrdC2 in S. 
coelicolor. The engineered HrdB4xR mutant was analysed for its association with RNAP using 
pull-down western blot analysis upon diamide treatment. Diamide activates alternative sigma 
factors to respond to the oxidative stress and therefore may encourage greater competition 
between σHrdB and other sigma factors for RNAP. The western blot analysis showed that both 
HrdBWT and HrdB4XR continue to associate with RNAP. The RNA-seq data for S401 (pRT802) had 
shown global down-regulation of growth related genes therefore the ChIP-seq data was 
analysed for growth related genes. The highly active tRNA promoters confirmed using ChIP-
sequencing, that the amount of HrdB4xR binding to tRNA genes was only reduced but not 
abolished in the absence of RbpA, compared to HrdBWT. Promoter alignments of the tRNA 
genes demonstrates a well conserved -10 whilst the -35 element is poorly conserved. This 
eludes to the possible necessity of RbpA at promoters with a poor consensus -35 promoter 
element. The ChIP-analysis involved producing a peak calling list of genes that have less HrdB4xR 
association compare to HrdBWT at promoters. The promoter alignments of these genes that 
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were identified again revealed a poorly conserved -35 consensus sequence compared to the -
10-promoter element. Other studies use the vapB10 gene which is annotated as a possible 
antitoxin in M. tuberculosis and is highly expressed, consists of a promoter that has a ‘poor’ -
35 element and has been shown to be dependent on RbpA (Hubin et al., 2015). The rrnAP3 is 
a ribosomal RNA gene and its AP3 promoter also in M. tuberculosis consists of a ‘good’ -35 
element and is not dependent on RbpA  (Hubin et al., 2015). One study tested the dependence 
of vapB, AP3 and AP3anti-35 (-35 from vapB swapped with the AP3 -35 element) promoters on 
RbpA and CarD and found that both transcription factors together increased transcription 
activity of vapB and AP3anti-35more so than AP3 (Hubin et al., 2017). In addition to this, it does 
not necessary mean that the HrdB4xR is functional, it is possible that its ability to dock at 
promoters is unaffected, but it is unable to activate transcription.  
 
5.5.3 Identification of targets dependent on RbpA 
RbpA has been shown to bind to group I and some group II sigma factors (Hubin et al., 2015; 
Tabib-Salazar et al., 2013). In addition to this, some promoters such as the probable antitoxin 
gene, vapB10 in M. tuberculosis has been shown to be dependent on RbpA in vitro (Hubin et 
al., 2015, 2017). To date, no other targets that are dependent on RbpA in vivo have been 
identified. Therefore, an RNA-sequencing experiment was implemented by comparing RbpAWT 
to ΔrbpA (pRT802, empty plasmid). The differential gene expression between the two strains 
revealed 3562 genes that were differentially expressed, of these 1352 genes were up-
regulated and 2210 were down-regulated. However, these lists were too large to enable any 
significant analysis therefore stringent filters were applied.  
 
5.5.3.1 Up-regulation of genes in the absence of rbpA 
The RNA-seq data revealed a match to the up-regulation of 37 genes induced by cell wall 
antibiotics, of these 22 belonged to the SigE regulon (Hesketh et al., 2011).  This list of SigE 
included the already characterised HrdD and DagA (Paget et al., 1999). The promoter 
alignments of the SigE targets revealed conservation of the -35-consensus sequence (GgAAC) 
and -10 (TCtpy). The expression levels of SigE are unchanged in S401 (pRT802::rbpAWT) and 
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S401 (pRT802) therefore western blot analysis comparing the levels of SigE using cell lysate 
and pull-downs from a RbpAWT and ΔrbpA strain were used to identify the levels of SigE 
associating with RNAP. The western blot analysis confirmed that the levels of SigE remain the 
same in the cell lysate however, more SigE associates with RNAP in the ΔrbpA strain. This is 
possibly because in the absence of RbpA, HrdB forms unstable RNAP-σHrdB holoenzyme and can 
easily be disassociated, therefore the competition between σE and σHrdB increase for RNAP 
(Mauri & Klumpp, 2014). Lastly, the genes that are up-regulated in both S401 
(pRT802::rbpA3KRA) and S401 (pRT802) were analysed after applying stringent filters. This 
highlighted the up-regulation of the light-dependant operons litRQ and litAB involved in 
carotenoid biosynthesis. Additionally, the expression levels of the ECF sigma factor, litS which 
is part of the litAB operon, remained unchanged. One possible explanation is the absence of 
RbpA or RbpA that is not capable of binding to HrdB dependant promoters in the S401 
(pRT802) and S401 (pRT802::rbpA3KRA) could increase the competition between the principle 
sigma factor, HrdB with other sigma factors like LitS. Thus resulting in more LitS binding with 
RNAP and activation of the crt biosynthetic gene cluster. To confirm this, western blot analysis 
would be required using the same basis as the SigE detection but using a specific LitS derived 
antibody. 
 
5.5.4 Future work 
To establish a growth phenotype of the M85 mutants, firstly growth curves using optical 
density are required. Next EMSA or BACTH assays could be used to establish binding between 
the RbpA M85 residue and the corresponding residue in σ. During the construction of the M85 
mutants, we also aimed to explore the importance of the RbpA N-terminus. Scanning alanine 
mutagenesis had identified that the L6 residue in the N-terminus was well-conserved and thus 
an RbpAL6A allele was created. This mutant did show a dominant phenotype, despite this the 
results were not conclusive. Therefore, as future directions, both the C and N-terminus require 
further exploration to understand the alternative function of RbpA. 
To identify the transcriptional changes that occur in response to ACT production of S401 
(pRT802::rbpAWT) and S401 (pRT802) we will need to re-culture the strains for 72-150 h to 
allow production of ACT and then to extract the RNA to perform qRT-PCR for ACT associated 
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genes. Lastly, all of the targets discussed in this chapter will require validation using techniques 




























Results chapter IV: Investigating the 
relationship between S. coelicolor 










6.1.0  Overview 
Previous multi-round in vitro transcription assays tested transcription at three ribosomal RNA 
promoters, P2, P3 and P4. Promoter P2 was constitutively expressed, whilst no transcription 
was observed at the P3 and P4 in the absence of RbpA and/or CarD suggesting that the 
transcription factors might have overlapping function (L. Humphrey and M. Paget, personal 
communication). Indeed, this might explain why mutation of key residues that contact DNA in 
both proteins do not lead to null mutation phenotypes; for example, a CarD W86A mutation, 
which should be affected in DNA binding, might be masked by the presence of RbpA that also 
stabilises open complexes.  Consistent with this, a ChIP-Seq experiment revealed co-
localisation of RbpA and CarD at all  HrdB-dependent promoters (Laurence Humphrey and M. 
Paget, personal communication) and a recent structural model has suggested that RbpA and 
CarD are able to simultaneously contact DNA upstream of the -10 promoter region from 
opposite directions (Hubin et al., 2017a). Therefore, this chapter set out to identify the possible 
overlapping role between the two RNA polymerase binding proteins in vivo, by developing a 
strain in which both proteins are co-depleted. 
 
6.1.1.0  Generation of stable RbpA-DAS and CarD-DAS strains 
RbpA and CarD are both essential proteins and therefore it is not possible to make stable 
deletions. Conditional mutants were generated for both transcriptional regulators, by placing 
wild-type alleles under the control of a thiostrepton-inducible promoter, while deleting the 
gene at the native locus. In theory, depletion of each protein could be enacted by removal of 
the inducer. However, potential differences in stability would result in differences in the rate 
of depletion which would complicate the experiment. It was therefore decided to co-ordinately 
deplete the proteins using the same method of directed proteolysis, by tagging each gene at 
the native chromosomal locus with a proteolytic “DAS” tag (Figure 6.2). This system of 
proteolytic degradation has already been used in several organisms such as Bacillus (Griffith & 
Grossman, 2008), E. coli (McGinness et al., 2006), M. tuberculosis (Kim et al., 2011) and has 
been modified for S. coelicolor (L. Humphrey and M. Paget, personal communication). The 
“DAS+4” proteolysis system has been developed from a natural proteolytic mechanism. There 
are several proteolysis pathways, each playing key roles in natural protein turnover. A 
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widespread system is the ClpXP protease system, which is involved in the degradation of 
misfolded proteins and the regulation of proteins responding to stresses (Gottesman et al., 
1998). ClpX is a hexameric AAA+ ATPase which recognises and unfolds proteins for degradation 
(Wawrzynow et al., 1995), delivering them for degradation by ClpP, a serine peptidase (Flynn 
et al., 2003). Collectively, different AAA+ ATPases recognise short peptide sequences so the 
specificity of the degradation event can be increased by using an N-terminal or C- terminal tag; 
C-terminal tags are favourable as they reduce interference of the protein function (Sauer et 
al., 2004).  One such C-terminal tag is the 11-residue peptide ssrA-tag (AANDENYALAA), which 
is co-translationally added to peptide chains by a transfer-messenger RNA (tmRNA), when 
ribosomes stall at, for example, truncated 3’ mRNA ends (Keiler et al., 1996). An adaptor 
protein SspB, helps to deliver the substrate to ClpXP by binding to the N-terminal sequence of 
the SsrA tag, while ClpX recognises the three C-terminus residues (Flynn et al., 2001). In theory, 
regulation of sspB could therefore determine the rate of degradation - however, in E. coli, 
ClpXP can degrade an SsrA-tagged protein in the absence of SspB (Kim et al., 2011; McGinness 
et al., 2006). To address this, and develop a controllable system, the SsrA-tag was changed to 
AANDENYSENYADAS (named DAS+4), which renders the tagged protein completely dependent 
on SspB for degradation (McGinness et al., 2006). SspB does not occur in Actinobacteria but 
has been shown to work in Streptomyces, where it was placed under the control of the 
thiostrepton-inducible tipA promoter (L. Humphrey and M. Paget, personal communication).  
Two stage PCR was implemented to introduce the proteolytic DAS+4 tag, AANDENYSENYADAS,  
at the C-terminus of rbpA and carD, immediately upstream from the stop codons of each. The 
first stage amplifies two 1,180 bp flanks, the oligonucleotides that provide coverage over the 
DAS+4 tag overlap by 22 bases (Table 2.11). The second stage uses the two PCR products from 
the first stage and two new internal oligonucleotides (one forward for the first PCR product 
and the reverse for the second PCR product) to amplify a rbpA-DAS+4 PCR product of 1,960 bp 
and carD-DAS+4 of 1,955 bp (Table 2.11). The PCR products (rbpA-DAS+4 and carD-DAS+4) 
with 500 bp upstream and downstream), was ligated into pBluescript II SK+ and were 
confirmed by sequencing.  
Traditionally, two-stage homologous recombination using non-replicating plasmids is used to 
introduce stable mutant alleles into the genome (Kieser et al., 2000). The first cross-over event 
involves integrating the mutant allele via one of the large flanking regions upstream or 
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downstream of the mutation, with a vector-borne antibiotic marker providing selection. The 
second cross-over event is identified by the loss of the resistance marker, the frequency of 
which is very low (<1%), making this a time-consuming screening method. Therefore, 
Fernandez-Martinez and Bibb (2014) developed the Meganuclease system for Actinobacteria 
to ease the isolation of stable, marker-less mutants and was slightly modified from Lu et al 
(2010). In this system, the non-replicating plasmid (pIJ2738) contains an 18 bp recognition site 
(5’-TAGGGATAACAGGGTAAT) for the Saccharomyces cerevisiae meganuclease I-SceI, which is 
a 235-amino acid monomeric endonuclease involved in mating type switching. Following the 
first cross-over event, a plasmid (pIJ2742) that expresses the meganuclease, I-SceI is 
introduced, which leads to lethal double strand breaks in the chromosome of any strain 
containing the 1st cross-over. The rbpA-DAS+4 and carD-DAS+4 alleles were isolated as 
NotI/SpeI fragments and cloned into pIJ2738 that had been digested with the same enzymes 
to give pIJ2738::rbpA-DAS+4 and pIJ2738::carD-DAS+4. The recombinant plasmids were used 
to transform E. coli ET12567/ pR9406, and then conjugated into S. coelicolor S101 (∆rbpA), 
J1915 (M145 ∆glkA, the parent of S101) and M145 (wild type; Fig. 6.1). S101 grows slowly and 
forms small colonies compared to M145, however first cross-over recombinants reverted to a 
wild-type phenotype, which confirmed that the rbpA-DAS+4 allele was functional for RbpA 
activity. After making spore stocks for these strains, pIJ2742, which expresses the I-SceI 
meganuclease, was conjugated into the first cross-over strains using thiostrepton for selection, 
and induction of the nuclease. The ex-conjugants were sub-cultured to single colonies on MS 
agar containing 15 µg/mL thiostrepton for the purification of the second cross-over 
recombinants, and then screened using colony PCR for the presence of the DAS+4 tag. The 
colony PCR primers were designed to amplify the open reading frame of rbpA and carD and 
the DAS+4 tag, recombinants were confirmed upon a small shift of 45 bp compared to rbpA 
and carD without the DAS+4 tag (Table 2.11).  Upon confirmation, these colonies were plated 
onto MS agar in the absence of selection and incubated at 37˚C for 4-5 days, to ensure the loss 
of pIJ2742, which contains the temperature-sensitive replication origin of pSG5. The potential 
marker-less stable mutants were checked for the absence of resistance genes by streaking to 
MS agar supplemented with apramycin or thiostrepton, at 30˚C for 4-5 days, followed by 
production of spore stocks.  The resulting strains were named S407 (M145 rbpADAS+4); S408 
(J1915 rbpADAS+4); S409 (M145 carDDAS+4); S410 (J1915 carDDAS+4); S411 (J1915 
rbpADAS+4/carDDAS+4). As was the case with rbpA, carDDAS+4 strain growth on solid media was 
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indistinguishable from that of the parent strain, suggesting that the tag had little if any impact 
on protein function. In order to target the DAS-tagged proteins for degradation, pIJ6902::sspB, 
whereby sspB expression is controlled by the thiostrepton-inducible tipAp promoter, was 
conjugated into each of the strains. The organisation of the engineered strains is summarised 
in Figure 6.2.  
 
 
Figure 6.1. The Meganuclease system to generate marker-less gene replacements in S. coelicolor. 
pIJ2738, which carries apramycin resistance, the Sce-I recognition site and the rbpADAS+4 or 
carDDAS+4 alleles flanked by 500 bp DNA, was conjugated into S. coelicolor J1915, M145 or S101.  
Single exconjugants were selected for conjugation with pIJ2742 which expresses the I-SceI 
meganuclease, controlled thiostrepton-inducible tipAp promoter. An overlay 15 µg/mL 
thiostrepton was applied to the plates to select for exconjugants that had undergone the 
second cross-over event, and therefore lost the Sce-I recognition site. Colonies confirmed by 
PCR for the presence of the DAS tag were cultured at 37˚C, which causes the loss of the 
temperature-sensitive pIJ2742, and this was confirmed by testing for absence of growth on 
thiostrepton. This figure shows an example of the meganuclease system using rbpADAS, the 
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same was carried out for carDDAS. This protocol has been modified from Fernandez-Martinez 
and Bibb (2014). 
Figure 6.2. Summary of the DAS+4 depletion system. The example given is S403 in which both 
rbpA-DAS+4 and carD-DAS+4 alleles are present, each at the native locus. The strain also 
contains a stable rbpB deletion and pIJ6902::sspB integrated at the C31 attachment site. The 
addition of thiostrepton activates tipAp causing expression of sspB. The adapter protein 





6.1.2.0 Validation of sspB-dependent depletion 
The DAS dependant depletion of RbpA and CarD on a protein level was first validated by 
inserting a FLAG tag at the 3’ end of the RbpA and CarD ORFs, but upstream of the DAS tag, 
using western blot analysis.  
 
6.1.2.1 Construction of the FLAG-DAS+4- tag strains 
To mimic the previously constructed DAS-tagged strains, an in-frame 3XFLAG tag was 
introduced immediately upstream of the C-terminal DAS+4 tags in rbpA and carD. Inverse PCR 
mutagenesis was performed using pIJ2738::rbpA-DAS+4 and pIJ2738::carD-DAS+4 as 
templates and oligonucleotides that introduced the 3xFLAG sequence, DIDYKDDDDKGS,  into 
rbpA (R/C_FLAGDASinvFand RbpAFLAGDASinvR; Table 2.12) and carD (R/C_FLAGDASincF and 
CarDFLAGDASinvR; Table 2.12). Following sequence confirmation, rbpA-FLAG-DAS+4 and carD-
FLAG-DAS+4 were cloned as SpeI/NotI fragments into pRT802, which was transformed into E. 
coli ETR and conjugated into S. coelicolor J1915 (pIJ6902) and J1915 (pIJ6902::sspB). To test for 
SspB-dependent proteolysis, spores were cultured to 0D450 0.8, a time point 0 min sample 
taken, and then thiostrepton (15 μg/mL, final concentration) was added to the cultures, before 
samples for soluble extract preparations were taken over a time course.  Initially time points 
0, 3, 6 and 22 h were used, but no protein was detected after 0 h. A shorter time-course of 0, 
15, 30, 60 and 120 min was repeated and revealed that protein depletion was only detected 
at the last time point. Therefore, samples were taken at 0, 1, 2, 4 and 6 h after thiostrepton 
treatment and RbpAFLG-DAS+4 and CarDFLG-DAS+4 levels were quantified at each time point (Fig. 6.3 
and 6.4).  Both engineered constructs demonstrate clear depletion of DAS-tagged RbpA and 
CarD upon addition of thiostrepton, whereas no depletion was observed in the absence of 
thiostrepton, implying that degradation is mediated by SspB. It appears however that depletion 
takes upwards of 4-6 h, which has important implications for studying the effects of RbpA/CarD 
depletion on the transcriptome. In the J1915 (pIJ6902::sspB, pRT802::carD-FLAG-DAS) strain 
low levels of CarD were detected even at time 0 min compared to the control, although this 
appeared to decrease upon thiostrepton addition. These data suggest that relatively weak 






Figure 6.3. sspB-mediated depletion of RbpA in S. coelicolor J1915 (pIJ6902::sspB, pRT802::rbpA-
FLAG-DAS+4). Two cultures of the strain were grown to OD450 0.8, and 15 µg/mL thiostrepton 
was added to one flask but not the other. 5 mL samples at 0, 1, 2, 4, and 6 h were harvested 
by centrifugation and soluble cell lysates prepared by sonication and centrifugation (Methods, 
2.5.3). Extracts were normalised using a Qubit HS protein assay before separation on a 10% 
SDS-PAG gel, followed by western blotting. The protein was detected using an anti-FLAG 
antibody (Sigma). The data are compiled from three biological replicates and represents fold-








Figure 6.4. sspB-mediated depletion of CarD in S. coelicolor J1915 (pIJ6902::sspB, pRT802::carD-
FLAG-DAS+4). J1915 (pIJ6902::sspB, pRT802::carD-FLAG-DAS+4) was cultured to OD450 0.8 in 
the presence/absence of 15 μg/mL thiostrepton. 5 mL samples at the time points 0, 1, 2, 4 and 
6 h harvested by centrifugation and the cell lysate was normalised using the Qubit HS protein 
assay before running on a 10% SDS-PAGE, followed by western blotting. This data is compiled 
from three biological replicates and the data represents fold change with respect to J1915 
(pIJ6902::sspB, pRT802::carD-FLAG-DAS+4) in the absence of thiostrepton at time point 0 min. 
 
6.1.1.1 Depletion of RbpA-DAS+4 and CarD-DAS+4 in a sspB-dependant 
manner 
Initial studies were carried out with DAS+4-tagged strains constructed in the J1915 background 
in which rbpB is present. Strains S408 (rbpADAS+4), S410 (carDDAS+4), S411 (rbpADAS+4 /carDDAS+4) 
and J1915, each additionally contained pIJ6902::sspB,  and were cultured on MS agar 
containing 0-15 μg/mL thiostrepton at 30°C for 3-4 days  to investigate dose responsiveness of 
sspB-dependant depletion (Fig. 6.5). In the case of S408 and S411(pIJ6902::sspB), thiostrepton 
inhibited growth significantly compared to J1915 (pIJ6902::sspB) suggesting that RbpADAS+4 was 
effectively depleted. However, for S410 (pIJ6902::sspB), inhibition of growth was only slightly 
greater than that of the control, suggesting either that CarDDAS+4 was not depleted, or that the 
CarD depletion did not have significant effect on growth. As expected, the growth of S411 
(pIJ6902::sspB), in which both rbpA and carD are DAS-tagged was inhibited by thiostrepton, 
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but no more so than S408 in which only RbpA is tagged. Therefore, there did not appear to be 
a cumulative effect of RbpADAS+4 and CarDDAS+4 co-depletion on growth. However, the data also 
raised the possibility that CarDDAS+4 depletion was not as effective as that of RbpADAS+4.   
 
 
Figure 6.5. The effects of sspB-dependent depletion of rbpA and carD on growth. The dose sspB 
dependent depletion of S408 (rbpA-DAS+4), S410 (carD-DAS+4) and S411 (rbpA-DAS+4/carD-
DAS+4) with each additionally containing pIJ6902::sspB. sspB is induced using 0-15 μg/mL 
thiostrepton which activates the tipA promoter sspB. The control does not contain any DAS+4 




6.1.2.2 The growth phenotype of the DAS+4 depletion strains are further 
amplified with ΔrbpB 
SspB-mediated depletion of RbpA did not completely inhibit growth, which is probably 
explained by the presence of rbpB. As described earlier, rbpB has an overlapping function with 
rbpA and together they confer an essential role in S. coelicolor. Therefore, to completely 
deplete RbpA/RbpB activity, DAS-tagged strains were re-constructed in a ΔrbpB derivative of 
S. coelicolor J1915, S406 (A. Tabib-Salazar and M. Paget, personal communication). The gene 
replacement plasmids pIJ2738::rbpA-DAS+4 and pIJ2738::carD-DAS+4 were introduced into 
S406 and the second cross-over recombination events again forced using pIJ2742, as described 
above and the new strains designated S414 (J1915 ΔrbpB rbpA-DAS+4, pIJ6902::sspB), S415 
(J1915 ΔrbpB carD-DAS+4, pIJ6902::sspB) and S416 (J1915 ΔrbpB rbpA-DAS+4/carD-DAS+4, 
pIJ6902::sspB) were introduced with pIJ690::sspB. The ΔrbpB DAS strains showed reduced 
growth compared to the presence of a wild-type rbpB (Fig 6.6A and 6.6B). The growth was 
almost completely redundant in the S414 (ΔrbpB rbpA-DAS+4, pIJ6902::sspB) and S416 (ΔrbpB 
rbpA-DAS+4/carD-DAS+4, pIJ6902::sspB) strains whilst a small difference in growth was shown 
for S415 (ΔrbpB carD-DAS+4, pIJ6902::sspB) strain when comparing to the respective wild-type 
rbpB strains. The control strain J1915 (pIJ6902::sspB) demonstrated a small reduction in colony 
size and growth which suggested that sspB or the inducer thiostrepton have non-specific action 
to some extent. These same strains in the ΔrbpB genetic background were plated onto MS agar 
containing 0 µg/mL, 5 µg/mL, 10 µg/mL and 15 µg/mL (Fig. 6.7). The biggest difference in 
growth exists between 0 µg/mL and 15 µg/mL. The depletion of RbpADAS+4 alone produces ACT 
whilst the co-depletion of RbpADAS+4/CarDDAS+4 produces noticeably more ACT but the 
depletion of CarD DAS+4 is slow and has little effect between 5-15 µg/mL. These data eluded to 







Figure 6.6. The effect of deletion of rbpB from the DAS+4 tagged rbpA and carD. (A) left: without 
thiostrepton induction of sspB, plated J1915 (pIJ6902:sspB) control, S411 (rbpA-DAS+4/carD-
DAS+4, pIJ6902::sspB), S412 (rbpA-DAS+4, pIJ6902::sspB) and S413 (carD-DAS+4, 
pIJ6902::sspB) . Right: the same strains as the left plate, with 20 µg/mL thiostrepton. (B) left: 
without thiostrepton induction of sspB, plated J1915 (pIJ6902::sspB), S416 (ΔrbpB rbpA-
DAS+4/carD-DAS+4, pIJ6902::sspB), S406 (ΔrbpB rbpA-DAS+4, pIJ6902::sspB)  and S406 (ΔrbpB 
carD-DAS+4, pIJ6902::sspB). Right: the same strains as the left plate, with 20 µg/mL 




Figure 6.7. The effects of sspB-dependent depletion of rbpA and carD on growth in a ΔrbpB null 
background. The dose sspB-dependent depletion of S414 ΔrbpB (rbpA-DAS+4), S415 ΔrbpB 
(carD-DAS+4) and S416 ΔrbpB (rbpA-DAS+4/carD-DAS+4) with each additionally containing 
pIJ6902::sspB. sspB is induced using 0-15 μg/mL thiostrepton which activates the tipA 
promoter sspB. The control does not contain any DAS+4 tagged proteins.  
 
6.1.2.3 Depletion of the DAS tagged proteins in liquid culture 
The initial studies of the sspB-dependent depletion of RbpA and CarD on solid MS agar 
confirmed a growth phenotype. This growth phenotype was further investigated by generating 
growth curves from liquid culture of the J1915 ΔrbpB (pIJ6902::sspB) DAS+4 strains. Each strain 
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was cultured in 2 flasks, 15 μg/mL thiostrepton was added to flask one at OD450 0.8 whilst no 
thiostrepton was added to flask two and this was repeated to obtain results for 3 biological 
replicates. Samples were taken at regular intervals up to 64 h and the optical density was 
measured (Fig. 6.8). The S414 (ΔrbpB rbpA-DAS+4, pIJ6902::sspB) and S416 (ΔrbpB rbpA-
DAS+4/carD-DAS+4, pIJ6902::sspB)  strains demonstrated a clear difference between the -/+ 
thiostrepton conditions. This confirmed that sspB is activated at the tipA promoter in the 
presence of thiostrepton, both RbpA and CarD are essential for growth, depletion of both 
reduces the growth rate of S. coelicolor. The difference is not completely clear for the S415 
(ΔrbpB carD-DAS+4, pIJ6902::sspB). The results of the liquid culture growth curves do confirm 
the western blot analysis of the sspB time dependant depletion of the DAS+4 tagged proteins. 
However, the error bars are large, it has been difficult to replicate the same conditions for each 
flask, this is because of Streptomyces’ ability to produce mycelium which clump differentially 
and attempts to reduce the effect of clumping by placing a sterile spring into the flasks and 










Figure 6.8. sspB-dependant depletion of RbpA and CarD in liquid media. Spore stocks for the 
S414 (ΔrbpB rbpA-DAS+4, pIJ6902::sspB; top), S415  (ΔrbpB carD-DAS+4, pIJ6902::sspB; 
middle), S416  (ΔrbpB rbpA-DAS+4/carD-DAS+4, pIJ6902::sspB; bottom) strains were 
normalised and pre-germinated for 3 h before culturing for up to 64 h in YEME supplemented 
with glycerol. For each strain, sspB was induced with 15 µg/mL thiostrepton in the first flask 
(blue) at OD450 0.8 whilst the second flask contains no thiostrepton (red). J1915 
(pIJ6902::sspB) serves as a control (green). The data is compiled from three biological 
replicates.   
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6.2.0 Testing for the relationship between rbpA and carD 
The CarDW86A mutant has been extensively researched in Mycobacteria, however relatively 
little is known about the CarDW85A function in S. coelicolor. The W85A residue lies within the 
CarD C-terminal domain and appears close to the DNA minor groove at around -12 bp 
promoter region (Srivastava et al., 2013).  In vitro studies demonstrated that the alanine 
substitution of W85, was unable to activate transcription (Srivastava et al., 2013). 
Contrastingly, CarDW85A was shown to bind to DNA, and associate with RNA polymerase 
however demonstrated a reduced growth rate in liquid media and reduced pigmentation on 
solid media in M. smegmatis (Garner et al., 2014). The true function of the tryptophan residue 
in CarD therefore remains unclear. The rbpA BL, DNA-binding determinant has been 
extensively described in results chapter I. RbpA and CarD have very well conserved DNA-
binding regions which may be important for binding at the same DNA promoters, therefore 
the co-depletion strain S416 (ΔrbpB rbpA-DAS+4/carD-DAS+4 (pIJ6902::sspB) was 
implemented in this study to investigate the growth phenotype of various combinations of the 
RbpA and CarD DNA-binding mutant alleles.  
 
6.2.1 Construction of the RbpA BL and CarDW85A integrative plasmids 
The DAS+4 strains already have integration of the pIJ6902::sspB at the phiC31 site, therefore 
mutant alleles were cloned into pRT802 which integrates at the phiBT1 attp site. Gibson 
assembly was used to insert rbpA with 100 bp upstream and downstream DNA using primers, 
1-pRT802:rbpA F and 2-carD-rbpA R (Table 2.13) and carD with 150 bp upstream and 100 bp 
downstream DNA into SpeI digested pRT802 using primers 3-rbpA-carD F and 4-carD-pRT802 
R (Table 2.13).  
The primers designed for this amplification, were used to engineer the following plasmids: 
1) pRT802::rbpAWTcarDWT  
2) pRT802::rbpAR80AcarDWT 
3) pRT802::rbpA3KA carDWT 
4) pRT802::rbpAWT carDW85A 
5) pRT802::rbpAR80A carDW85A 
6) pRT802::rbpA3KA carDW85A 
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7) pRT802  
The constructs were confirmed with sequencing and transformed into E. coli ETR and 
conjugated into S416 (ΔrbpB rbpA-DAS+4/carD-DAS+4 (pIJ6902::sspB), Figure 6.10 summarizes 
the engineered elements of this strain. To test the phenotypes of the engineered constructs, 
spores were plated in the absence/presence of 15 µg/mL thiostrepton on MS agar (Fig. 6.11).  
 
Figure 6.10. The engineered elements of the rbpA-DAS+4 and carD-DAS+4 strains with pRT802. 
Constructs are engineered with ΔrbpB, rbpA-DAS+4/carD-DAS+4 with integration of 
pIJ6902::sspB (orange) at phiC31 site, sspB is under the control of a tipA promoter induced by 
thiostrepton. The Gibson assembled rbpA and carD mutant alleles with native promoters are 
ligated to pRT802 (red) and are integrated at the phiBT1 attp site. The pRT802 constructs are: 
pRT802::rbpAWTcarDWT, pRT802::rbpAR80AcarDWT, pRT802::rbpA3KA carDWT, pRT802::rbpAWT 




Figure 6.11. Phenotype of RbpA BL and CarDW85A mutant alleles in the sspB-dependent co-
depletion of rbpA/carD strain. The engineered constructs have been conjugated into S416 
ΔrbpB rbpA-DAS+4/carD-DAS+4 via the attp integration site. Spore stocks for each of these 
constructs are plated onto MS agar in the presence/absence of 15 μg/mL thiostrepton. 
pRT802::rbpAWT/carDWT, pRT802, pRT802::rbpA3KRA/carDWT, pRT802::rbpAR80A/carDWT, and 
pRT802::rbpA3KA/carDWT in the (A) absence and (C) presence of 15 μg/mL thiostrepton. 
pRT802::rbpAWT/carDW85A, pRT802, pRT802::rbpA3KRA/carDW85A, pRT802::rbpAR80A/carDW85A, 
pRT802::rbpA3KA/carDW85A in the (B) absence and (C) presence of 15 μg/mL thiostrepton. 
 
S416 pRT802::rbpAWT/carDWT and S416 pRT802::rbpAWT/carDW85A appear to grow similarly 
which means that the loss of tryptophan 85 in CarD alone does not affect the growth 
phenotype. The growth phenotype for S416 (pRT802::rbpA3KRA/carDWT) was significant, 
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compared to S416 (pRT802::rbpAWT/carDW85A), suggesting an important role for RbpA DNA 
binding region compared to the DNA binding tryptophan of CarD. The growth phenotype is 
amplified in S416 (pRT802::rbpA3KRA/carDW85A) compared to S416 (pRT802::rbpAWT/carDW85A) , 
indicated that both DNA binding determinants are required for growth of S. coelicolor. In 
addition to this, S416 (pRT802::rbpA3KRA/carDWT) complements, whilst  S416 
(pRT802::rbpA3KRA/carDW85A) is unable to complement supporting the idea that both DNA 
binding regions are important for growth, and that both transcriptional regulators have 
alternative roles, aside from the already elucidated role in growth. 
The phenotypes of the rbpA BL mutant alleles (Figure 6.11C) further confirms the phenotypes 
of the same mutant alleles in the conditional rbpA strain, S401 (Results chapter I). As seen 
previously, in results chapter I, the BL mutant (pRT802::rbpA3KA/carDWT) does not show a clear 
phenotype, nor does this change with the CarDW85A.  
  
6.3.0 Discussion 
6.3.1 Induced degradation of RbpADAS+4 and CarDDAS+4 
RbpA and CarD are well conserved across the Actinobacteria and appear to play individually 
essential roles in transcription initiation, despite each contacting the upstream edge of the -10 
element to stabilise transcription intermediates (Hubin et al., 2015; Srivastava et al., 2013). 
However, the finding that the essential function of RbpA is unlikely to be in contacting 
promoter DNA at this location presents a scenario where the RbpA and CarD are redundant in 
contacting -10 upstream edge, but that one or both have essential additional functions that 
cannot be compensated by the other. The aim of this chapter was to investigate redundancy 
between RbpA and CarD in interacting with the upstream edge of the -10 element by depleting 
the wild type proteins whilst expressing DNA-binding alleles of RbpA and CarD in different 
combinations.  To co-ordinately deplete wild-type versions of RbpA and CarD, both genes were 
DAS+4-tagged at their native loci. The efficiency of the DAS+4-tag system was investigated by 
monitoring levels of RbpAFLG-DAS+4 and CarDFLG-DAS+4 upon thiostrepton-induced SspB 
expression.   Depletion of RbpAFLG-DAS+4 was shown to occur within 1 h of sspB induction whilst 
the depletion of CarDFLG-DAS+4 was not so clear. Other studies have shown depletion times upon 
sspB induction of 12 h using a GFP-DAS system in M. smegmatis (Kim et al., 2011), 24 h in a 
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Rho-DAS system in M. tuberculosis (Botella et al., 2017) and 15 min in E. coli (McGinness et al., 
2006). The efficient  generation of the different DAS+4-tagged strains was enabled by the use 
of the meganuclease counterselection system (Fernández-Martínez & Bibb, 2014). Depletion 
of RbpADAS+4 in a rbpBWT background only slightly reduced growth, consistent with partial 
redundancy of RbpA and RbpB. Therefore, further experiments were conducted in a ΔrbpB 
mutant and confirmed that RbpA is essential for growth in this background. However, 
depletion of CarDDAS+4 in both rbpB+ and ΔrbpB led to only minimal inhibition of growth, which 
was surprising because previous depletion using vector-borne carDDAS+4 in a ΔcarD background 
significantly impacted growth suggesting that carD was essential (L. Humphrey, personal 
communication). Interpretation was also complicated by a slight inhibition of growth caused 
by sspB induction at the higher thiostrepton concentration in the parental strain J1915 (rbpAWT, 
carDWT) suggesting that sspB may signal other proteins for degradation non-specifically. It is 
not clear why carDDAS+4 depletion failed to prevent growth on growth solid media, although 
one possibility is that it is expressed at a higher level from its native locus, preventing SspB 
from fully depleting the protein.  Another possibility for incomplete CarDFLG-DAS+4 depletion 
could be a result of the absence of a terminator in the integrative plasmid, resulting in unstable 
mRNA (Nouaille et al., 2017). Additionally, to this, 420 bp upstream of the CarD ORF was used 
for cloning, in this study, one possibility is that CarD may contain some regulatory elements 
further upstream of the 420 bp chosen resulting in an unclear depletion. Growth in liquid 
media reflected that on solid, with the simultaneous depletion of RbpADAS+4 and CarDDAS+4 
inhibiting growth. Interestingly, however, depletion of only RbpADAS+4 had less impact on 
growth suggesting some redundancy between RbpA and CarD.  
 
6.3.2 Validation of the DAS system using integrative RbpA BL mutants  
Thus far, this study has shown the successful implementation of the sspB dependant DAS 
depletion system in RbpA and CarD. The DAS depletion system was validated by integrating 
mutants important for DNA binding in RbpA and CarD. The residues important for RbpA DNA 
binding were chosen because these had been created using an independent conditional 
system, therefore comparing the phenotypes of the same mutants in two different systems 
would help validation. The depletion of RbpA and CarD with integrated BL/CarDWT mutants 
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demonstrate the exact same phenotype as the thiostrepton inducible rbpA condition system 
in which the RbpA BL mutants were integrated (Results Chapter I).   
 
6.3.3 Investigating a possible relationship between the DNA binding regions 
in RbpA and CarD 
The CarD W85 is a well conserved residue across the Actinobacteria and has been predicted to 
interact with the open/closed promoter junction at dsDNA (-12) and ssDNA (-11). RNAP 
holoenzyme crystal structures have also eluded to RbpA BL interaction with the extended -10 
promoter element (Hubin et al., 2017a). Both RbpA and CarD contact DNA from opposing 
directions and this suggested a possible overlapping role. This section focused on 
implementing the sspB-DAS dependant system to investigate a possible relationship between 
the two DNA binding determinants in RbpA and CarD. There is a well-defined phenotype for 
RbpA3KRA/CarDWT however the phenotype for RbpA3KRA/CarDW85A a lot more striking. Whilst 
establishing a relationship between RbpA and CarD in vivo, two studies were published 
focusing on the RbpA and CarD relationship in vitro (Hubin et al., 2017a; Rammohan et al., 
2016).  The crystal structure of RbpA/RNAP-SigA complex in M. smegmatis was superimposed 
with the CarD/RPo structure in T. aquaticus, which revealed that both transcription factors 
interact with the -10 promoter element from opposite sides of the DNA (Hubin et al., 2017a). 
Abortive initiation assays investigating the transcription activation at the VapB and AP3 
promoters showed that the presence of RbpA and CarD increased transcription greater than 
RbpA and CarD alone (Hubin et al., 2017a). In addition to this, the strong -35 element of AP3 
was substituted with the weak -35 element of vapB to create AP3anti-35, transcription activation 
was increased with both RbpA and CarD present and appears to compensate for a weak -35 
element (Hubin et al., 2017a). The binding kinetics of RbpA and CarD appear to increase the 
rate and amount of RPo formation and stabilise RPo (Hubin et al., 2017a; Rammohan et al., 




























7.0 Overview  
RbpA was first discovered when it consistently co-eluted with Streptomyces RNAP during 
affinity chromatography and gel filtration (Newell et al., 2006; Paget et al., 2001). RbpA was 
shown to confer basal levels of resistance to rifampicin in the first instance, and able to activate 
transcription in vitro (Tabib-Salazar et al., 2013). The ΔrbpA mutants in S. coelicolor produced 
a small colony and slow growing phenotype but were still viable, however rbpA and rbpB 
knockouts were not viable (Aline Tabib-Salazar and Mark Paget, personal communication) and 
rbpB was found to be non-essential. This demonstrated that RbpA together with RbpB 
conferred an essential function in S. coelicolor (Newell et al., 2006), whilst it was shown that 
RbpA is essential in M. tuberculosis with no known equivalent of RbpB (Forti et al., 2011). 
Additionally, RbpA was shown to activate transcription from σHrdB-dependent promoters in S. 
coelicolor (Tabib-Salazar et al., 2013) and σA-dependant promoters in M. tuberculosis (Hu et 
al., 2012). Later on, kinetic studies proved that RbpA was responsible for stabilisation of the 
RNAP holoenzyme at the transcription initiation bubble (Bortoluzzi et al., 2013; Hubin et al., 
2017; Prusa et al., 2018; Rammohan et al., 2016). 
During the period of this study, multiple publications provided new insights that have improved 
our knowledge of the structure and function of RbpA. Firstly, the RbpA BL R79 residue and SID 
in M. tuberculosis were shown to be sufficient for transcription activation and interactions with 
promoter DNA (Hubin et al., 2015). Secondly, several solved crystal structures provided 
evidence of the close interaction of the RbpA BL to the promoter DNA upstream of the 
extended -10 promoter element (Boyaci et al., 2018; Hubin et al., 2017; Hubin et al., 2015). 
Thirdly, cryo-EM techniques revealed that the RbpA NTT was positioned to thread through the 
active cleft of RNAP, raising important questions of the interaction between rifampicin and 
RbpA (Boyaci et al., 2018). Additionally, knock-outs of RbpA NTT have demonstrated that it is 
not required for viability in M. smegmatis, but does cause transcriptional changes identified 
using RNA-seq (Hubin et al., 2017; Prusa et al., 2018).  
 
7.1  Highlights of this study 
The first aim of this study was to investigate the importance of the RbpA BL in S. coelicolor. This 
study has shown that the RbpA BL in S. coelicolor is important for growth although not essential 
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as it grows more than the empty vector control in each case. The RbpA BL is also responsible 
for producing significantly more ACT than RbpAWT. It appears that the lysine residues are not 
important alone, however may carry some overlapping function with R80. Transcriptional 
analysis of the RbpA BL mutant has demonstrated a global transcriptional change, this could 
be a direct effect or the lack of a functional RbpA could inhibit growth thereby causing an 
indirect global transcriptional down-regulation of most genes.   
Secondly, this study aimed at investigating the importance of the RbpA BL in M. tuberculosis. 
The RbpA BL mutants did not exhibit any growth-related phenotype in liquid culture, however 
a growth phenotype was clear on solid media.  We did see a difference in culturability for all of 
the RbpA BL mutants, using the MPN assay. The MPN assay paired with CFUs indicates that the 
empty vector and RbpA3KRA are able to grow in liquid to higher dilutions compared to solid 
media. This has suggested that the PI inducible system may be leaking expression of rbpA in 
the absence of the inducer suggestive or that the bacilli are entering a non-culturable state. 
The RbpA3KRA transcriptome was investigated in further detail using RNA-seq technology, this 
showed down-regulation of the devR mediated stress response. 
Thirdly, this study investigated the mechanism and biological importance of RbpA in S. 
coelicolor. The well conserved M85 residue appears to fulfil an important role in sigma binding, 
amino acid substitutions demonstrate a distinct small colony phenotype with ACT production. 
Multiple crystals structures have found that the RbpA-SID interacts with the σ2 domain of the 
group I sigma factor (Hubin et al., 2017; Hubin et al., 2015; Tabib-Salazar et al., 2013). This 
study has shown that substituting well conserved residues in σHrdB, important for RbpA binding 
to the corresponding residues of a group II does not prevent binding to σHrdB-dependent genes. 
This was the first study to show that HrdB4xR can still associate with RNAP albeit at a lower level 
than HrdBWT. This suggests that RbpA is not required for RNAP binding and promoter 
interactions in vivo. The HrdB4xR was mapped to most of the HrdBWT binding sites across the S. 
coelicolor genome but showed a reduced level of binding. Further to this, transcriptional 
analysis of a ΔrbpA null mutant strain demonstrated global transcriptional changes, a large 
proportion of this is down-regulation of growth-related pathways and induction of stress 
responses. 
Like RbpA, CarD is an essential transcription factor in M. tuberculosis, ΔcarD mutants exhibited 
a slow growth phenotype (Stallings et al., 2009b). CarD is up-regulated in response to DSBs and  
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nutrient limitation (Stallings et al., 2009b). ChIP-seq experiments showed that HrdB co-localises 
with RbpA and CarD at HrdB-dependant promoters (Laurence Humphrey, personal 
communication). This was supported by structural models at the time which superimposed 
RbpA and CarD contacting the upstream of the extended -10 promoter DNA from opposing 
directions. This preliminary evidence strongly suggested a potential relationship between the 
two essential transcription factors.  To test a possible relationship between RbpA and CarD, we 
engineered a DAS-tagged system to exploit the cells protein degradation pathway for 
controlled co-depletion of rbpA and carD. The carD depletion did not work as clearly as the 
rbpA-DAS depletion possibly because both transcription factors are involved in different steps 
in transcription.  
 
7.2 Future directions 
7.2.1 Understanding promoter structure which governs transcription 
initiation by RbpA and CarD 
The promoter sequence determines the level of expression of a gene and is recognised as a 
sequence 10-35 bases upstream of the transcriptional start point whereby RNAP docks and 
enables transcription of a gene (Newton-Foot & Pittius, 2013). Generally E. coli promoters  start 
with a purine base at position +1 whilst M. tuberculosis TSS do not favour any particular base 
at +1, possibly because of the difference in GC content (Newton-Foot & Pittius, 2013). The -35 
sequence is found to be more elusive for most promoters possibly because of the variety of 
sigma factors that can recognise a single promoter (Newton-Foot & Pittius, 2013). Additionally, 
the extended -10 promoter element (TGn) plays an important role in determining promoter 
strength in mycobacteria. Understanding the differences in promoter structures for both M. 
tuberculosis and S. coelicolor compared to E. coli could provide a better insight into the 
dependency of certain promoters on transcriptional regulators. 
Genes belonging to a ribosomal RNA operon have been previously tested by Laurence 
Humphrey (unpublished data), rrnp3 which consists of a ‘poor’ -35 and ‘good’ -10 and was 
shown to be dependent on RbpA and/or CarD, whilst rrnp2 was constitutively expressed in the 
absence of RbpA/CarD and consisted of a ‘good’ -10 and ‘good’ -35 promoter element. The p2 
‘good’ -35 was swapped with the corresponding ‘poor’ -35 from p3, this resulted in a poor level 
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of transcription activation at the p2 promoter. Additionally, a FLAG-tagged HrdB4xR mutant that 
cannot bind to RbpA has shown less binding at the promoters of genes on the periphery of the 
S. coelicolor genome compared to HrdBWT. The sequence alignments of the promoters for 
these genes, has shown conservation of the consensus -10 whilst no real consensus -35 was 
recognised. This further indicates that genes regulated by RbpA are composed of a poor -35 
consensus sequence in S. coelicolor. To follow up these experiments and to establish a link 
between the presence of a poor -35 promoter element and dependency on RbpA, in vitro 
transcription assays and S1 nuclease mapping techniques are required using the 
RbpADAS+4/CarDDAS+4 system.  
Additionally, a recent publication investigated the importance of the recognition of the 
extended -10 DNA element for transcription initiation. RbpA was shown to be dispensable for 
promoters which consist of an extended -10 promoter element (TG motif), whilst necessary 
for RPo stabilisation (Perumal et al., 2018) 
 
7.2.2 Exploiting cryptic gene cluster for antibiotic production 
Thus far, this project has shown that manipulation of the RbpA basic linker results in production 
of ACT. This could be a result of the down-regulation of growth related genes and hence RNAP 
is free to bind to other factors involved in secondary metabolite production. Several studies 
have shown RbpA closely interacts with the upstream extended -10 promoter region, -13/-14, 
(Boyaci et al., 2018; Hubin et al., 2015, 2017) so there is a potential that RbpA prevents 
antibiotic regulatory proteins binding to promoters involved in antibiotic production. The RbpA 
BL mutants could be exploited for production of antibiotic gene clusters, achieved by over-
expression of the RbpA3KRA allele which consists of a strong promoter and ribosome binding 
site. This RbpA3KRA mutant allele expression should outcompete native RbpA for σHrdB and thus 
would mimic the BL mutant phenotype. Alternatively, random mutagenesis of RbpA could help 
isolate mutants that are responsible for production of ACT.  
We have identified that RbpA and CarD co-localise at the same HrdB-dependant promoters 
(Aline Tabib-Salazar, Personal communication) during log-phase growth. To analyse these 
transcription factors during log-phase and late-stationary phase growth using ChIP-seq may 
provide an insight into binding level changes of RbpA and CarD during the switch to antibiotic 
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production in late-stationary phase. This PhD project has attempted to substitute the native 
rbpA promoter with the pstS promoter which is highly expressed under phosphate limiting 
conditions.  This ppstS-rbpA mutant however did not overproduce ACT therefore data was not 
shown in this project (Appendix 4). 
Synthetic biology for the discovery of novel antibacterial compounds is a rapidly expanding 
area. More specifically, the genomics era has allowed the utilisation of Actinobacteria for the 
activation of ‘cryptic gene clusters’ in vitro for isolation of antibacterial compounds. Most 
Actinobacteria only produce a few secondary metabolites under standard laboratory 
conditions whilst harbouring 30-40 secondary metabolite gene clusters in their genome 
(Ahmed et al., 2017). One such approach to activate these ‘cryptic gene clusters’, is the use of 
cell free in vitro transcription-translation system developed in E. coli and has since been applied 
in Actinobacteria spp (Moore et al., 2017). The advances of next generation sequencing and 
better databases for cataloguing gene clusters using for example, antiSMASH and 
CLUSTERtools helps drive advancement (Rutledge & Challis, 2015; Santos & Challis, 2017).  
Additionally, the research focus of many Actinobacteria groups has been aimed at isolating 
novel bacteria that are not culturable under standard laboratory conditions. Methods to 
alleviate this problem have been developed, for example iChIP (isolation ChIP) which enables 
in-situ isolation of non-culturable bacteria in the native environment. This approach uses a 
semi-permeable membranes to isolate the organisms and the device is placed back into the 







































Quality control results from Oxford genomics centre for the RNA-sequencing samples 
 
Agilent 4200 Tapestation quality control results for the S. coelicolor BL RNA samples from Oxford 
genomics centre. A. Gel image of the RNA profiles, lanes A1, B1 and C1 correspond to the 3 
biological replicates for RbpAWT, lanes D1-F1 correspond to the 3 biological replicates for 
pRT802, and lanes G1-A2 correspond to the 3 biological replicates of RbpA3KRA. B. RNA 
concentrations and RNA integrity number equivalent (RIN) of the RNA samples. C. RNA profile 






Purification of core RNAP: 
Optimisation of growth conditions for RNAP purification  
Several conditions have been tested initially to maximise the production of soluble core RNA 
polymerase (Fig. A1). However, attempts to purify native RNAP from S. coelicolor was 
unsuccessful, therefore recombinant RNAP in E. coli was used optimised and utilised instead. 
Firstly, Rosetta 2 (DE3) pLysS cells were transformed with pSU904E (created by Simon Hodges), 
single colonies were used to inoculate cultures overnight. The culture was diluted to 1:100 and 
grown to OD600 0.8, followed by testing multiple variables; 1 mM or 250 μM IPTG, with or 
without cold shock, 16˚C or 20˚C and 4 h or 24 h post IPTG induction. 2mL samples pre/post 
IPTG induction were collected and cells were lysed by sonication 6 times for 10 sec with 30 sec 





Figure A1. Optimisation of pSU904E recombinant core RNA polymerase in E. coli. SDS-PAGE 
analysis of soluble recombinant core RNA polymerase purification. (A) 1- PageRuler Prestained 
protein marker,  2- 4 h post 1 mM IPTG at 20 ̊C, 3- overnight post 1 mM at 20 ̊C, 4- 4 h post 1 
mM IPTG at 20 ̊C without cold shock, 5- overnight post 1 mM at 20 ̊C without cold shock, 6- 4 h 
post 250 μM IPTG at 20 ̊C, 7- overnight post 250 μM IPTG at 20 ̊C, 8- 4 h post 250 μM IPTG at 20 ̊
C without cold shock, 9- overnight post 250 μM at 20 ̊C without cold shock. (B) 1- 4 h post 1 mM 
IPTG at 16 ̊C, 2-  overnight post 1 mM at 16 ̊C, 3- 4 h post 1 mM IPTG at 16 ̊C without cold shock, 
4- overnight post 1 mM at 16 ̊C without cold shock, 5- 4 h post 250 μM IPTG at 16 ̊C, 6- overnight 
post 250 μM at 16 ̊C, 7- 4 h post 250 μM IPTG at 16 ̊C without cold shock, 8- overnight post 250 
μM at 16 ̊ C without cold shock, 9- PageRuler Prestained protein marker. (C) 1- PageRuler 
Prestained protein marker, 2- Pre-IPTG addition soluble fraction, 3- 24 h 1 mM IPTG, 4- 48 h 1 
mM IPTG, 5- 72 h 1 mM IPTG, 6- 24 h 250 μM IPTG, 7- 48 h 250 μM IPTG, 8- 72 h 250 μM IPTG.  
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The recombinant S. coelicolor RNA polymerase was overexpressed from plasmid pSU904E in E. 
coli BL21 λDE3 pRARE2. RNAP overexpression was induced by the addition of 500 μM IPTG to 
cultures at OD600 0.8 and the incubation was continued for 24 h at 20˚C without any cold shock 
prior to adding the IPTG. The cells were recovered by centrifugation and stored at -80˚C. The 
cell pellet from 500 mL cultures was re-suspended in 30 mL 20 mM Tris-HCl pH 7.9, 5 mM 
imidazole, 500 mM NaCl, 5mM β- mercaptoethanol, 1 mM fresh PMSF. The cell suspension was 
lysed by sonication 10 times with 30 sec ON and OFF at 35% and centrifuged. The cleared cell 
lysate was bound to a 5mL Nickel Sepharose HP HisTrap column (GE healthcare). The column 
was washed with 20 mM Tris-HCl pH 7.9, 5 mM imidazole, 500 mM NaCl, 5 mM β-
mercaptoethanol until no A280 was detectable, and eluted with a 40 mL gradient of 5 to 2000 
mM imidazole in 20 mM Tris-HCl pH 7.9, 500 mM NaCl, 5mM β-mercaptoethanol. The pooled 
fractions containing RNAP were dialyzed into 10 mM Tris-HCl pH 7.9; 200 mM NaCl, 0.1 mM 
EDTA, 1 mM MgCl2, 20 µM ZnCl, 10 mM DTT however RNAP had crashed out of solution and a 
precipitation was visible. The presence of EDTA and MgCl2 in the same buffer was responsible 
for the precipitation. Therefore, the purification was repeated by using a combination of 
different gel filtration buffers: 
Buffer A: 10 mM Tris-HCl pH 7.9, 500 mM NaCl, 5% glyercol, 10 mM DTT 
Buffer B: 10 mM Tris-HCl pH 7.9, 500 mM NaCl, 0.1mM EDTA, 10 mM DTT 
Buffer C: 10 mM Tris-HCl pH 7.9, 500 mM NaCl, 5% glyercol, 1mM MgCl2, 20 μM ZnCl2, 10 mM 
DTT 
Fractions were run on a 10% SDS-PAGE gel and silver stained to observe the best purification 
after size exclusion and dialysis. Buffer C provided the best purification and therefore a large 
scale purification was undertaken to purify core RNA polymerase.   
3L core Rosetta II BL21 (pSU904E) chemically competent cells were set up at 37 ˚C to OD600 0.8 
and induced with 500 μM IPTG and further cultured for 24 h at 20 ˚C. The 3L pellet was re-
suspended and sonicated to produce a cleared cell lysate which was loaded onto the 5 mL 
HisTrap Nickel column using the Akta Prime. A 2 M imidazole elution gradient was used to 
produce fractions (Fig. A2A). Fractions around 600 mM imidazole were pooled together and 
dialysed overnight using buffer C (Fig. A2B). The pooled sample was concentrated to 2 mL using 
a 15 mL Vivaspin device (10,000 MW cut off; GE Healthcare) following the manufacturer's 
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instructions. The sample was loaded onto a pre-calibrated (Fig. A2C) the size exclusion Superdex 
200 column (GE healthcare). Fractions containing RNA polymerase were pooled (Fig A2D), 
concentrated to ≥1 mg RNAP/mL, dialyzed overnight at 4 °C with storage buffer, and stored in 




Figure A2. Purification of recombinant S. coelicolor RNA polymerase.  Rosetta II BL21 chemically 
competent cells transformed with pSU904E containing the S. coelicolor recombinant core RNA 
polymerase subunits. 3L LB cultures for Rosetta II BL21 with pSU904E cultured at 37 ̊ C to OD600 
0.8 and induced with 500 μM IPTG and continued culturing at 20 ̊ C for 24 h. The cultures were 
harvested by centrifugation 4 ˚C, the cell pellet was re-suspended in 60 mL 20 mM Tris-HCl pH 
7.9, 5 mM imidazole, 500 mM NaCl, 5mM β-mercaptoethanol, 1 mM PMSF. The resuspension 
was sonicated for 10 cycles of 30 sec ON/OFF at 35% frequency. The lysate was cleared by 
centrifugation and passed through a 0.2 μM filter. The cleared lysate was loaded onto a 5 mL 
nickel HisTrap column following the manufacturer’s instructions using the Akta Prime. (A) UV 
reading from the Akta prime for the fractionated elutions using a 2 M imidazole gradient 
concentration. (B) 1- cell lysate, 2-flow through, 3-9 fractions from the HisTrap using 2 M 
imidazole gradient elution with the Akta prime. The protein fractions 3-9 were pooled together 
and dialysed with buffer C overnight. The dialysed sample was centrifuged at full speed for 10 
min at 4 ˚C before loading onto the Size exclusion Superdex 200 column. (C) UV read out of the 
size exclusion column showing three peaks. The (D) fractions corresponding to the peaks were 
run on a 10% SDS-PAGE and stained with Coomassie brilliant blue stain, 1- PageRuler Pre-
stained marker, 2-9 fractions, 10- post dialysis overnight sample before size exclusion column. 
The fractions from the size exclusion column were pooled together and concentrated using a 
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Vivaspin column to achieve 500 μL sample. The sample was dialysed overnight using the 
storage buffer, 10 mM Tris-HCl pH7.9, 500 mM NaCl, 1 mM MgCl2, 20 μM ZnCl2, 50% glycerol 
and 2 mM DTT at 4 ˚C. (E) Purified core RNA polymerase samples post dialysis and stored in 
storage buffer at -80 ˚C.  
 
Appendix 3 
Investigating the dependency of RbpA and CarD on promoters 
Previous studies, indicate that RbpA and CarD may compensate for the loss of a -35 consensus 
sequence at certain promoters (Hubin et al., 2017). Therefore, this section focused on 
investigating the in vitro transcription of RbpA and CarD at the S. coelicolor ribosomal rrnD 
operon, rrnDp2 and rrnDp3, promoters. The rrnDp2 promoter consists of a strong -10 and -35 
consensus sequences whilst the rrnDp3 consists of a strong -10 and weak -35 consensus 
sequences. The pSRE3 plasmid (created by Sven Reisloehner) is a derivative of pRT802 and 
consists of ypet (yellow protein) and kanamycin resistance marker. The pSRE3 plasmid was 
modified by Sven Reisloehner so that the ypet protein does not have a start codon or ribosome 
binding site, resulting in the inhibition of translation and production of unstable mRNA which 
was ideal for this experiment as the level of expression at the promoters was investigated using 
S1 nuclease mapping. To investigate the dependency of RbpA and CarD on rrnDp2 and rrnDp3 
and on the -35 element, promoters were designed by swapping the consensus -35 sequence 
from rrnDp2 with the poor consensus sequence of rrnDp3, this has been referred to as rrnDp2-
3 (Fig. A3). The poor -35 element from rrnDp3 was also swapped with the consensus -35 
sequence from rrnDp2, this is referred to as rrnDp3-2 (Fig. A3). The oligos were annealed 





Figure. A3 Promoters tested for dependency on RbpA and CarD. The rrnDp2 good -35 consensus 
sequence was swapped with the rrnDp3 poor -35 consensus sequence to create rrnDp2-3. The 
rrnDp3 poor -35 consensus sequence was swapped with the rrnDp2 good -35 consensus 
sequence which created rnDp3-2. The restriction sites are shown, BamHI (in italics) and HindIII 
(underlined and italics) and the TSS is shown in red. The TSS for the rrnD operon were identified 
by Baylis and Bibb (1988).  
 
All of the promoters were conjugated into the S416 (pIJ6902::sspB) strain. To optimise the S1 
nuclease mapping experiment, only the S416 (pIJ6902::sspB; pSRE3::p2-3) plasmid was 
cultured in liquid media. The cells from this strain were subjected to thiostrepton treatment 
for RbpA and CarD co-depletion, followed by RNA extractions at 0, 2, 4 and 6 h. The S1 oligo 
was designed to overlap the ypet gene with an 8 bp random sequence at the 3’ (Fig. A4B) and 
radiolabelled with 32P on the 5’ end. To perform the S1 nuclease mapping, 30 µg of RNA for 
each time point was mixed with 5-10 ng of probe, samples were run on an 8% denaturing urea 
polyacrylamide gel and visualised by phosphorimaging. Unfortunately, none of the samples 
showed a signal for any transcript in any of the wells.  The whole S1 nuclease mapping 
experiment was repeated for the S416 (pIJ6902::sspB; pSRE3::p3) and the same results were 




Figure. A4 Organisation of the S416 RbpADAS+4/CarDDAS+4 pSRE3::p2-3 (pIJ6902::sspB) strain. (A) 
The strain consists of ΔrbpB, rbpA-DAS+4/carD-DAS+4 with pIJ6902::sspB integrated at the 
phiC31 site, sspB is under the control of a thiostrepton tipA promoter. pSRE3 has integrated at 
the phiBT1 attp site and the p2-3 promoter has been inserted as a BamHI-HindIII fragment into 
pSRE3, upstream of the ypet gene and downstream of the terminator. (B) The terminator (red), 
rrnDp2-3 promoter (blue) and ypet gene (yellow). The S1 nuclease mapping oligo (grey) aligns 
from a 3’- 5’ direction with RNA in a 5’-3’ direction. The oligo consists of 8 bp random 





Figure A5. S1 nuclease mapping of the S416 (pIJ6902::sspB; pSRE3::p2-3) ± thiostrepton. No 
thiostrepton treatment was used as a control in lane 1-5. Lane 1- 0 h, Lane 2- 2 h, Lane 3- 4 h, 
Lane 4- 6 h. Samples in lanes 6-8 contain 15 µg/mL thiostrepton, Lane 5- 0 h, Lane 6- 2 h, Lane 










Manipulation of RbpA to over-produce actinorhodin 
Streptomyces has long been used to find novel compounds suitable for therapeutic purposes. 
S. coelicolor produces up to 12 useful compounds, of these is actinorhodin (ACT). ACT is 
overproduced in the RbpA3KRA mutants and therefore this section aims to identify promoters 
that are strongly expressed which could be used for the overexpression of RbpAWT and 
RbpA3KRA via a fusion of the strong promoter and translational signals to RbpA. Transcriptional 
start site data showed that psts (SCO4142) was highly expressed during transition, late 
exponential and stationary phase (Jeong et al, 2016). TSS RNA-seq data from Streptomyces 
venezualae (SVEN15_3808) showed that psts is switched on at transition phase when the cells 
are depleted of phosphate, and highly expressed throughout transition and late log phase 
(Matt Hutchings, personal communication). The sequence alignment of SVEN psts against SCO 
psts showed that the transcriptional and translational signals are highly conserved. pstS is 
switched on upon low phosphate conditions which is detected by the two component 
regulatory system phoR-phoP. PhoP recognises PHO boxes in the regulon, one of which is psts.  
The psts promoter was translationally fused to the ORF RbpA with the 3XFLAG tag using a two-
stage PCR method. Figure A6 shows the experimental set up of the two stage PCR for the fusion 
of the psts promoter to rbpA 3XFLAG tag (Table 10).  
 
Figure A6. Two stage PCR for the over-expression of RbpA. Oligos in green are for the upstream 
PCR product, oligos in magenta are for downstream PCR product and the oligos in blue amplify 
the promoter, RbpA and 3 X FLAG in a single PCR product using the upstream and downstream 
PCR products from stage 1 as the template for the second stage.  
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The first stage of the two-stage PCR involves using the oligos Psts UF and Psts UR to amplify 
the upstream Psts fragment using S. coelicolor genome DNA whilst the downstream (Psts DF 
and Psts DR) fragment was amplified using pRT802::rbpAWT3XFLAG or pRT802::rbpA3KRA3XFLAG 
as the template. The second stage of the PCR was set up using the psts upstream PCR product 
and psts downstream PCR product. The second stage of the PCR uses the oligos Psts UBamHI 
and Psts DBamHI (Table 2.14). This produced one single fragment ~620 bp which was gel 
purified. PCR products from the second stage PCR were ligated to pBluescript using the EcoRV 
restriction site, blue white screening was used to screen for recombinants and subsequent 
recombinants were confirmed with sequencing. The confirmed insert was digested with BamHI 
and ligated into the integrative vectors, pRT802 and pSET152. Recombinants were screened 
and the subsequent recombinants for pRT802 were transformed into an ETR E. coli conjugative 
strain, whilst the pSET152 were transformed into ETZ E. coli.  These were finally conjugated 
into the M145 (wild-type S. coelicolor), S101 (ΔrbpA) and S401 (J1915 ΔrbpA ΔrbpB) 
backgrounds. The samples were plated onto 0-0.5 mM phosphate concentrations which 
demonstrated no increased production of ACT in the absence of rbpA (Fig A7) nor was there 




Figure. A7 Actinorhodin over-production in an M145 and S101 Streptomyces background. The 
M145 pRT802::pstS-rbpAWT, M145 pRT802::pstS-rbpA3KRA, M145 pRT802, S101 pRT802::pstS-
rbpAWT, S101 pRT802::pstS-rbpA3KRA, S101 pRT802 were plated onto SMMS agar at 0-0.5 mM 









Figure.  A8 Actinorhodin over-production in the S401 genetic background. S401 (pRT802), S401 
(pRT802::pstS-rbpAWT) and S401 (pRT802::pstS-rbpA3KRA) were plated onto SMMS in the 
absence of thiostrepton and phosphate concentrations 0-0.5 mM. The plates were cultured at 
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